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ABSTRACT 
Throughout history, especially beginning in the mid-twentieth century, humans 
have adapted numerous specialized metabolites produced by microbes as therapeutics. 
Since their inception, antibiotics have been a powerful tool used in science and 
medicine. We have uncovered a great deal about the cellular functions that antibiotics 
target, mechanisms of resistance, and their application in treating disease. However, 
there are still gaps in our understanding of the ecological function and roles of 
specialized metabolites. Additionally, in recent years we’ve begun to appreciate the 
importance of microbial communities in diverse environmental settings, including the 
human microbiome. The structure and maintenance microbial communities resulting 
from networks of competitive interactions and are driven by many factors including the 
production and response to antibiotics and other specialized metabolites. Currently, 
whole microbial communities are not tractable to study. To address fundamental 
questions relating to the fitness of members in a community I use a model competitive 
system with two soil bacteria: Bacillus subtilis and Streptomyces sp. Mg1 (S. Mg1).  
 
On an agar surface, colonies of B. subtilis lyse and degrade in response to S. Mg1 
cultured at a distance. In this dissertation, I determined that B. subtilis lysis is caused by 
the family of polyketides known as linearmycins. I obtained mutants of B. subtilis that 
were spontaneously resistant to linearmycins and formed biofilms. Each resistant mutant 
that I identified had a missense mutation in yfiJK, which encodes a previously 
uncharacterized two-component signaling system. In response to linearmycin exposure, I 
 iii 
 
found that the YfiJK system activates expression of the yfiLMN operon. This operon 
encodes an ATP-binding cassette transporter that is both necessary and sufficient for 
both the linearmycin resistance and biofilm formation phenotypes of the yfiJK mutants. 
Finally, I determined that linearmycin biosynthesis and expression of the linearmycin 
(lny) biosynthetic gene cluster are coordinated during S. Mg1 growth. In particular, we 
observe an increase in both linearmycins and extracellular vesicles during stationary 
phase, suggesting an autolytic origin for linearmycin-laden extracellular vesicles 
produced by S. Mg1. Together, my results demonstrate that coordinated regulation of 
developmental processes including autolysis, biofilm formation, and motility with 
specialized metabolism and antibiotic resistance promote competitive fitness of bacteria. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW
1
 
 
Summary 
 Microbial communities span many orders of magnitude ranging in scale from 
hundreds of cells on a single particle of soil to billions of cells within the lumen of the 
gastrointestinal tract. Bacterial cells in all habitats are members of densely populated 
local environments that facilitate competition between neighboring cells. Accordingly, 
bacteria require dynamic systems to respond to the competitive challenges and the 
fluctuations in environmental circumstances that tax their fitness. The assemblage of 
bacteria into communities provides an environment where competitive mechanisms are 
developed into new strategies for survival. In this chapter, we will highlight a number of 
mechanisms used by bacteria to compete between species. We focus on recent 
discoveries that illustrate the dynamic and multifaceted functions used in bacterial 
competition, and discuss how specific mechanisms provides a foundation for 
understanding bacterial community development and function. 
 
Introduction 
 Microbes compete to survive in naturally mixed communities and diverse 
environments. Microbial communities colonize niches as different as the surface of our 
                                                 
1
Adapted with permission from “Multifaceted Interfaces of Bacterial Competition” by Stubbendieck RM, 
Straight PD. Copyright ©2016 American Society for Microbiology, [J. Bacteriol. 198:2145-2155. doi: 
10.1128/JB.00275-16.] 
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teeth to the soils beneath our feet. The taxonomic diversity of organisms within these 
communities is a complex function of differing nutrients, niches, and interactions 
between species.  In general, the abiotic influences on communities are identified 
through analysis of the chemical, spatial, and other relevant parameters that define local 
environments. Abiotic factors are varied and influence microbial growth in many ways, 
but can often be manipulated in the laboratory to understand their influence on microbial 
communities. The interactions between species, on the other hand, are functions of a 
particular community and are a greater challenge to identify and resolve. Some broad 
categorization provides guidelines for outcomes expected during interaction between 
species. Specifically, when interactions occur between species and are non-neutral, they 
are at times cooperative, but this appears to be the exception to the rule (1). More 
commonly, competition between species appears to define the interactions that may 
predominate in microbial communities.  
 
Competition is categorized into two modes, exploitative and interference (2). 
Exploitative competition is passive in the sense that one organism depletes its 
surroundings of nutrients, thereby preventing competitors from gaining access to those 
resources. In contrast, interference competition invokes antagonistic factors produced to 
impede competitors (3). In microbial systems, competition is typically framed in the 
context of growth limitation or inhibition due to exploitation and interference. However, 
while species may be sensitive or resistant to growth inhibitory activities, they also may 
engage in antibiotic synthesis, motility, sporulation, predatory functions, and biofilm 
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formation in response to competition. Though not universal amongst all bacteria, these 
physiological changes represent the diversity of mechanisms to enhance the competitive 
fitness of bacterial species equipped with them. The ability of individual species to 
employ a spectrum of competitive mechanisms and responses to challenges may be 
essential to their survival in communities of diverse organisms, where competitive stress 
may take many forms. To better understand the forces that enable bacteria to thrive in 
communities, we consider numerous competitive functions that determine the relative 
fitness of different bacteria within a community. 
 
 Direct studies on natural communities such as those in soils or plant and animal 
hosts are notoriously difficult, because they are complex and variable. Also, explanting 
environmental isolates to the laboratory creates additional complications. For instance, 
many organisms do not grow under standard laboratory conditions. Recent technological 
advances such as the iChip (4) enable the growth of many previously uncultured 
bacteria, but in situ manipulation of whole bacterial communities remains challenging. A 
frequently used approach to study microbial community interactions is to culture two or 
more species together under defined conditions. By investigating simple microbial 
communities, culture-based studies can provide powerful mechanistic insights into 
competitive functions.  
 
In recent years, competition studies between bacteria have contributed to a more 
informed view of competitive mechanisms used by different species. We focus this 
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chapter on mechanisms of interference and exploitation competition between species 
involving specialized metabolites, enzymes, and functions associated with the cell 
envelope, highlighting interaction outcomes that differ from growth inhibition by 
classical antibiotics. The cell envelope forms the barrier between a bacterial cell and its 
surroundings, which include competing bacteria. We will parse different competitive 
mechanisms into those that occur across the envelope due to exchange of diffusible 
factors, and those that require contact between cell envelopes, either directly or via their 
embedded proteins.  
 
Interference and exploitation at a distance 
Specialized metabolites 
 Competition between species is often mediated through bioactive metabolites 
synthesized by competitors. Specialized metabolites (SMs) are molecules produced by 
bacteria that are not involved in primary metabolism but are involved in other biological 
processes. Many specialized metabolites were previously called “secondary” metabolites 
because their presence is dispensable under laboratory conditions and their production 
often occurs during late stages of growth (5). However, SMs may be essential for some 
bacteria to persist in the environment (6) or under competitive stress. In the context of 
competitive interactions, SMs of primary interest are those affecting the growth and 
development of competing bacteria. For instance, antibiotics provide some of the 
clearest mechanistic insights for chemical interactions between competing species of 
bacteria. However, considering their measurable biological activities at subinhibitory 
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concentrations, even the empirical roles of antibiotics in nature are subject to debate (7–
10). Overall, the biological functions of SMs are numerous and, arguably, largely 
unknown. We will focus, therefore, on several illuminating examples where bacteria use 
antibiotics and other SMs in precisely targeted mechanisms that affect competing 
organisms in ways other than inhibition of growth. The abilities of bacteria to respond 
dynamically to a range of chemical stresses may have profound effects on their fitness in 
competitive multi-species communities.  
 
Exploitation competition due to SMs 
 In some cases, clearly self-serving functions of SMs indirectly lead to 
exploitation of resources, yielding a competitive advantage. Exploitation competition 
occurs when one organism disrupts the growth of its competitors by using a shared, 
limited resource (11). Exploitation often occurs when one bacterial species alters its 
external environment through their various metabolic functions and prohibits the growth 
of other bacterial species (3). This exploitation can arise from direct consumption of 
nutrients, buildup of toxic waste products, or the activity of SMs. An example of SM-
mediated exploitation is found in siderophores, which are SMs produced for capture of 
iron (12). Iron is essential for cytochromes and iron-sulfur proteins, and competition for 
iron is driven by its availability. Siderophores are one mechanism to chelate external 
iron, which is then imported as a complex into the producer cells (13). Siderophore 
production thus increases the bioavailability of iron while simultaneously depleting the 
supply available to competitors. The significance of iron is underscored by the numerous 
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examples of siderophore-mediated competition in different environments, including 
competition for colonization of the light organ in Hawaiian bobtail squid by different 
strains of Vibrio fischeri (14) and between the human opportunistic pathogens 
Staphylococcus aureus and P. aeruginosa (15). Bacteria also acquire iron from their 
environment and engage in exploitation competition by using other iron uptake systems 
including transporters (16). However, because siderophores are extracellular SMs, they 
are also subject to piracy by other species, posing a competitive risk to the producing 
organism (e.g. 17, 18). These examples of siderophores illustrate the potential 
complexity of specialized metabolites and exploitative interactions that are probably 
pervasive in nutrient-limited environments. 
 
Interference competition due to SMs 
Antibiotic activity without antibiosis 
 The classic view of antibiotics and other SMs as weapons has guided their 
isolation and characterization since their discovery. In the process of discovery, 
antibiotic molecules are isolated from bacterial strains grown in the laboratory and tested 
for growth inhibition of target organisms (19). This approach has been effective for 
identifying the majority of antibiotics, but it has left gaps in our understanding of the 
ecological functions of these molecules. For instance, concentrations of antibiotics 
sufficient to inhibit growth may be rare in natural environments (20, 21). Do antibiotics 
at lower than inhibitory concentrations have functions relevant to competitive 
interactions? This question has inspired investigation into the effects of subinhibitory 
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concentrations of antibiotics on bacteria, where a wide range of responses has been 
observed among organisms exposed to different antibiotics. For example, subinhibitory 
concentrations of jadomycin B cause Streptomyces coelicolor to prematurely sporulate 
and produce a pigmented antibiotic prodigiosin (22), subinhibitory concentrations of 
kanamycin induce the expression of type VI secretion genes in Pseudomonas aeruginosa 
(23), and numerous other antibiotics induce global transcriptional responses (reviewed in 
depth, 24). Cellular stresses from subinhibitory antibiotic concentrations may trigger 
these responses as early warning systems of chemical warfare. Alternatively, the natural 
functions of some antibiotics and SMs may be reflected in the subinhibitory responses of 
competitors, independent of inhibitory activity (10). Clearly delineated mechanisms of 
concentration-dependent activities and responses during competition are needed to 
understand the roles of antibiotics and other SMs in community dynamics. 
 
Multifunctional metabolites 
 Bacteria produce many SMs, representing an enormous chemical diversity with 
poorly understood function (20). Although antibiotic activity is the most common 
activity ascribed to SMs, many antibiotics also have effects on bacterial competitors that 
are independent of growth inhibition (see above). There are numerous reports detailing 
the effects of SMs on the multicellular development of a bacterial species. For example, 
the soil bacterium Pseudomonas protogens produces 2,4-diacetylphloroglucinol, a SM 
with antifungal activity that is used in biocontrol (25). The cellular differentiation of B. 
subtilis is inhibited by 2,4-diacetylphloroglucinol when cultured with P. protogens (26). 
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In contrast, B. subtilis biofilm formation is stimulated by the antifungal nystatin (27) and 
by peptide antibiotics (28). Bacillaene, is a B. subtilis produced SM that was originally 
identified as an antibiotic inhibitor of protein synthesis (29). Bacillaene also interferes 
with prodigiosin production in Streptomyces coelicolor and Streptomyces lividans 
without inhibiting growth (30, 31). 
 
Another mechanism for SM interference in competitor development is to derail 
normal signaling processes. For example, some marine bacteria produce SMs that 
interfere with quorum sensing, and thus disrupt subsequent downstream processes reliant 
on communication between competitor cells (32, 33). One challenge is to understand the 
fitness benefits of such modulatory activities in competitive interactions between 
bacteria. However, in many cases the connection between SMs and the responses they 
elicit in competitors is unknown. Model systems using two or more bacteria cultured 
together have been developed to investigate how SMs and other factors influence 
competitive fitness under controlled settings. 
 
Model systems of SM-mediated competition between species 
 Multi-species model systems are advantageous because they open the door to the 
diversity of competitive functions used by a single organism, including production of 
multiple SMs and different patterns of response to competitor SMs. Soil bacteria provide 
an illustrative example of diverse competitive functions. Species of Streptomyces are 
ubiquitous in the soil and renowned for their capacity to synthesize SMs (34). 
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Streptomyces species undergo developmental phases of their lifecycle, including aerial 
growth and sporulation (35). Sporulation of some streptomycetes depends upon the 
peptide SapB that acts as a surfactant and lowers surface tension, enabling aerial hyphae 
to expand upward (36). Bacillus subtilis produces its own lipopeptide surfactant, 
surfactin. Bacillus subtilis requires surfactin for biofilm development and some types of 
motility (27, 37, 38). Intriguingly, surfactin also antagonizes aerial development of many 
Streptomyces species (39, 40). Insight into the mechanism arose from S. coelicolor, 
which when treated with surfactin was unable to process and secrete SapB to support 
aerial growth (41). When compared to antibiotics that target growth, inhibition of 
sporulation is a subtle developmental effect that presumably prevents the spread of 
Streptomyces. Although B. subtilis does not likely produce multifunctional surfactin 
explicitly for competition, the inhibition of Streptomyces development may enhance 
competitive fitness in natural environments. Indeed, some species of Streptomyces have 
acquired enzymatic resistance to surfactin, consistent with a natural competitive 
function. Using imaging mass spectrometry it was demonstrated that Streptomyces sp. 
Mg1 hydrolyzes surfactin (Figure 1A-B) (40). The enzyme, surfactin hydrolase, was 
shown to specifically inactivate surfactin and plipastatin, another lipopeptide produced 
by B. subtilis (40). Hydrolytic inactivation is a common resistance mechanism for many 
antibiotics (42). Analogously to the emergence of new β-lactamases, production of 
surfactin hydrolase and other antibiotic degrading enzymes promotes the competitive 
fitness of their bacterial producers, although with surfactin the selection is against a 
developmental process. 
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Figure 1. Mechanisms of bacterial competition 
 
(A and B) Detecting patterns of SM production and degradation through imaging mass spectrometry. (A) 
False-colored extracted ion image showing the distribution of surfactin (orange) produced by B. subtilis 
and hydrolyzed surfactin (blue) caused by hydrolysis of surfactin by surfactin hydrolase produced by 
Streptomyces sp. Mg1. (B) The extracted ion image from (A) overlaid onto a photograph of a culture of B. 
subtilis and Streptomyces sp. Mg1 to highlight the localization patterns of each SM during competition. (C 
and D) Revealing essential SM functions using predator-prey interactions. (C) Photograph of Myxococcus 
xanthus spotted onto the center of a wild-type B. subtilis NCIB3610 colony. The colony is opaque due to 
intact, viable B. subtilis. (D) A mutant B. subtilis strain deficient in bacillaene production becomes 
transparent as it is consumed by M. xanthus, which forms fruiting bodies on the lysed remains of the B. 
subtilis colony. (E and F) Structural features of a contact-mediated competitive apparatus. (E) Cryo-
electron micrographs of a T6SS apparatus inside an intact Vibrio cholerae cell. Scale Bar is 100 nm. (F) 
Comparison of flagellum (F) and T6SS sheath (S) isolated from V. chloerae. Scale bar Is 100 nm. Panels 
C and D were provided by John Kirby. Panels E and F were reproduced from (43) with permission. 
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Competitive culture models enable us to interpret the functions of SMs in new 
ways that enhance our view of competition dynamics. Several reports show that SMs 
provide defense against otherwise overwhelming forces. For instance, laboratory strains 
of B. subtilis are preyed upon by Myxococcus xanthus, but the undomesticated B. subtilis 
strain NCIB 3610 is resilient (44). Many domesticated laboratory strains of B. subtilis 
lack a gene, sfp, required for production of several SMs, including bacillaene (45, 46). 
This defect, which renders domesticated B. subtilis susceptible to M. xanthus predation, 
was subsequently shown to be specific to the loss of bacillaene production (44) (Figure 
1C-D). Indeed, exogenous application of bacillaene protected sensitive strains of B. 
subtilis and Escherichia coli from predation. Thus, under the pressure of predation, 
bacillaene is essential for defense of B. subtilis. Intriguingly this is not the only 
demonstration of a defensive role for bacillaene. Strains of B. subtilis deficient in 
bacillaene production are also hypersensitive to lysis by S. Mg1 (47). Bacillaene was 
originally discovered as an antibiotic inhibitor of protein synthesis, (29) and its function 
dispensable for growth of B. subtilis. However, competition studies expand our view of 
bacillaene to include essential defensive functions, the precise mechanisms of which are 
not known. Nevertheless, examples such as bacillaene and surfactin serve to illustrate 
that SMs provide important competitive functions for the producer organisms. 
 
As seen in examples from antibiotics to siderophores, SMs have varied and 
sometimes essential functions in competition between species. However, aside from 
antibiotics, little mechanistic detail is available for the targets and processes affected by 
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SMs (e.g. 32, 33).  The identification of chemically mediated mechanisms of 
competition will require continued exploration of competitive dynamics between 
species. An important consideration is how the SMs operate along with other entities 
that mediate interactions between competing species. 
 
Secreted enzymes 
In addition to SMs, bacteria secrete enzymes that participate in competition. 
Secreted enzymes that confer antibiotic resistance have a clear competitive benefit (40). 
Additionally, bacteria benefit by interfering with the development of their competitors, 
e.g. using enzymes to degrade signaling molecules like acyl homoserine lactones (48–
51). However, surprisingly little is known about how bacteria use secreted enzymes to 
kill or inhibit their competitors. The predatory bacteria M. xanthus is a prolific producer 
of degradative enzymes and encodes in its genome more than 300 degradative hydrolytic 
enzymes (52, 53). The functions of many of these enzymes are unknown, but 
bacteriolytic activity has been demonstrated for some (54). An example of competitive 
enzyme function is found where Staphylococcus epidermidis competes with 
Staphylococcus aureus for colonization of the human nasal cavity (55). Staphylococcus 
epidermidis secretes a serine protease, Esp, which inhibits S. aureus biofilm formation 
(56). Esp degrades S. aureus biofilms by inactivating autolysins and preventing release 
of DNA that is an essential component of the biofilm extracellular matrix (57). The 
presence of Corynebacterium spp. in the nasal cavity is often inversely correlated with 
pathogenic Streptococcus pneumoniae (58). Like S. epidermidis, Corynebacterium 
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accolens also utilizes a secreted enzyme, LipS1, to interfere with a competitor. LipS1 is 
a triacylglycerol lipase that produces oleic acid from the hydrolysis of a human-
produced triglyceride, triolein (59). Oleic acid and other free fatty acids inhibit the 
growth of S. pneumoniae (59, 60). Esp and LipS1 interfere with bacterial competitors 
but through fundamentally different mechanisms. Thus, secreted enzymes may have 
many active roles at the cell surface of competitors, although this area is in need of 
further study.  
 
Extracellular vesicles 
Extracellular vesicles are of great interest for both bacterial and eukaryotic 
interaction processes. Vesicles are capable of vectoring proteins, lipids, nucleic acids, 
and small molecules that function in competitive and signaling processes (61). Many 
bacteria produce extracellular vesicles (EVs) during normal growth. The precise 
mechanisms of EV biogenesis and cargo loading are beginning to be identified. Gram-
negative bacteria produce EVs (also called outer membrane vesicles) when the outer 
membrane is “pinched,” and the vesicle buds from the cell surface (62). A second 
vesicle-release mechanism is reported to occur within biofilms of P. aeruginosa (63). In 
this system, prophage-encoded endolysins activate cellular lysis, releasing membrane 
fragments that form vesicles and permeate the extracellular space. The problem for 
Gram-positive bacteria is more complicated due to the lack of an outer membrane, and 
the mechanism of EV generation is currently unknown, although several models have 
been hypothesized (64). After formation, EVs are released into the environment. When 
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an EV encounters a Gram-negative cell the vesicular membrane and the outer membrane 
fuse, which delivers the cargo into the recipient’s periplasm (65). Extracellular vesicles 
have been observed to adsorb to the cell wall of Gram-positive bacteria, thereby 
delivering their contents to target cells (65). 
 
Extracellular vesicles are used by bacteria for diverse processes including biofilm 
formation (66), carbon storage (67), virulence (68), and quorum sensing (69). Bacteria 
also use EVs for defensive measures against several types of antimicrobial insult. For 
instance, the EVs of Prochlorococcus adsorb phages (67), and EVs from P. aeruginosa 
and Staphylococcus aureus protect β-lactamases from proteolytic degradation (70, 71). 
Though EVs are often characterized for their defensive functions (72), bacteria also use 
vesicles to deliver antagonistic agents to competing bacteria. These agents can be 
enzymes, such as the peptidoglycan-degrading hydrolases produced by P. aeruginosa 
(65) and Lysobacter sp. XL1 (73), or antibiotic SMs like actinorhodin or prodigiosins 
found in the EVs produced by S. coelicolor (74) and S. lividans (75), respectively.  
 
The EVs of M. xanthus are of tour de force in regards to their competitive 
potential. The EVs produced by M. xanthus not only contain 29 predicted hydrolytic 
enzymes (11 of which were not found in the outer membrane) but also 16 specialized 
metabolites including the myxalamids, which are known antibiotics, and DKxanthene 
534 (76). DKxanthene 534 and myxalamids are polyketide and hybrid polyketide-
peptide molecules, respectively, both having non-polar hydrocarbon regions. Consistent 
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with membrane localization, both molecules are typically extracted from cell pellets and 
have low abundance in supernatants (77, 78). These characteristics highlight an 
important function of EVs to facilitate transfer of hydrophobic molecules, including 
antibiotics, across aqueous environments (69).  
 
Extracellular vesicles also intersect with SMs in intriguing patterns that may 
affect competition between bacteria. Recently, it was shown that B. subtilis disrupts its 
own EVs by secreting surfactin (79). The targeted lysis of EVs by surfactin may serve as 
a defensive mechanism against antibiotic-laden vesicles produced by competing 
organisms or as an offensive tool to prevent non-polar signaling molecules, including 
quorum sensors, from reaching their intended targets. Extending on overlapping 
functions, bacteria reportedly become reversibly resistant to antibiotics when they swarm 
(80). In B. subtilis, swarming motility requires surfactin (81, 82). As an intriguing 
hypothesis for niche exploration, B. subtilis might produce surfactin not only to promote 
its movement over surfaces but also as a defense mechanism against EVs produced by 
other organisms. 
 
Contact-mediated competition 
Different species of bacteria physically interact at high cell densities in ways that 
promote information exchange, such as plasmid conjugation, or through competitive 
interaction mechanisms. Some competitive functions appear to have evolved to function 
specifically in close proximity. In particular, bacteria use membrane and cell envelope 
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embedded functions that are outwardly directed toward competitors. Such mechanisms 
are likely to be important for survival under crowded conditions through both their 
inhibitory functions and their contributions to community structure. 
 
Contact-dependent inhibition 
As a specific mechanism of interference competition, contact-dependent 
inhibition (CDI) describes a membrane protein that operates as a delivery system for a 
cellular toxin. The prototypical CDI system was first described in uropathogenic E. coli 
EC93 and consists of three components: CdiA, CdiB, and CdiI (83). CdiA and CdiB are 
homologous to the two-partner secretion system proteins TpsA and TpsB, respectively. 
In two-partner secretion systems, the secreted substrate TpsA is translocated across the 
outer membrane through its cognate beta-barrel protein TpsB (84). Likewise, in CDI 
systems the toxin CdiA is attached to CdiB, which is an outer membrane beta-barrel 
protein that extends away from the cell. This arrangement leads to CDI being referred to 
as a “toxin on a stick” (85). CdiI provides the producing cell with immunity towards its 
own toxin by specifically binding to CdiA and inhibiting its activity (86). When a CDI-
producing cell (CDI
+
) makes direct contact with a susceptible target cell, its CdiA toxin 
interacts with the outer membrane protein BamA (87). The CdiA protein is then 
deposited onto the target cell surface and undergoes self-cleavage, which transports the 
carboxy-terminal (CT) portion of CdiA into the periplasm (88). Many CdiA toxins are 
nucleases and require entry into the cytoplasm to exert their effects (86). Translocation 
of the toxin into cytoplasm requires the proton motive force (89) and interaction with 
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toxin-specific inner membrane protein receptors (90). The requirement for a membrane 
receptor protein on target cells limits CDI to a narrower range of specificity when 
compared to diffusible agents like antibiotics. This specificity is due to variability in 
extracellular loops 6 and 7 of BamA, which form the CdiA-CT-binding site (91). Due to 
the narrower target range, it has been speculated that CDI systems are a means to inhibit 
closely related species. This would allow CDI
+
 bacteria to inhibit other bacteria that are 
more likely in direct competition for the same or very similar ecological niches (85).  
 
Biofilms are community structures that form as a result of the concerted effort 
between many cells. The conditions within a biofilm are inherently stressful to cells. 
Resources including nutrients, oxygen, and physical space are limiting (92). These 
conditions breed competition between cells within the biofilm and provide strong 
selection for competition. For example, growth within a biofilm selects for bacteria that 
engage in exploitation competition by preferentially occupying biofilm surfaces and 
gaining access to oxygen (93). Biofilm growth has also selected for cells that are able to 
engage in inference competition with their neighbors. Burkholderia thailandensis 
illustrates the utility of CDI functions for promoting competitive success in a biofilm. 
Disruption of the CDI system (CDI
-
) of B. thailandensis both sensitizes cells to CDI 
from isogenic siblings and abolishes biofilm formation (94). Both functions are tied to 
BcpA (homologous to CdiA), but the biofilm functions are independent of CDI activity 
(95).  These observations suggest that CDI systems help to ensure a competitive 
advantage by supporting biofilm formation while excluding competitors. CDI-dependent 
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cell adhesion and defects in biofilm production for CDI
-
 strains have also been reported 
in E. coli (96) and P. aeruginosa (97), further solidifying the link between CDI and 
biofilm development.  
 
Aside from the costs of biofilm formation and the cellular challenges within a 
biofilm, these structures serve to protect bacteria from various external stresses (98, 99). 
For instance, bacteria have evolved mechanisms, including CDI, to competitively 
exclude non-sibling cells from biofilms (100). Developing biofilms contain three-
dimensional structures called “pillars” for B. thailandensis (101). These structures 
extend outwards from the biofilm attachment site, providing cells within the pillars 
better access to oxygen and nutrients than the cells in the biofilm substratum (92). The 
CDI system of B. thailandensis excludes CDI-sensitive cells from developing pillars 
(101). Cells that produce the same CDI system, presumably siblings, are not killed by 
CDI due to their cognate immunity genes. This selective killing by CDI provides a kin 
discrimination mechanism for B. thailandensis biofilms and likely protects the biofilm 
from invaders. Taken together, the CDI functions of B. thailandensis demonstrate 
important competitive advantages that arise in close cellular proximity through direct 
inhibition of competitors and through construction of defensive biofilm structures. 
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Type VI secretion systems 
The type VI secretion system (T6SS) was originally identified as a virulence 
factor produced by V. cholerae against amoebae and macrophages (102). Subsequently, 
genes encoding T6SS were found in roughly one-quarter of Proteobacteria with 
sequenced genomes (103) including, but not limited to, opportunistic pathogens such as 
Acinetobacter baumannii (104) and Serratia marcescens (105). The observation that 
many of the identified T6SS had no apparent effect on eukaryotic cells and that T6SS 
gene clusters occurred in non-pathogenic bacteria prompted investigation into potential 
antibacterial activities (105, 106).  
 
The T6SS of Gram-negative bacteria have emerged as a powerful weapon in 
close-quarters interference competition between bacteria. The basic mechanism of 
function for T6SS is to inject toxic effector molecules directly into the cytoplasm of 
target cells. Structurally and functionally the T6SS apparatus is homologous to 
bacteriophage contractile tails (107). The T6SS apparatus is a cylindrical spiked-tipped 
inner tube that is surrounded by a sheath and anchored to the inner membrane (Figure 
1E-F). When the cell is in physical contact with its target, the sheath contracts, and the 
inner tube is propelled outward and punctures the membrane of a target cell using its 
spiked tip. Within the target cell the spike disassociates from the tube and the toxic 
effectors are delivered. Common effectors characterized thus far include phospholipases 
(108–110), peptidoglycan hydrolases (111–113), and nucleases (114, 115).  
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 In addition to T6SS being an effective delivery system for toxic payloads, one 
example demonstrates that the sharpened spike of the T6SS is a potent weapon even in 
the absence of toxic effectors. Using its TagQRST-PpkA-Fha1-PppA sensing system, P. 
aeruginosa detects cell envelope damage caused by the T6SS of other bacteria (116). 
This detection or “danger sensing” allows the cell to mount a response against its 
antagonist and minimize future damage to the cell or its siblings (117). In the case of P. 
aeruginosa, the cell retaliates against T6SS-mediated attacks, directing its own T6SS in 
the same direction as the initial attack in a behavior called “dueling” (118). Duels 
damage target cells and can cause membrane blebbing, plasmolysis, and even lysis. 
Strains of P. aeruginosa that are deficient in production of all known T6SS effectors still 
retaliate against T6S-mediated attacks and engage in dueling with effective killing 
activity (116). If P. aeruginosa cells lose their duels and are lysed by competitors, they 
release diffusible danger signals that stimulate T6SS activity and promote the survival of 
siblings (119). 
 
 Like CDI, The T6SS killing mechanism also functions to favor siblings in 
biofilm formation. Strains of Proteus sort self from non-self in mobile multicellular 
swarms. This kin-discrimination is observed as cell-free zones between swarms called 
Dienes lines (named for their discoverer Louis Dienes) on agar surfaces. In these zones, 
opposing swarms of P. mirabilis do not intermingle. The establishment of Dienes line 
formation was found to be due to T6SS (120). At the intersection between opposing 
swarms, P. mirabilis use their T6SS to kill, and in turn are killed by T6SS of 
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competitors, creating a demilitarized zone (DMZ) where the Dienes lines exist between 
mobile populations. As with B. thailandensis, strains join the beneficial swarm when 
they are not killed by the T6SS. An added benefit of this kin-discrimination arises 
because swarming provides increased resistance to antibiotics (80). Thus, entry into the 
swarm promotes competitive fitness of bacteria by excluding unrelated cells and from 
enhancing defense against antibiotics. Similar boundary formation has also been 
reported for M. xanthus (121) and B. subtilis (122). The observation of discrimination in 
B. subtilis demonstrates that CDI and T6SS are not the only mechanisms that bacteria 
use for kin-discrimination, as B. subtilis does not produce CDI or T6SS. The question 
remains whether B. subtilis demarcates Dienes lines through a contact-dependent or –
independent mechanism, although evidence suggests combinatorial mechanisms are used 
(123). 
 
 Both the CDI and T6SS are analogous in that a toxin is delivered directly to a 
target cell. However, like many antibiotics, these toxins are typically soluble molecules. 
How then, are insoluble effectors delivered? In one case the T6SS toxin Tse6, produced 
by P. aeruginosa, contains transmembrane domains that are shielded from the aqueous 
environment by an associated chaperone. The chaperone, EagT6, protects Tse6 until 
delivery into the target’s periplasm (124). This example appears to be the exception, 
where the majority of membrane-associated effectors lack a chaperone or other clear 
vectoring mechanism. As described previously, extracellular vesicles are another 
mechanism for delivery of otherwise insoluble cargo. 
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Outer membrane exchange 
 In addition to CDI, T6SS, and EVs, Gram-negative bacteria appear to use the 
outer membrane itself as an effective delivery system for otherwise insoluble toxins. 
Outer membrane exchange (OME) for Myxobacteria, for example, is a contact-
dependent mechanism for cells to share membrane components, including phospholipids 
and insoluble lipoproteins, with other cells (125). OME has been demonstrated to 
extracellularly complement mutants deficient in production of particular outer membrane 
products. For example, via OME the gliding motility of non-motile M. xanthus mutants 
is stimulated when mutant cells are mixed with wild type cells (126). OME is also 
intertwined with colony swarming and sporulation (126). Furthermore, a recent report 
implicates OME as a powerful defensive mechanism to dilute membrane damage over a 
population of cells (127).  
 
OME requires the production of an outer membrane protein complex TraAB in 
both the donor and recipient cell (126). TraAB appears to be the only component 
necessary to mediate OME (128) and, similarly to the BamA receptor in CDI systems, 
TraAB contains a polymorphic domain that limits OME to a narrow range of related 
targets (129). Given the functional similarities to CDI systems and the potential of OME 
to directly deliver toxic effectors into the envelope of target bacteria, it is not surprising 
that Myxobacteria use OME to mediate competition and engage in kin recognition. 
Motile cells of M. xanthus are killed when cultured with their non-motile siblings. 
Killing is dependent upon the presence of TraA in the target motile cell and a polyploid 
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prophage in the killer non-motile sibling (130). Currently, the effector delivered by 
OME is not known, but it is likely produced from toxin-antitoxin module encoded on the 
prophage (130). No further examples of OME-mediated competition have been reported 
thus far. However, as with EVs, new studies will likely uncover fascinating roles for 
these membrane-derived strategies in bacterial competition. 
 
Conclusions 
Bacteria use competitive mechanisms that are nearly as diverse as the 
competitors they encounter (Figure 2). Inherent in each competitive strategy are 
advantages and disadvantages. When bacteria use secreted effectors like antibiotics, 
enzymes, or vesicles, they are able to compete while minimizing the risks of direct 
damage during contact-mediated competition. Once a cell exports its competitive 
molecules across its envelope, those molecules are subject to diffusion, which 
diminishes their growth inhibitory effect on competitors at a distance. However, many of 
these metabolically expensive products operate between inactive and inhibitory 
concentrations and may possibly act as chemical cues for competitors (131). Exposure to 
subinhibitory antibiotic concentrations can induce resistant states (132–134), select for 
resistant competitors (135), stimulate biofilm formation (136–138), and motility (139). 
Activation of a resistant state allows a competitor unrestricted access into a previously 
protected niche. If potential prey senses a cue and escapes predation, then the producer 
loses nutrients in the form of that lysed cell. Thus, if a competitor senses a cue, the 
producer may suffer the consequences for competitive fitness. However it is important to 
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note that our current understanding of response to subinhibitory concentrations of 
antibiotics and other SMs in the context of bacterial communities is limited and requires 
further investigation. The direct delivery of toxins into a target cell by CDI or T6SS 
circumvents diffusion and the potential costs of subinhibitory antibiotic concentrations. 
The tradeoff is that contact-mediated competition puts a cell in direct contact with its 
competitor and allows the risk of retaliation such as in the dueling response (116) or 
from high concentrations of diffusible SMs. 
 
 We have emphasized the differences between competitive mechanisms that are 
contact-mediated and those that occur at-a-distance. However, bacteria are not mutually 
exclusive in the systems they employ. For example, Pseudomonas species use T6SS but 
are also prolific producers of SMs including antibiotics and siderophores (140). Bacteria 
also use direct contact to deliver secreted factors at high local concentration. Predatory 
Bdellovibrio species physically collide with target cells, pierce their cell envelope, and 
digest their prey from within using an impressive cocktail of secreted enzymes that 
includes nucleases and peptidoglycan hydrolases (141, 142). The differences between 
contact-mediated and distance approaches may reflect how bacteria use both systems in 
competition. A cell producing secreted molecules, like antibiotics, creates a chemical or 
enzymatic protective shell around itself. Within this shell the cell is also able to 
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Figure 2. Summary of mechanisms used in bacterial competition 
 
Contact-mediated mechanisms involve either direct contact between cell envelopes (OME) or are 
facilitated by protein complexes (CDI and T6SS). In the case of CDI and T6SS, toxic effectors (square or 
Pac-Man) are delivered into the target cell. Bacteria compete at-a-distance using SMs (examples shown 
are bacillaene and streptomycin), secreted enzymes, and extracellular vesicles. CDI, contact-dependent 
inhibition; EVs, extracellular vesicles; M, membrane; MT, target cell membrane; IM, inner membrane; 
OM, outer membrane; PG, peptidoglycan; T6SS, type VI secretion system. 
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simultaneously engage in exploitative competition via its exclusive access to nearby 
nutrients. The spectrum of inhibitory activities, in concert with small size, low charge, 
and ease of entrance into target cells (143, 144), place antibiotics at the foundation of 
such protective chemical shells. However, if a competitor breaches the defenses, then the 
delivery of toxic effectors by CDI or T6SS directly into the target may stop the invasion. 
A remarkable balance of antibiotic resistance and contact-dependent mechanisms has 
been shown with A. baumanii (145). Several multi-drug resistant A. baumannii strains 
carry a plasmid that provides antibiotic resistance while also inhibiting expression of 
T6SS systems. However, the plasmid is unstable, and loss of the plasmid provides a 
mechanism to activate T6SS at the cost of losing antibiotic resistance in some cells. The 
net result is a population with shared functions in competitive fitness through defense 
and through close quarters exclusion of competitors. Perhaps contact-mediated 
mechanisms like CDI, T6SS, or OME are needed to selectively inhibit closely related 
competitors with the capacity to pass unharmed across a chemical defensive barrier (91, 
129, 145). 
 
 Culture-based studies have revealed many mechanistic details of bacterial 
competition. However, we note that many of the studies highlighted in this introduction 
used simple, small-scale bacterial communities with minimal mixing. To gain a deeper 
understanding of bacterial competition in natural communities, systems are needed that 
combine the use of multiple approaches and expanded knowledge of diverse competitive 
mechanisms. Although beyond the scope of this introduction, mathematical modeling is 
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a powerful approach to understand how bacterial communities are formed and 
maintained (e.g. 146, 147). Mathematical approaches stand to become more powerful as 
they incorporate diverse competitive outcomes in addition to killing or survival. For 
instance, what effects does T6SS-mediated retaliation have in a modeled competition? 
How does SM-mediated developmental inhibition affect a community? What are the 
consequences of exposure for cells outside the inhibitory ranges of SMs? Using 
controlled experiments in the laboratory, new mechanistic details of competition are 
being identified, despite limitations to our understanding of these mechanisms in natural 
environments. The genomes of many antibiotic producing bacteria contain silent SM 
gene clusters that are not expressed under laboratory conditions (148). Likewise, many 
studies with CDI and T6SS require artificial expression conditions (149, 150). These 
obstacles are a central focus of current efforts to understand competitive mechanisms. 
Meanwhile, models that better mimic the native environment are being developed to 
provide a clearer view of bacterial interactions under natural conditions (e.g. 86, 115, 
151) The examples above and many more innovative studies are expanding our views of 
the interactive interfaces between two bacterial cells. The emerging challenge is to build 
these interfaces into networks, which will represent the many facets of competition 
within microbial communities. 
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CHAPTER II  
ESCAPE FROM LETHAL BACTERIAL COMPETITION THROUGH COUPLED 
ACTIVATION OF ANTIBIOTIC RESISTANCE AND A MOBILIZED 
SUBPOPULATION
2
 
 
Summary 
Bacteria have diverse mechanisms for competition that include biosynthesis of 
extracellular enzymes and antibiotic metabolites, as well as changes in community 
physiology, such as biofilm formation or motility. Considered collectively, networks of 
competitive functions for any organism determine success or failure in competition. 
How bacteria integrate different mechanisms to optimize competitive fitness is not well 
studied. Here we study a model competitive interaction between two soil bacteria: 
Bacillus subtilis and Streptomyces sp. Mg1 (S. Mg1). On an agar surface, colonies of B. 
subtilis suffer cellular lysis and progressive degradation caused by S. Mg1 cultured at a 
distance. We identify the lytic and degradative activity (LDA) as linearmycins, which 
are produced by S. Mg1 and are sufficient to cause lysis of B. subtilis. We obtained B. 
subtilis mutants spontaneously resistant to LDA (LDA
R
) that have visibly distinctive 
morphology and spread across the agar surface. Every LDA
R
 mutant identified had a 
missense mutation in yfiJK, which encodes a previously uncharacterized two-component 
                                                 
2
Reprinted from Stubbendieck RM, Straight PD. Escape from Lethal Bacterial Competition through 
Coupled Activation of Antibiotic Resistance and a Mobilized Subpopulation. PLoS Genet 11(12): 
e1005722. doi:10.1371/journal.pgen.1005722 under the Creative Commons Attribution License 
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and 
reproduction in any medium, provided original work is cited. Copyright ©2015 Stubbendieck, Straight. 
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signaling system. We confirmed that gain-of-function alleles in yfiJK cause a 
combination of LDA
R
, changes in colony morphology, and motility. Downstream of 
yfiJK are the yfiLMN genes, which encode an ATP-binding cassette transporter. We 
show that yfiLMN genes are necessary for LDA resistance. The developmental 
phenotypes of LDA
R
 mutants are genetically separable from LDA resistance, suggesting 
that the two competitive functions are distinct, but regulated by a single two-component 
system. Our findings suggest that a subpopulation of B. subtilis activate an array of 
defensive responses to counter lytic stress imposed by competition. Coordinated 
regulation of development and antibiotic resistance is a streamlined mechanism to 
promote competitive fitness of bacteria. 
 
Introduction 
Bacteria are communal organisms. As such, bacteria have mechanisms to interact 
with other species that range from cooperative to antagonistic. Antibiotics are a classic 
example of molecules produced by bacteria that probably function in shaping microbial 
communities due to their bioactive function, including growth inhibitory and stimulatory 
activities (3, 5, 152, 153). The study of antibiotics has revealed a great deal about the 
cellular functions they target, mechanisms of resistance, and uses in treating disease. The 
traditional approach to discovery of antibiotics typically begins with extraction of 
metabolites from culture media, followed by direct screening of culture extracts to 
identify growth inhibitory agents (19). While this approach has had tremendous success 
for antibiotic discovery, it has left great gaps in our understanding of competitive 
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dynamics between bacteria. Approaches to bacterial competition that rely on culture of 
two or more organisms together are emerging as a powerful tool to discover new 
bioactive molecules and reimagine mechanisms of competition between diverse species 
of bacteria (154, 155). For instance, microbial competitive functions include secreted 
enzymes, type VI secretion systems, and specialized metabolism, including 
developmental signals and antibiotics (152, 153, 156). In addition, changes in 
community functions such as biofilm formation or motility are recognized increasingly 
as important competitive strategies for bacteria (80, 157). 
 
 Specialized metabolism and developmental functions are common features 
among soil bacteria, including the actinomycetes, bacilli, and myxobacteria (34, 35, 
158–162). In these bacteria, antibiotic production and cellular development are often 
intertwined and co-regulated processes, which is thought to provide fitness benefits to 
the organisms (31, 163, 164). For example, during typical development Streptomyces 
species differentiate and develop spores (35). During Streptomyces sporulation the 
substrate mycelium is cannibalized, which is thought to provide the cells with necessary 
nutrients to complete sporulation (165, 166). Cannibalization of the substrate mycelium 
is concurrent with production of many antibiotics, which are thought to protect the 
nutrient resources from opportunistic competitors (167). Use of simple, tractable assays 
of two or more competing bacteria is one approach to identify new specialized 
metabolites, enzymes, and bacterial functions that determine the outcomes of 
competitive interactions. Indeed, interaction assays reveal not only growth inhibitory 
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metabolites, but also changes in development and colony morphology that expose 
abundant and poorly understood survival mechanisms for bacteria. Dynamic patterns of 
interaction based on models of competition are producing new insights into bacterial 
competitive mechanisms (28, 31, 39, 40, 44, 157, 168). 
 
 As a model for competitive interactions, we use different species of Bacillus and 
Streptomyces. This competition model has led to identification of new functions for 
known molecules, including bacillaene and surfactin (31, 39). In the case of surfactin, a 
secreted hydrolase was identified from Streptomyces sp. Mg1 (S. Mg1) and shown to be 
a resistance mechanism that specifically degrades surfactin and plipastatin produced by 
Bacillus subtilis (40). The current study stems from observing colonies of S. Mg1 and B. 
subtilis placed side by side on agar media. In this format, cellular lysis occurs along with 
progressive degradation of the B. subtilis colony (47). Previously, imaging mass 
spectrometry revealed the loss of the polyglutamate component of colony extracellular 
matrix in the area of lysis, indicating degradation of both cellular and extracellular 
materials (169, 170). Streptomyces sp. Mg1 encodes production of many specialized 
metabolites with potential to participate in lysis and degradation (171). One gene cluster 
encodes the biosynthetic enzymes for chalcomycin A, which inhibits the growth of B. 
subtilis but does not cause lysis and colony degradation (47).  Here we report both the 
identification of a lytic degradative activity (LDA) from S. Mg1, as well as a mechanism 
of resistance to LDA for B. subtilis. We show that resistant mutants of B. subtilis have a 
complex phenotype, which includes LDA resistance and visible changes in colony 
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morphology and motility. We show the LDA resistance and the changes in colony 
morphology and motility are genetically separable functions, all regulated by a two-
component system of previously unknown function. Our results indicate that a 
subpopulation of B subtilis cells in a colony trigger a complex mechanism for 
competitive fitness when challenged by the streptomycete. 
 
Results 
Identification of the molecule responsible for LDA 
 When cultured next to S. Mg1, Bacillus subtilis colonies are progressively 
degraded and the underlying cells are lysed (Figure 3A) (47). Progressive degradation of 
the cells and the extracellular matrix is visible as a translucent patch that develops on a 
formerly opaque colony (Figure 3A). Our initial interest was to identify causes of lysis 
and colony degradation. To identify candidate lytic agents, we chose a direct approach to 
isolate S. Mg1 metabolites or enzymes that contribute to the lytic and degradative 
activity (LDA). Initially, we found active material present in whole plate butanol 
extracts from S. Mg1 grown on agar. To improve yields and decrease complexity of 
LDA extracts, we cultured S. Mg1 in liquid medium in the presence of non-polar HP-20 
resin for adsorption of metabolites. Adsorbed metabolites were eluted using methanol to 
generate the crude extract. Bacillus subtilis colonies exposed to the crude extract lysed, 
indicating the presence of the activity. To isolate the active agent, we fractionated the 
crude extract, first using a stepwise (10%) methanol gradient followed by time-based 
HPLC fractionation, and tested for active fractions (see methods section for a detailed 
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description). The ΔpksX strain of B. subtilis was used for enhanced sensitivity in these 
assays, because the mutant is hypersensitive to lysis in co-culture with S. Mg1 (47). We 
isolated a single peak from a HPLC fraction that caused lysis and colony degradation 
similar to S. Mg1 (Figure 3A,C).  The similarity between the effects of isolated LDA and 
a competing S. Mg1 colony suggested that lysis and colony degradation of B. subtilis 
may result from the action of a single compound. 
 
 
 
 
Figure 3. Identification of linearmycin B as the causative agent of LDA 
 
(A) When co-cultured on MYM agar, S. Mg1 (left) releases molecule(s) that cause cellular lysis and 
colony degradation of B. subtilis (PDS0067) (right) at a distance. (B) We cultured B. subtilis (PDS0067) 
(right) alone on MYM7 agar for 24 h before adding isolated LDA onto a filter paper disc (left) adjacent to 
the colony, which subsequently lysed over 48 h similarly to co-culture with S. Mg1. (C) HPLC trace of the 
isolated LDA. The peak is detected by UV absorbance at 333 nm (blue). The background is shown by the 
254 nm absorbing trace (red). (D) The structure of linearmycin B. Scale bar is 5 mm. 
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The linearmycins were originally identified as a pair of compounds, linearmycin 
A and B (172, 173). We examined the crude extracts and found them to also contain 
linearmycin A, which is also active for lysis of B. subtilis (m/z 1140) (Figure A2). 
Furthermore, the S. Mg1 genome (GenBank Accession CP011664) (171) includes a 
polyketide gene cluster predicted to be responsible for linearmycin biosynthesis. We 
tested a mutant strain, S. Mg1-Δ37, which contains a chromosome truncation that 
removes the linearmycin biosynthetic cluster, and found the mutant failed to lyse B. 
subtilis or produce linearmycins (Figure A2). In a parallel study, a targeted deletion of 
the acyl-transferase encoding gene in the linearmycin biosynthetic gene cluster disrupts 
linearmycin production specifically and blocks all lytic activity from the strain (personal 
communication, B. Chris Hoefler). Taken together, we conclude that S. Mg1 produces 
linearmycins, which are sufficient for LDA against B. subtilis. For simplicity, we 
collectively refer to these molecules as LDA. 
 
No mechanism is known for either growth inhibition or the lytic effect that we 
observe with LDA. Linearmycin A was originally shown to inhibit growth of 
Escherichia coli and Staphylococcus aureus in addition to three fungal species, but no 
antibacterial mechanism of action was reported (172). Structurally related polyene 
antibiotics include antifungal agents such as amphotericin B (174), nystatin (175), and 
ECO-02301 (176). Amphotericin B and nystatin inhibit fungal growth specifically by 
interactions with ergosterol and the fungal plasma membrane (177–180). However, 
bacterial membranes lack ergosterol, suggesting a different mechanism of action against 
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bacteria for LDA. Nystatin was found to induce biofilm formation by B. subtilis grown 
in LB media (27), demonstrating that antifungal polyenes are biologically active in the 
absence of ergosterol. The lytic activity of LDA indicates a mechanism of action for the 
linearmycins that differs from nystatin. In the absence of a known target, we sought an 
approach to better understand the lysis and degradation of B. subtilis. 
 
LDA resistance caused by activation of the YfiJK two-component system 
 When plated next to extracts of LDA or S. Mg1 colonies, small B. subtilis 
colonies emerge in the region of lysis and appear to be resistant to LDA (47). We wanted 
to identify mechanisms of resistance as an approach to better understand the lytic 
process caused by LDA (181). Direct comparison of ∆pks and wild-type strains of B. 
subtilis, either in culture with S. Mg1 or when treated with LDA, showed that the ∆pks 
strain is hypersensitive to lysis but has no other observable phenotype in these assays 
(47). Therefore as before, we used the ∆pks strain of B. subtilis for these assays, because 
the LDA hypersensitivity provided an expanded area of lysis in which we could scan for 
potential resistant mutants. We challenged colonies of the ΔpksX strain of B. subtilis 
with extracts from S. Mg1 cultures and observed small colonies appearing in the 
degraded portion of the parent colony after lysis occurred (e.g. Figure 3B). We isolated 
60 small colonies from several lysed colonies and tested them for resistance to LDA in 
co-culture with S. Mg1. The majority of the isolates lysed when cultured again with S. 
Mg1, indicating only transient resistance to LDA. However, ten isolates were stably 
resistant to LDA (LDA
R
), potentially having acquired mutations leading to resistance 
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(Figure 4A). Notably, all of the stable LDA resistant colonies developed a rough, 
wrinkled colony morphology that is distinct from the parental strain (Figure 4A). Due to 
a biofilm-like appearance of the LDA
R
 colonies, we suspect the mutations have 
pleiotropic effects on growth mode and development, as well as resistance to LDA. 
 
To identify the mutant alleles in the LDA
R
 isolates, we sequenced six of the ten 
mutant genomes and compared the sequences to the parental genome (∆pks strain). 
Surprisingly, all six isolates had point mutations in either of the two genes in the yfiJK 
operon. In addition, eleven non-overlapping mutations occurred in a subset of the 
spontaneous LDA
R
 mutants (Table A2). Three spontaneous LDA
R
 mutants possessed 
point mutations only in yfiJ, which prompted our focus on the yfiJK operon.  Using PCR 
and Sanger sequencing we found that the other four LDA
R
 isolates also contained point 
mutations in yfiJ. In total, nine of ten mutations were found in yfiJ and one in yfiK 
(Figure 4B, Table 1). The yfiJ gene encodes a membrane-bound sensor histidine kinase 
(HK), and the yfiK gene encodes its cognate cytoplasmic response regulator (RR) (182). 
Together these proteins comprise a two-component system (TCS). In a canonical TCS, a 
HK dimer senses a signal and autophosphorylates on a conserved histidine residue (183). 
The phosphate is subsequently transferred to the cognate RR, which then effects a 
response, most commonly through DNA binding and regulation of gene expression 
(183). In the case of YfiK, the effector domain is a helix-turn-helix domain that likely 
binds DNA to modulate changes in gene expression (182). A role in LDA resistance is 
the first indication of a native function for this two-component system. 
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Figure 4. Point mutations in yfiJK are responsible for LDA resistance 
 
(A) The parental strain of B. subtilis, ΔpksX (PDS0067, top), and a representative spontaneous LDAR 
mutant (bottom). The colony formed by the parental strain is lysed but the mutant colony remains intact. 
The spontaneous LDA resistant mutant has a distorted shape and more wrinkled surface than its parental 
strain. (B) Diagrams of YfiJ and YfiK. The amino acid substitutions identified in spontaneous LDA
R
 
mutants are shown in red. The predicted conserved phosphoacceptor residues are shown in black. (C) 
Strains of B. subtilis deleted for yfiJ (PDS0555) or yfiK (PDS0556) independently or yfiJK together 
(PDS0554) are lysed in co-culture with S. Mg1. (D) We complemented the yfiJK deletion strain by 
inserting at the non-essential amyE locus either wild-type yfiJK (PDS0627) or alleles identified in 
spontaneous resistant strains: yfiJ
A152E
K (PDS0685) and yfiJK
T83I
 (PDS0628). In co-culture with S. Mg1, 
wild-type yfiJK
+
 complement was lysed and degraded, but the strains complemented with LDA
R
 alleles of 
yfiJK were LDA resistant. The complementation strains reproducibly had a more wrinkled morphology 
than wild type, similar to the spontaneous LDA
R
 strain. All cultures place S. Mg1 on the left and B. 
subtilis on the right. Photographs were taken after 72 h co-incubation on MYM agar. Scale bar is 5 mm. 
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Table 1. Alleles of yfiJK identified in spontaneous LDA
R
 mutants 
 
Allele Nucleotide Change Number Isolated LDA Resistance 
yfiJ
+
 n/a n/a – 
yfiJ
A88V
 C257T 1 + 
yfiJ
A152E
 C455A 1 + 
yfiJ
T164M
 C491T 1 + 
yfiJ
H167Y
 C499T 6
*
 + 
yfiJ
L254P
 T761C 1
†
 + 
yfiJK
+
 n/a n/a – 
yfiJK
T83I
 C248T 1 + 
 
Each allele is designated by the amino acid substitution. All numbering is with respect to the first amino 
acid or the first nucleotide of the start codon. Wild-type alleles are included to indicate LDA sensitivity 
and designated with a superscript 
+
 symbol. The – symbol indicates LDA sensitivity, and the + symbol 
indicates LDA resistance in co-culture with S. Mg1.  
*
We isolated C499T from three independent experiments.  
†
This resistant mutant was isolated from a transposon-mutagenized strain. 
 
 
 
 
To determine whether LDA resistance requires active YfiJK, we deleted yfiJ and 
yfiK independently, or yfiJK together, in otherwise wild-type genetic backgrounds, and 
co-cultured these mutants with S. Mg1. In all three cases the mutants lysed and were 
indistinguishable from wild-type B. subtilis (Figure 4C). The absence of any observable 
phenotype for the yfiJK deletion mutations suggested that resistance arises from gain-of-
function alleles that activate the two-component system. As a test for gain-of-function 
alleles, we genetically complemented the deletion strains of yfiJ or yfiJK with PCR-
amplified alleles from the spontaneous LDA
R
 strains. Control strains complemented with 
native alleles were wild type with respect to lysis and colony morphology (Figure 2D). 
Conversely, complementation with the mutant alleles caused B. subtilis to be resistant to 
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LDA when cultured with S. Mg1, and the mutants developed a more wrinkled colony 
surface than wild type (Figure 4D, Table 1). Based on these observations, we concluded 
that each LDA
R
 allele is likely activating YfiJK to stimulate both abnormal colony 
development and LDA resistance. 
 
We next investigated how YfiJK may relate to the mechanism of lysis and colony 
degradation. We considered the results of a previous microarray study to define the 
regulon of each known RR in B. subtilis (184). In that study, overexpression of yfiK 
repressed expression (≥ 4-fold) of 29 different genes, the majority involved in amino 
acid biosynthesis (184). The reported regulon also includes skfF, which encodes the 
ATP-binding cassette (ABC) transporter necessary for release of spore-killing factor 
(SKF), and iseA, a cell wall-associated protein that inhibits two major autolysins (185–
187). We hypothesized that SKF and autolysis might be involved in linearmycin-induced 
lysis, and that yfiJK may regulate the expression of those functions. We tested sensitivity 
to LDA using four strains of B. subtilis. First, we tested a strain unable to produce SKF 
(ΔskfA-H) to determine if the cannibalism peptide functions as a lytic agent. Second, we 
tested whether a strain deficient in iseA would show enhanced lysis in the absence of an 
autolysin inhibitor. Third, because iseA regulates autolysins, we tested whether a strain 
deficient in production of three major autolysins (ΔlytABC ΔlytD ΔlytF) may show 
diminished lysis when exposed to LDA. Fourth, we tested a strain with a deletion of the 
major motility/autolysin regulator (ΔsigD) (188). All four strains lysed when cultured 
with S. Mg1, indicating that SKF and autolysis do not likely contribute to the lysis 
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mechanism (Figure A3). In a parallel approach, we used transposon mutagenesis to 
identify genes in B. subtilis that may cause lysis under linearmycin-induced stress. We 
obtained a single, stable LDA
R
 mutant, however LDA resistance was unlinked to the site 
of transposon insertion in this strain. We sequenced the mutant genome and identified an 
additional point mutation in yfiJ (yfiJ
L254P
) (Table 1). Thus, using multiple approaches to 
identify functions conferring LDA
 
resistance, we have found only apparent gain-of-
function alleles in yfiJK. 
 
LDA resistance requires YfiJK with active phosphotransfer function 
Two-component signaling systems require conserved phosphoacceptor residues 
for activation and downstream signaling (183). We identified the phosphoacceptor 
histidine (H201) in YfiJ and the phosphoacceptor aspartate (D54) in YfiK using multiple 
sequence alignment to experimentally characterized TCS. Using site-directed 
mutagenesis we disrupted the phosphoacceptor residues and created the new alleles 
yfiJ
H201N
 and yfiK
D54A. As anticipated based on the ∆yfiJK phenotype, both 
phosphoacceptor mutants were sensitive to LDA when cultured with S. Mg1 (Table 2). 
Next, we constructed new alleles that combined the phosphoacceptor disruptions with 
substitutions found in LDA
R
 alleles to generate the new, double mutant alleles yfiJ
A152E, 
H201N
 and yfiK
D54A, T83I
. When cultured with S. Mg1 these mutant strains lysed, which 
confirmed the disruption of the gain-of-function LDA
R
 phenotype in the absence of 
functional a TCS (Table 2). As a final test that LDA resistance results from specific 
downstream signaling of YfiJK, we constructed a pair of double mutants: (i) combining 
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the LDA
R
 allele yfiJ
A152E
 with the phosphoacceptor disruption yfiK
D54A
 and (ii) 
combining the phosphoacceptor disruption yfiJ
H201N
 with the LDA
R
 allele yfiK
T83I
. When 
these strains were cultured with S. Mg1 they were sensitive to LDA (Table 2). These 
results suggest that LDA resistance is due to specific downstream signaling of YfiJK, 
leading us to conclude that LDA
  
resistance is due specifically to activation of the TCS. 
 
LDA
R
 alleles show specificity for linear polyene metabolites 
Amphotericin B and nystatin are cyclic polyene antifungals (174, 175). The 
structurally related linear polyene, linearmycin A, is also antifungal but has also been 
shown to have antibacterial activity as well (172). We tested amphotericin B, nystatin, 
and ECO-02301, a polyene structurally related to the linearmycins (176), for activity 
against B. subtilis.  
 
 
 
 
Table 2. LDA resistance requires phosphoacceptor residues 
 
Allele LDA Resistance 
yfiJ
A152E
 + 
yfiJ
H201N
 − 
yfiJ
A152E, H201N
 − 
yfiJK
T83I
 + 
yfiJK
D54A
 − 
yfiJK
D54A, T83I
 − 
yfiJ
A152E
K
D54A
 − 
yfiJ
H201N
K
T83I
 − 
 
The conserved phosphoacceptor residues in YfiJ (H201) and YfiK (D54) were mutated to non-
phosphorylatable residues. The + symbol indicates LDA resistance in co-culture with S. Mg1. The – 
symbol indicates LDA sensitivity. All numbering is relative to the first amino acid of the YfiJ and YfiK 
proteins. 
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ECO-02301 caused lysis similar to linearmycins, but the macrocyclic polyenes 
amphotericin B and nystatin were not lytic (Figure 5). When tested against purified 
ECO-02301, the LDA
R
 mutant (yfiJ
A152E
) strain appeared to be partially resistant in this 
assay (Figure 5). We next sought a quantitative measure of the difference between LDA 
resistance and sensitivity to LDA and ECO-02301. First, we measured the minimum 
lytic concentration (MLC) for ECO-02301 using a quantitative agar diffusion assay and 
determined that a LDA
R
 strain of B. subtilis was 3.65-fold more resistant to ECO-02301 
(Table 3). We applied the same assay to LDA, containing both linearmycin A and B, 
isolated from S. Mg1 cultures and quantified the fold difference in resistance between 
LDA
R
 and wild-type B. subtilis. The LDA
R
 mutant was nearly ten-fold more resistant to 
LDA compared to the sensitive strain (Table 3). The difference in relative resistance to 
ECO-02301 and LDA may be in part due to structural differences in the molecules. The 
synthesis of ECO-02301 includes tailoring reactions that glycosylate the polyketide 
backbone and condense an amidohydroxycyclopentenone moiety onto the terminal 
carboxylic acid group (176, 189). The structural differences may affect target affinity, 
solubility, or other properties of the molecule, leading to differences in overall activity. 
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Figure 5. LDA
R
 alleles are specific to LDA caused by linear polyenes 
 
Strains of B. subtilis (right) were pre-incubated for 24 h on MYM agar before exposure to the antibiotics 
on filter paper discs (left). Colonies were photographed 48 hours after antibiotic exposure. Amphotericin B 
(500 µg/filter disc) and nystatin (500 µg/filter disc) are not lytic to B. subtilis, which can grow around the 
filter paper disc. A yfiJ
+
 strain of B. subtilis (PDS0571) is lysed by the linear polyene ECO-02301 (6.25 
µg/filter disc) but a strain with the LDAR allele yfiJ
A152E
 (PDS0572) shows resistance to ECO-02301 at 
this concentration. However both yfiJ
+
 and yfiJ
A152E
 strains are susceptible to daptomycin-induced lysis 
(250 µg/filter disk). Scale bar is 5 mm. 
 
 
 
 
 
 
 
 
Table 3. Minimum lytic concentrations 
 
Antibiotic yfiJ
+
 MLC (µg/mL) yfiJ
A152E
 MLC (µg/mL) 
Fold Difference 
(yfiJ
A152E
/yfiJ
+
) 
Daptomycin 32.74 32.68 0.99 
ECO-02301 0.40 1.46 3.65 
LDA
*
 ND
†
 ND 9.58 
 
*
Linearmycins A and B extracted from S. Mg1 cultures. 
†
ND, not determined.  
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Because polyene antibiotics typically exert their effects on the cellular 
membrane, we wanted to determine if LDA resistant alleles of yfiJK provide B. subtilis 
with a generalizable cross resistance to membrane-active antibiotics. Daptomycin is a 
lipopeptide antibiotic that targets the cell membrane (177, 178, 190). The killing 
mechanism of daptomycin is not lytic, although lysis follows prolonged exposure (191). 
We found that daptomycin caused a morphologically similar lysis and degradation of B. 
subtilis when spotted on a filter paper disc adjacent to a colony (Figure 5). A LDA
R
 
strain of B. subtilis also lysed when exposed to daptomycin. In comparison to the LDA 
sensitive strain, the LDA
R
 strain showed some residual opacity following lysis, 
suggesting that LDA
R
 alleles might provide cross-protection to daptomycin (Figure 5). 
However, we found the MLC of daptomycin was identical between the LDA resistant 
and sensitive strains (Table 3). Our results suggest that YfiJK signaling provides 
resistance either specifically to linear polyene molecules related to linearmycins, or 
commonly to the type of lytic cell damage caused by linearmycins. 
 
The ABC transporter YfiLMN is necessary for LDA resistance 
 Immediately downstream of the yfiJK operon are three genes, yfiLMN, predicted 
to encode an ABC transporter (182, 192). This genetic architecture is similar to peptide-
antibiotic resistance systems previously characterized in B. subtilis and other Firmicutes 
(193). In these systems, a TCS and an ABC transporter are functionally linked and 
required for antibiotic resistance. We hypothesized that YfiJK-LMN may function 
similarly to confer LDA resistance. Thus, we were interested in determining if YfiLMN 
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is necessary for LDA resistance. We engineered a strain with all five genes, yfiJKLMN, 
deleted. The ∆yfiJKLMN strain was lysed in co-culture with S. Mg1 (Figure 6). We 
inserted resistant alleles of yfiJK at the non-essential amyE locus to generate strains 
unable to produce YfiLMN but possessing LDA
R
 alleles of yfiJK. When cultured with S. 
Mg1, these strains were sensitive to LDA (Figure 6). We then complemented the loss of 
yfiLMN in these strains by inserting the yfiLMN genes, including the intergenic region 
between yfiK and yfiL, at the non-essential lacA locus. A predicted terminator exists 
downstream of yfiK (-8.9 kcal/mol) (genolist.pasteur.fr/SubtiList) (194). Our initial 
yfiLMN complementation construct included sequence immediately downstream of the 
terminator. However, this construct failed to complement the loss of resistance (Figure 
A4). Upon further investigation, we found no recognizable promoter elements in the 
intergenic region between the yfiK terminator and yfiL (143 bps). We hypothesized that 
yfiJKLMN may constitute a single operon with some level of terminator read-through 
resulting in yfiLMN expression. To circumvent the lack of an independent promoter, we 
placed the expression of yfiLMN under a constitutive Pspac(c) promoter and inserted these 
constructs at the non-essential yhdG locus (195). Under constitutive expression, the 
yfiLMN-complementation strains were LDA resistant, showing only minimal lysis in co-
culture with S. Mg1 (Figure 6). This effect was observed even in a strain complemented 
with wild-type yfiJK and in a strain lacking yfiJK entirely. These results demonstrate that 
YfiLMN is necessary for LDA resistance, and that constitutive expression bypasses the 
need for YfiJK. We speculate that YfiLMN either removes linearmycins from B. subtilis 
cells to provide resistance, or alternatively, functions in cell envelope processes or 
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regulatory functions that control LDA resistance. Determining the mechanism of 
YfiLMN-mediated LDA resistance will require further investigation. 
 
 
 
 
 
 
 
 
Figure 6. The ABC transporter YfiLMN is necessary for LDA resistance 
 
(A) Strains with deletions of yfiJKLMN from B. subtilis (PDS0653) and yfiJK alleles inserted at the amyE 
locus as labeled on the right: yfiJK
+
 (PDS0658), yfiJ
A152E
K (PDS0686), or yfiJK
T83I
 (PDS0660). When 
cultured with S. Mg1, all B. subtilis ∆yfiLMN strains were lysed including those with a LDAR allele of 
yfiJK. (B) Strains with the alleles of yfiJK as shown in (a), but containing Pspac(c)-yfiLMN inserted at the 
yhdG locus. All strains were resistant to LDA from S. Mg1 with minimal lysis visible next to the S. Mg1 
colony. LDA resistance was observed in a strain lacking yfiJK (PDS0718), a strain with yfiJK
+
 (PDS0719), 
and in strains with LDA
R
 alleles yfiJ
A152E
K (PDS0720) and yfiJK
T83I
 (PDS0721). All cultures place S. Mg1 
on the left and B. subtilis on the right. The cultures were photographed after 72 hours co-incubation on 
MYM agar plates. All images represent triplicate samples. Scale bar is 5 mm. 
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Intersection of colony developmental phenotypes and LDA resistance in LDA
R
 strains 
 In our study of the different LDA
R
 alleles, we observed some variation in the 
degree of wrinkled, motile phenotype in competition with S. Mg1 or under LDA 
exposure. To separate effects of the competitor from inherent LDA
R
 phenotypes, we 
plated colonies of LDA
R
 strains in isolation to view morphological features. All of the 
yfiJK mutant strains displayed a pattern of increased colony wrinkling and spreading 
across the agar surface and were distinct from the wild-type strain (Figure 7). We asked 
if differences in LDA
R
 morphology would be visible on the biofilm-inducing medium, 
MSgg (196). The mutant B. subtilis colonies developed a wrinkled appearance similar to 
wild type, indicating that traditional biofilm morphology and development are not 
disrupted in the mutant strains (Figure 7). We also noted that B. subtilis strains, either 
wild type or ∆yfiJ, formed smooth colonies in the absence of S. Mg1 when grown on 
rich media (Figure 7). In contrast, the same B. subtilis colonies in competition assays 
tend so show a somewhat wrinkled morphology, regardless of the yfiJK alleles present. 
Thus, the morphology of the B. subtilis colonies appears to be influenced by a 
combination of both the LDA alleles and the presence of the competitor species. 
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Figure 7. LDA
R
 mutants display aberrant wrinkled morphology 
 
Representative colonies of B. subtilis with LDA
R
 alleles yfiJ
A88V 
(PDS0575), yfiJ
A152E
 (PDS0572), 
yfiJ
T164M
 (PDS0573), and yfiJ
H167Y
 (PDS0574) show architecturally complex colonies on MYM, while 
wild type (PDS0066), ∆pks (PDS0067), and ∆yfiJ (PDS0555) do not (top panels). The LDAR colonies 
show both biofilm-like morphology and motile outgrowths at the colony periphery. When cultured on 
MSgg media, the LDA
R
 mutant strains develop biofilm colony morphology similar to control strains 
(lower panels). The ΔpksX yfiJA152E strain is a representative spontaneous LDAR mutant. All photographs 
were taken after 72 h. Scale bar is 5 mm. 
 
 
 
 
To directly compare colony morphology in isolation and with the competitor, the 
wild type and LDA
R
 strains were cultured at different distances to S. Mg1. We 
inoculated colonies of LDA
R
 B. subtilis and S. Mg1 in a perpendicular, cross-wise 
pattern on 1.5% agar MYM medium to provide a format for increasing distances 
between colonies of each species (Figure 8). The growth of B. subtilis with the wild-type 
yfiJ allele showed smooth colony formation with lysis proximal to the S. Mg1. In 
contrast, the B. subtilis strain with the yfiJ
A152E
 allele revealed different effects based on 
its proximity to S. Mg1 (Figure 8). The LDA
R
 colonies distant from S. Mg1 had the 
expected wrinkled morphology and spreading outgrowths, as was observed when 
cultured in isolation (Figure 7). However, the S. Mg1-proximal colonies were 
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morphologically different with a flattened surface and more uniform spreading pattern. 
The observed changes in colony morphology associated with LDA
R
 suggest that the 
YfiJK TCS regulates both specific resistance and developmental functions that 
coordinate a survival response to the competitor species. 
 
 
 
 
 
Figure 8. LDA
R
 mutants display a visible response to S. Mg1 in addition to inherent 
colony phenotypes 
 
Wild type and LDA
R
 mutants were spotted in a perpendicular pattern, cross-wise to each other- B. subtilis 
(vertical) and S. Mg1 (horizontal). (Left) Strains of B. subtilis with yfiJ
+
 (PDS0571) have flat, immotile 
colonies. Proximal to S. Mg1, the colonies are lysed and degraded. (Right) Strains of B. subtilis with the 
LDA
R
 allele yfiJ
A152E
 (PDS0572) develop heterogeneous colonies, having wrinkled surfaces and motile 
outgrowths. Notably, the colonies of yfiJ
A152E
 B. subtilis near S. Mg1 have a distinctive spreading 
morphology. Plates were photographed after 96 hours co-incubation on MYM + 1.5% agar. Plates 
represent duplicate experiments. 
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LDA
R
 and colony morphology phenotypes are genetically separable 
 To gain insight into possible connections between colony phenotypes and 
resistance to lysis, we considered that changes to extracellular matrix (ECM), the 
associated biofilm-like colony morphology, and changes in motility, may be responsible 
for LDA resistance (80, 98). For instance, the ECM may impede access of linearmycins 
to their target, possibly through overproduction of EPS or other matrix components (98). 
To test whether LDA resistance is dependent on known components of biofilm ECM, we 
sought to separate the two processes. We generated an ECM-defective strain, which was 
unable to produce exopolysaccharide (EPS) due to an epsH deletion (196), in an 
otherwise LDA resistant background (yfiJ
A152E
). This strain developed as a flat, mucoid 
colony, but remained LDA resistant in co-culture with S. Mg1 (Figure 9). Based on this 
result, we concluded that, while EPS production is necessary for the wrinkled colony 
morphology, intact biofilm matrix in the LDA
R
 strains is not responsible for the LDA 
resistance mechanism. However, LDA
 
resistance may require other biofilm matrix 
components (197). We asked whether hyperactivation of biofilm production would 
mimic the LDA resistance phenotype. We deleted the gene encoding sinR, the master 
biofilm repressor (198), in a LDA sensitive strain. When sinR is deleted, B. subtilis 
overproduces biofilm matrix and the colonies grow with a profoundly wrinkled 
appearance (198). If biofilm formation is responsible for LDA resistance, then a ΔsinR 
mutant should be resistant in co-culture with S. Mg1. However, the ΔsinR strain was 
sensitive to lysis (Figure 9). LDA resistance was observed in a ∆sinR strain only in the 
presence of the mutant yfiJ (yfiJ
A152E
). 
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Figure 9. Colony morphology and LDA resistance are separable phenotypes 
 
Genes involved in biofilm formation (epsH, sinR, and degU) and motility (sigD) were deleted from strains 
with either (A) yfiJ
+
 (PDS0571) or (B) the LDA
R
 allele yfiJ
A152E
 (PDS0572). In all cases, the biofilm and 
motility mutant strains were sensitive to lysis with wild-type yfiJ and were resistant to lysis with yfiJ
A152E
. 
All cultures place S. Mg1 on the left and B. subtilis on the right. Colonies were photographed after 72 
hours co-incubation with S. Mg1 on MYM medium. Images are representative of triplicate samples. Scale 
bar is 5 mm. 
 
 
 
 
 Biofilm formation is controlled not only by SinR but also by the TCS DegSU. 
This TCS is responsible for control of the production of biofilm extracellular matrix 
components. Among these components are BslA and γ-poly-DL-glutamate (γ-PGA) 
(199–201). To test if matrix functions provided by DegU may contribute to LDA 
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resistance, we deleted degU in a LDA resistant background (yfiJ
A152E
) and cultured the 
strain with S. Mg1. This mutant developed as a flat colony that was LDA resistant, 
suggesting that resistance to LDA does not require functions provided by DegU (Figure 
9). Based on this finding and our SinR and EpsH experiments, we conclude that the 
changes in colony morphology of LDA
R
 mutants are not the principle cause of LDA 
resistance. 
 
In addition to wrinkled colony morphology, the enhanced motility of LDA
R
 
strains may be linked to resistance. For instance, swarming motility has been associated 
with elevated antibiotic resistance in multiple bacteria (80). Previously, we observed 
lysis in a ∆sigD strain, which is deficient in swarming and autolysin production (188, 
202, 203) (Figure A3). We tested whether a ∆sigD, yfiJA152E double mutant strain would 
undergo lysis despite the presence of the LDA
R
 allele (Figure 9). This strain maintained 
both LDA resistance and morphological changes, including colony spreading. The 
spreading phenotype in the absence of sigD is consistent with LDA
R
 mutants exhibiting 
sliding motility when cultured with S. Mg1 (82). In sum, the combined phenotypes of 
LDA
R
 support a model wherein activation of YfiJK leads to LDA resistance through 
YfiLMN activation coordinated with separable changes in colony motility and 
morphology that promote survival during competition. 
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Genes identified by differential expression in a LDA
R
 strain 
 In an effort to identify a regulatory network for YfiJK, we sought to identify 
genes differentially expressed in a LDA
R
 mutant that may contribute to colony 
phenotypes. To perform differential expression analysis, we isolated and sequenced 
RNA from yfiJK
+
 (PDS0627) and yfiJ
A152E
K (PDS0685) strains cultured on agar plates. 
In our analysis, we identified six genes with statistically significant changes in 
expression between the two strains (Table 4).  Expression of yfiLMN was increased on 
average ~18-fold in the LDA
R
 mutant. To corroborate this result we used qRT-PCR and 
observed a ~20-fold increase in yfiL expression from the yfiJ
A152E
K strain (Figure A5). 
We did not observe a change in expression of yfiJK in our RNA-seq experiments, which 
is consistent with an additional control element between yfiK and yfiL. Three other 
differentially expressed genes were all decreased in the LDA
R
 mutant: des, which 
encodes a phospholipid desaturase responsible for cold shock adaptation (204, 205) and 
yvfRS, which encodes an ABC transporter of unknown function (192). Surprisingly, no 
genes in the eps operon or other known biofilm-related genes were identified as 
differentially expressed between the LDA
 
sensitive and LDA
R
 strains. Also of note, we 
found no correspondence between the YfiJK-regulated genes we identified by RNA-seq 
and the regulon previously defined by microarray study of yfiK overexpression (184). In 
the absence of a clear connection to established biofilm and motility functions, the RNA-
seq results suggest that the morphological changes observed in LDA
R
 colonies may arise 
directly from activation of YfiLMN function combined with repression of des 
(phospholipid content) and yvfRS (unknown function) by an unknown mechanism. 
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Alternatively, the morphological changes may occur only in a subpopulation of cells 
insufficient to be detected during our analysis. 
 
YfiJK is required for transient LDA resistance and small colony formation 
One of our initial goals was to identify mechanisms of resistance in an attempt to 
expose mechanistic aspects of linearmycin activity. We considered that LDA resistance 
may only exist under aberrant conditions, which arise through mutations that 
hyperactivate the YfiJK signaling system. In the absence of a clear phenotype for 
deletion of the genes, we sought an approach to identify wild-type YfiJK function in 
colony morphology and LDA resistance. We returned to an early observation that small 
colonies resistant to LDA emerge in the lysed region of a B. subtilis colony. The 
majority of the isolated LDA resistant colonies isolated were only transiently resistant  
 
 
Table 4. Differential expression analysis between yfiJ
A152E
K and yfiJK
+ 
 
Gene 
Fold Difference 
(yfiJ
A152E
K/yfiJK
+
) 
FDR 
yfiN 21.28 2.02
-22
 
yfiM 19.15 1.70
-20
 
yfiL 14.14 3.59
-17
 
des 0.20 3.05
-7
 
yvfR 0.15 2.54
-7
 
yvfS 0.14 1.81
-5
 
 
Differential gene expression between a yfiJ
152E
K strain (PDS0685) and a yfiJK
+
 strain (PDS0627). Fold 
differences > 1 indicate increased expression in the yfiJ
A152E
K strain relative to the yfiJK
+
 strain. 
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(50/60). We reasoned that if the natural function of YfiJK is to provide temporary 
resistance to LDA-induced damage, the emergence of transient resistance would depend 
upon the function of YfiJK. Therefore, we tested 6 independent colonies, each in 
triplicate, of wild type and ∆yfiJK versus S. Mg1 to determine if resistant colonies would 
emerge in the absence of YfiJK (Figure 10, Figure A6). The resulting cultures showed 
many small colonies arising in the lysed areas of the wild-type B. subtilis colonies. By 
contrast, the few small colonies observed with the ∆yfiJK strain did not grow 
appreciably and lacked the morphological features of the yfiJK
+
 colonies (Figure 10). 
This result is consistent with the natural function of YfiJK providing transient resistance 
to LDA-induced stress. In the case of yfiJK gain-of-function alleles, the substitutions in 
YfiJK may lock the TCS into an active state wherein every cell becomes resistant to 
LDA in contrast to the subpopulations observed among wild-type cells. Intriguingly, the 
transient resistance appears in only a subset of cells in the colony. Variable antibiotic 
resistance among a clonal population of cells has been described as heteroresistance, and 
is thought to be advantageous for survival of bacteria during antibiotic treatment (206–
208). The ability to activate YfiJK in a subset of cells may constitute a mechanism of 
transient heteroresistance to linearmycins and related molecules, but defining the 
mechanism and limitation to a subpopulation of cells will require further investigation. 
The observed pattern of YfiJK-dependent LDA resistance highlights that this TCS, and 
possibly many TCS, may transiently serve a subset of cells in a population during times 
of competitive crisis. 
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Figure 10. Small colonies among lysed cells in wild-type but not ΔyfiJK colonies 
 
Eighteen wild-type and ΔyfiJK colonies of B. subtilis were cultured with S. Mg1. Many small, potentially 
LDA
R
, colonies appeared in the region of lysis of wild-type colonies, while few could be seen in the 
∆yfiJK strain. The few small colonies observed in the zone of lysis for ∆yfiJK did not have the 
morphological features of the wild-type colonies. Note, Figure A6 shows all eighteen replicate colonies for 
each strain. All cultures place S. Mg1 on the left and B. subtilis on the right. Photographs were taken after 
96 hours co-incubation on MYM agar. Scale bar is 5 mm. 
 
Discussion 
 In this study, we used a two-species culture model of bacterial competition to 
identify functions that contribute to bacterial competitive fitness. The present study 
stemmed from an earlier observation of lysis and degradation of B. subtilis colonies 
when cultured adjacent to S. Mg1 (47). Here, we first identified linearmycins, produced 
by S. Mg1, as the primary cause of progressive lysis and colony degradation. The culture 
format used for competition revealed small B. subtilis colonies spontaneously resistant to 
lysis. When isolated, the resistant colonies showed a biofilm-like appearance with 
increased wrinkled colony morphology and aberrant motility. We sequenced whole 
genomes of the resistant colonies and identified mutations that confer resistance. 
Genomic analysis revealed alleles of the yfiJK operon, which encodes a two-component 
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system of previously unknown function. Based on our observations, we define yfiJK as a 
regulator of yfiLMN, encoding an ABC transporter, and possibly other target genes that 
govern modes of colony growth and motility (Figure 11).  
 
 
 
 
 
 
Figure 11. Model for YfiJK-LMN functions in LDA resistance and development 
 
LDA is sensed either directly by the ABC transporter YfiLMN, similarly to the ABC transporter BceAB 
and peptide antibiotics, or indirectly as membrane damage. This signal is transferred to the histidine kinase 
YfiJ, which then activates YfiK via phosphorylation. YfiK~P then activates the transcription of yfiLMN 
and likely represses des and yvfRS, leading to LDA resistance, biofilm formation, and motility through an 
unknown mechanism. These functions promote survival of B. subtilis under competitive stress. The YfiJK 
system differs structurally and functionally from other TCS that control either antibiotic resistance, such as 
the BceRS-AB system, or development, such as the DegSU system. Interactions between HKs and ABC 
transporters are shown with double-headed arrows. Hypothesized interactions of molecules with ABC 
transporters or membranes are shown with dashed arrows. 
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We show that the LDA resistance is not dependent upon known biofilm-specific 
functions, suggesting that colony morphology and LDA
R
 are separable processes, 
unified under YfiJK regulation. Two-component systems are well established as 
regulators for cellular responses to environmental stresses, including antibiotics (209, 
210). The significance of the current work is the use of model interspecies competition 
to reveal both the agent of aggression, linearmycins, and a multifaceted survival 
response from genes with no prior functional assignment, yfiJKLMN. 
 
 Only gain-of-function mutations in yfiJK were identified in this study to cause 
LDA resistance. The resistance alleles of yfiJK were due to missense mutations causing 
changes to four regions of YfiJK: (i) the third TM helix in YfiJ, (ii) the cytoplasmic 
linker between the fifth TM helix and the dimerization and histidine phosphotransfer 
(DHp) domain in YfiJ, (iii) the C-terminal end of the DHp, and (iv) the regulator domain 
in YfiK. We hypothesize that each of these amino acid substitutions are responsible for 
conformational changes in YfiJK, leading to a constitutively active state. A previous 
study described a similar phenotype caused by point mutations of pmrAB in 
Pseudomonas aeruginosa. Gain-of-function alleles in pmrB lead to polymyxin B 
resistance via increased signaling through the histidine kinase (211). We also considered 
an alternative mechanism, wherein point mutations in yfiJK could lead to non-cognate 
interactions of YfiJ or YfiK and aberrant signal transduction (212). However, we view 
this mechanism as unlikely because only one of the affected residues (L254) lies in the 
DHp domain, which is predicted to be involved in specificity (212), and LDA resistance 
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required the presence of the phosphoacceptor residue in the cognate partner. Thus, we 
conclude that gain-of-function alleles cause LDA resistance and changes in both colony 
morphology and motility, and that the signaling is specific to YfiJK. Although the 
specific defects caused by each allele will require further investigation, we note that 
many of the mutations we observed are responsible for amino acid changes in the 
cytoplasmic linker of YfiJ. The cytoplasmic linker domain of HKs has been best 
characterized in periplasmic-sensing histidine kinases. In these kinases, the linker may 
contain conserved PAS or HAMP domains that are necessary for signal transduction 
from the sensory machinery to the kinase domains (183, 213–215). YfiJ has neither of 
these conserved domains, suggesting that the short linker in this protein is the sole 
signal-transducing domain. The mutations in the yfiJ linker, through fixing the protein in 
activated state, may be very informative for determining the mechanism of signal 
transduction via the YfiJ intramembrane histidine kinase. 
 
 Two-component systems are commonly involved in sensing antibiotic and 
environmental stress (209, 210). Among Firmicutes, a conserved mechanism for 
resistance to peptide antibiotics pairs genes for two-component systems and ABC 
transporters (193, 216, 217). The identification of mutations in yfiJK suggests the cell 
envelope is the linearmycin target, based on comparison to other TCS-ABC transporter 
pairs in B. subtilis (193). Immediately downstream of yfiJK are three genes, yfiLMN, that 
are predicted to encode an ABC transporter. We found that when B. subtilis was unable 
to produce YfiLMN, the colonies were LDA sensitive and failed to develop altered 
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colony morphology, regardless of the presence of a LDA
R
 allele of yfiJK. Furthermore, 
expression of yfiLMN under a constitutive promoter resulted in LDA resistance, even in 
the absence of yfiJK. Thus, the YfiLMN transporter is necessary and sufficient for LDA 
resistance. We hypothesize that YfiLMN may act as an exporter either for linearmycin 
or for cell envelope remodeling factors that lead to LDA resistance.  
 
 We used RNA-seq to identify genes that may be regulated by YfiJK. As expected 
we identified that yfiLMN expression was increased in a LDA
R
 mutant. We also 
identified yvfRS, encoding an ABC transporter of unknown function, and des as genes 
downregulated by YfiJK. The des gene encodes a fatty acid desaturase that is 
responsible for altering membrane fluidity in response to cold shock (204, 205). 
Intriguingly, B. subtilis strains with des deletions are more susceptible to daptomycin-
treatment, potentially due to their altered membrane fluidity (218). Antifungal polyenes 
structurally related to linearmycins target ergosterol in fungal membranes (177–180). 
The decreased expression of des in LDA
R
 mutants may contribute to resistance by 
affecting interactions between linearmycins and the cell membrane. Characterization of 
the cell envelopes of LDA sensitive and LDA
R
 strains may provide insight into the 
mechanism of linearmycin-induced lysis. 
 
 Mutants with LDA
R
 alleles of yfiJK grow as rugose colonies that resemble some 
aspects of biofilm development on rich media, which does not support traditional biofilm 
development. We demonstrated that we could functionally divorce this colony 
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morphology phenotype and LDA resistance by expressing yfiLMN constitutively and by 
introducing deletions of genes specifically required for biofilm development (epsH, 
sinR, degU). In so doing, we found that changes to the biofilm extracellular matrix are 
not responsible for resistance. LDA resistance may be modulated by specific matrix or 
cell envelope modifications activated by YfiJK-LMN, but such modifications remain to 
be identified. Although we found no obvious candidates in our RNA-seq data to explain 
colony morphological changes, the decreased expression of des or yvfRS may contribute 
to alterations in colony development. We also observed that LDA
R
 mutants respond to S. 
Mg1 by inducing motility, whereas wild type B. subtilis colonies are lysed. The 
pleiotropic phenotypes of yfiJK LDA
R
 alleles differentiate this coupled TCS-ABC 
transporter system from the BceRS-AB, PsdRS-AB, YxdJK-LM systems in B. subtilis, 
which appear to be dedicated antibiotic resistance systems (193, 219–222). To our 
knowledge, there are no phenotypes associated with development that have been 
attributed to these TCS-ABC transporter pairs, suggesting that YfiJK holds a specialized 
role in providing specific LDA resistance and in activating biofilm development and 
motility, both of which are known to increase resistance to antimicrobials (80, 98). We 
propose that activation of YfiJK-LMN promotes competitive fitness of B. subtilis by 
coupling a specific resistance mechanism (LDA
R
) with generalized-resistance that 
occurs as a consequence of altered development and motility. A recent study using 
strains of Pseudomonas aeruginosa demonstrates that biofilm formation is stimulated in 
response to competition, as opposed to a cooperative function of different strains or cell 
types (157). The identification of YfiJK as a regulator of biofilm and motility functions 
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is consistent with a model wherein competition with S. Mg1 induces developmental 
responses, including biofilm and colony spreading, among a subpopulation of resistant 
cells of B. subtilis. 
 
 Using microbial competition we assigned resistance and developmental functions 
to a previously uncharacterized TCS in B. subtilis. Without imposing the conditions of 
competition on B. subtilis, these TCS functions may be difficult to identify, because the 
yfiJ, yfiK, and yfiJK deletion mutants have no phenotype when compared to wild type. 
The B. subtilis genome encodes 36 histidine kinases and 34 response regulators (223). 
The functions of at least 11 of these TCS are currently unknown. Bacteria use these 
systems to sense and respond to their environment, which include stresses and nutrient 
conditions, but also include other bacteria and their antagonistic enzymes and 
specialized metabolites. Many TCS of unknown function may have a role in the context 
of microbial competition, despite having no distinct phenotype under laboratory 
conditions. Thus, microbial competition studies provide an effective approach to identify 
functions for TCS and other genes that promote competitive fitness of bacteria. By 
expanding our knowledge of individual competitive functions, a more comprehensive 
view of bacterial competitive fitness will emerge. 
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Materials and methods 
Bacterial strains, media, and general cloning 
The strains of B. subtilis we used in this study are listed in Table A3. We 
cultured B. subtilis strains at 37 °C in lysogeny broth (LB) [1% tryptone (Bacto), 0.5% 
yeast extract (BBL), 0.5% sodium chloride (Sigma)] or on LB agar plates [1.5% Agar 
(Bacto)]. We maintained Streptomyces sp. Mg1 (PSK0558) as a spore stock in water at 4 
°C. Unless otherwise stated all co-cultures were grown on MYM [0.4% malt extract 
(Bacto), 0.4% yeast extract (BBL), 0.4% D-(+)-maltose monohydrate (Sigma)] with 2% 
agar (Bacto). We used chloramphenicol (5 µg/mL), kanamycin (5 µg/mL), MLS (1 
µg/mL erythromycin, 25 µg/mL lincomycin), spectinomycin (100 µg/mL), and 
tetracycline (20 µg/mL) as needed. The primers we used in this study are listed in Table 
A4. We used Escherichia coli DH5α or XL-1 blue for plasmid maintenance and 
manipulation. We prepared All B. subtilis genetic manipulations in either the 168 or 
PY79 strain background and then transduced them to NCIB3610 using SPP1 phage 
transduction as previously described (224). 
 
LDA extraction and identification 
 We wetted 1 g Diaion HP-20 resin in 25 mL methanol (MeOH) followed by 
washes with 25 mL of water five times while shaking. Next, we removed the bulk liquid 
and resuspended the resin in 250 mL of MYM. We sterilized the media and resin by 
autoclaving the mixture. We inoculated cultures using 1 mL of S. Mg1 that was grown 
overnight (10
7
 spores in 3% tryptone soy broth). We cultured the S. Mg1 for 6 d at 30 °C 
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while shaking at 225 RPM in the dark. We performed all culture growth and extractions 
in low ambient light, because the activity of extracts was diminished or lost if 
manipulated in the light. We separated the HP-20 resin from the bulk of the S. Mg1 by 
repeatedly washing the resin with water until all visible filaments were removed. To 
extract resin-bound molecules, we washed the resin with successive 25 mL volumes of 
MeOH until the solvent was clear. To generate our crude extract, we pooled the washes 
and removed MeOH using a rotary evaporator. The crude extract was dissolved to 100 
mg/mL in 50% acetonitrile (ACN) and fractionated over a C8 solid-phase extraction 
(SPE) column eluted with a MeOH/water stepwise gradient. We removed solvent from 
our fractions using a rotary evaporator and suspended the fractions to 50 mg/mL in 50% 
ACN. We tested the fractions for lytic activity against B. subtilis by spotting 10 µL on a 
filter paper disc adjacent to a B. subtilis colony that had been pre-grown for 24 h and 
observing lysis over a period of 48 h. The 70% and 80% MeOH fractions were active in 
the lysis assay and pooled for further fractionation. 
 
 Using an Agilent 1200 HPLC system, we further fractionated the active extract 
fractions over a semi-preparative (10 x 250 mm, 5 µm) Phenomenex Luna C18 column 
and eluted with an ACN/20 mM ammonium acetate pH 5 (NH4OAc) gradient running at 
5 mL/min. The elution program was as follows: 1) 5 min at 40% ACN then 2) a gradient 
up to 50% ACN over 10 min then 3) a gradient up to 75% ACN over 5 min, and 4) a 
gradient diminishing to 40% over 5 min. We injected 35 µL of pooled active fraction per 
injection. We collected time based fractions and tested them for lytic activity as above. 
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Active fractions were analyzed by mass spectrometry using a Bruker microTOF mass 
spectrometer. For NMR analysis, the sample was dried and resuspended in 300 µL 
deuterated dimethylsulfoxide (DMSO-d6). We collected spectra on a Bruker Avance III 
500 MHz spectrometer equipped with a cryoprobe. 
 
 
LDA resistant mutant isolation and whole genome sequencing 
We diluted overnight cultures inoculated with a single colony of B. subtilis 
ΔpksX (PDS0067) into 5 mL of LB at OD600 = 0.08 with no antibiotics. We cultured the 
cells to early stationary phase (OD600 = 0.9-1.5) at 37 °C and spotted 2 µL on MYM7 
plates [as above with 100 mM MOPS and 25 mM potassium phosphate buffer pH 7, 
1.5% agar (Bacto)]. After 24 h incubation, we placed 6 mm filter paper discs next to the 
B. subtilis colonies and added 10 µL of extract from S. Mg1. We returned the plates to 
the incubator and observed lysis and colony degradation over the next 48 h. After 
incubation, small colonies were observed in the region of lysis. We isolated 60 small 
colonies and passaged them on LB plates. We tested each isolate for LDA resistance 
using co-culture, as described below. 
  
 LDA
R
 mutants that were stable through passage in isolation and the parental 
ΔpksX strain were used for whole genome sequencing. Sequencing libraries were 
prepared using the PCR-free TrueSeq Kit from Illumina. 250 bp paired-end reads were 
sequenced using an Illumina MiSeq. We mapped reads from the LDA
R
 mutants onto the 
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parental ∆pks strain using MIRA and identified mutations by consensus discrepancy 
between the sequences (225, 226). 
 
Transposon mutagenesis 
We used a strain of Bacillus subtilis harboring the pMarA plasmid transposon 
mutagenesis system (227) (PDS0121) to identify genes that may cause lysis under 
linearmycin-induced stress. pMarA is a single copy plasmid that contains a Himar1 
transposase gene under control of the housekeeping sigma factor σA. Transposition 
occurs during growth and each cell should undergo a single transposition event. We 
diluted cultures of PDS0121 that were grown overnight at 22 °C to OD600 = 0.05 in 5 mL 
of LB with kanamycin (5 µg/mL). When the OD600 reached 0.3-0.4 we raised the 
temperature from 22 °C to 42 °C, which restricts replication of pMarA. When the culture 
reached OD600 = 1 (~10
9
 cells/mL) we added 10 µL of LDA-containing and returned 
cultures to 42 °C. At this point the culture represented a library of transposon-insertion 
mutants. After ~3 hours of incubation, the OD600 decreased ≥ 10-fold upon cell lysis. We 
plated the surviving cells on LB containing LDA extract. Following incubation of the 
plates, we isolated ~200 survivors, which we subsequently passaged on LB without 
LDA extract. We then tested the passaged isolates for LDA resistance in culture with S. 
Mg1. Only a single stable LDA
R
 mutant passed through the selection. We mapped the 
transposon insertion to the yopC gene, which encodes a predicted membrane protein 
within the Spβ prophage sequence (228). A ΔyopC strain was not LDA resistant in 
culture with S. Mg1. We backcrossed the mutant strain to wild type and found the 
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transposon-associated marker was unlinked to LDA resistance. To locate the LDA
R
-
conferring allele, we sequenced this strain. The sequence revealed an additional point 
mutation in yfiJ (L254P substitution), which we confirmed for resistance to LDA (Table 
1). 
 
Construction of yfiJK and yfiJKLMN deletion mutants 
 We used long-flanking homology PCR to delete yfiJK and yfiJKLMN. Briefly, to 
delete yfiJK we amplified the upstream sequence using primers 13 and 14, the 
downstream sequence using primers 15 and 16, and the kanamycin resistance cassette 
from pDG780 using primers kn-fwd and kn-rev. We mixed the three PCR products 
together and used primers 13 and 16 to amplify a product, which we directly transformed 
into PDS0312 to generate PDS0546.  
 
To delete yfiJKLMN we used primers 76 and 77 to amplify the upstream 
sequence of yfiJ and primers 78 and 79 to amplify the downstream sequence of yfiN. We 
combined these fragments with the kanamycin resistance cassette and amplified a 
product using primers 76 and 79, which we directly transformed into PDS0312 to 
generate PDS0652. 
 
Complementation of yfiJ and yfiJK 
 To test alleles of yfiJ, we complemented the ΔyfiJ deletion. We amplified yfiJ 
with primers 25 and 26 from wild type and spontaneous LDA
R
 mutants. These primers 
include a BamHI and EcoRI site, which we used to clone the product into plasmid 
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pDR183 (lacA::mls). We transformed the plasmids into PDS0559 and verified insertion 
into the lacA locus by PCR. We moved these constructs into PDS0555 using SPP1 phage 
transduction. 
 
We tested alleles of yfiK by complementing both yfiJK together into a ΔyfiJK 
strain. We complemented both genes together because yfiK is the second gene in the 
operon. We amplified yfiJK using primers 54 and 75 from wild-type or spontaneous 
LDA
R
 mutant and the plasmid backbone of pDR111 (amyE::spc, without the IPTG-
inducible system) using primers 59 and 74. We combined these products together using 
Gibson assembly (229), transformed the plasmid into PDS0546, and verified insertion 
into the amyE locus by PCR. We moved these constructs into PDS0554 using SPP1 
phage transduction. 
 
Complementation with Pspac(c)yfiLMN 
To complement yfiLMN we first amplified Pspac(c) from BJH157 using primers 
112 and 113. These primers included an EcoRI and SpeI site, which we used to clone the 
Pspac(c) fragment into pBB275 to generate pRMS1. We amplified yfiLMN using primers 
120 and 121 and the backbone of pRMS1 using primers 118 and 119. We assembled 
these fragments using Gibson assembly and transformed them directly into PDS0652 to 
generate PDS0717. 
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Site-directed mutagenesis 
 We used primer-mediated site-directed mutagenesis to generate phosphoacceptor 
residue changes. To generate yfiJ
H201N
 alleles we used primers 42 and 43. To generate 
yfiK
D54A
 alleles we used primers 50 and 51. Briefly, we PCR amplified plasmids 
containing yfiJ or yfiJK using overlapping primer pairs that included a single nucleotide 
change, DpnI-digested the reactions, and transformed E. coli. We isolated the plasmids 
and sequenced them to verify the mutation. We used plasmids containing the mutations 
to transform B. subtilis as above. 
 
Lysis co-culture assays 
To observe lysis, we grew cultures of B. subtilis as above and spotted 1 µL of B. 
subtilis on 20 mL MYM plates. We then spotted 5 µL of a 10
9
 spores/mL stock of S. 
Mg1 ~6 mm from B. subtilis. These plates were incubated at 30 °C and monitored every 
24 h. 
 
Motility co-culture assays 
 To observe the effect of yfiJ alleles on motility we used a modified version of a 
motility assay we previously described (31). We plated 2.5 µL of a 10
7
 spores/mL stock 
of S. Mg1 on a 25 mL MYM plate and incubated the plate at 30 °C. After 12 h of 
growth, we spotted 1.5 µL of B. subtilis, grown as above, perpendicularly to S. Mg1, 
returned the plates to the 30 °C incubator, and monitored the plates every 24 h. 
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Measuring minimum lytic concentrations 
 To measure MLC values we used an agar diffusion assay. We grew cultures of a 
LDA sensitive strain (PDS0571) and a LDA
R
 strain (PDS0572) in 25 mL of MYM to 
OD600 = 2. When the cultures reached this density, we centrifuged the cultures at 3220 x 
g for 5 min and resuspended the cell pellet in half the volume to reach OD600 = 4. We 
mixed 1.5 mL of resuspended cells with 4.5 mL of MYM agar (0.67%) and poured the 
layer over a MYM plate to generate an overlay with OD600 = 1 and 0.5% agar. We 
placed 6 mm filter paper discs onto the overlay and added 10 µL of 2-fold serial 
dilutions of daptomycin, ECO-02301, and LDA to the discs. Afterwards we incubated 
the plates for 4 h at 30 °C and then photographed the plates. We measured haloes of lysis 
using ImageJ and determined MLC values by plotting natural log-transformed antibiotic 
concentrations versus the area of lysis, and calculated the intercept to determine MLC 
values for the lytic agents (230). 
 
RNA-seq 
We grew two independent cultures each of yfiJK
+
 (PDS0627) and yfiJ
A152E
K  
(PDS0685) strains as above. When the cultures reached early stationary phase we diluted 
them 10
-3
 in LB and spread plated 100 µL on MYM plates. After 24 h we scraped the 
lawns of B. subtilis into RNAprotect Bacteria Reagent (Qiagen) and isolated RNA using 
an RNeasy mini kit (Qiagen). We removed trace DNA from the RNA samples using a 
Turbo DNA-free kit (Applied Biosystems). The ribosomal RNA was removed from 
RNA samples using a Ribo-Zero rRNA Removal Kit (Gram-Positive Bacteria) 
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(Illumina). 50-bp single-end reads libraries were prepared using a TruSeq Stranded Total 
RNA Kit (Illumina) and sequenced on an Illumina HiSeq 2500. We mapped reads to 
each open reading frame (ORF) in the B. subtilis 168 genome (GenBank: NC_000964.3) 
with kallisto (231) and used edgeR (232) for differential gene expression analysis. We 
filtered out lowly expressed ORFs (<1 count per million and only represented in one of 
the four samples) and used trimmed mean of M-value normalization to calculate 
effective library sizes before analysis [98]. We used the single-factor exact test and 
reported differentially expressed genes with a false discovery rate cutoff of < 1
-4
 (233). 
The raw reads for this experiment are accessible from NCBI BioProject Accession 
PRJNA295934. 
 
qRT-PCR 
We isolated RNA from PDS0627 and PDS0685 as above and preformed qRT-
PCR similarly as previously described (31). Briefly, we used 100 ng of total RNA as 
template for cDNA synthesis using a High-Capacity RNA-to-cDNA Kit (ThemoFisher 
Scientific). We used an SsoAdvanced Universal SYBR Green Supermix Kit (Bio-Rad) 
for and preformed quantitative PCR with a CFX96 Touch real-time PCR thermocycler 
(Bio-Rad). We used the following cycling parameters: denaturation at 95 °C for 30 s; 40 
cycles of denaturation at 95 °C for 15 sec, annealing at 58 °C for 30 s, and extension at 
72 °C for 30 s; and a final melting curve from 60 °C to 95 °C for 6 min. We used gyrB 
as our reference gene. We amplified yfiL using primers q1 and q2 and gyrB using 
primers gyrB qPCR-fwd and gyrB qPCR-rev (Table A4). We ran each reaction in 
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triplicate. Using LinReg (234) we calculated primer efficiency and quantification cycle 
values. We normalized yfiL abundance to gyrB and report fold difference relative to 
PDS0627. 
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CHAPTER III  
LINEARMYCINS ACTIVATE A TWO-COMPONENT SIGNALING SYSTEM 
INVOLVED IN BACTERIAL COMPETITION AND BIOFILM FORMATION 
 
Summary 
  The mechanisms that bacteria use in competition are numerous and differ among 
species. For instance, some bacteria produce chemically diverse specialized metabolites 
with numerous competitive activities including antibiosis. Meanwhile, other species of 
bacteria engage biofilm formation and motility mechanisms to survive and escape 
competition. While specialized metabolite production and biofilm formation are 
relatively well understood for bacterial species isolated in monoculture, how bacteria 
collectively employ and respond to these and other mechanisms during competitive 
interactions is not well studied. Within the context of bacterial communities, fitness is 
determined, in part, by success in competitive interspecies interactions. Therefore, to 
address fundamental questions relating to the competitive functions of different species, 
we have developed a model system using two species of soil bacteria: Bacillus subtilis 
and Streptomyces sp. Mg1 (S. Mg1). Using this system, we previously found that 
linearmycins produced by S. Mg1 cause lysis of B. subtilis cells and degradation of 
colony matrix. We identified linearmycin resistant mutants that activate the YfiJK two-
component signaling system resulting constitutive expression of the yfiLMN operon, 
encoding an ATP-binding cassette transporter. Intriguingly, we observed that the 
linearmycin resistant mutants also form biofilms. Here, we determined that expression of 
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the yfiLMN operon, particularly yfiM and yfiN, is necessary for biofilm formation. Using 
transposon mutagenesis we identified highlight chaperone functions and other gene 
products that contribute to YfiLMN-mediated biofilm formation. To understand how 
YfiJ is activated we generated a transcriptional fusion of the yfiLMN promoter to lacZ. 
We found that YfiJ signaling is activated by linearmycins and other polyene metabolites. 
Finally, using a truncated YfiJ, we show that YfiJ requires its transmembrane domain 
and to activate downstream signaling. Taken together, our results suggest coordinated 
antibiotic resistance and biofilm formation by a single ABC transporter promotes 
competitive fitness of B. subtilis. 
 
Introduction 
 Bacterial cells distribute themselves in the environment according to their 
individual metabolic and physiological needs. Though, neighboring cells may also 
cooperate with each other, competition is more likely to be the dominant mode of 
bacterial interaction in nature (1). Bacteria have evolved numerous mechanisms to 
engage in competition with their neighbors. Competitive mechanisms include production 
of specialized metabolites including antibiotics, contact-dependent inhibition systems, 
and type VI secretion systems that directly deliver toxins into cells, among others 
(reviewed in 235). As an outcome of competition, cells may be killed or displaced from 
favorable microenvironments, thus eliciting changes to the structure of the microbial 
community at large. As community dynamics change, other individuals or aggregates of 
cells may suffer fitness costs if they fail to adapt (236). Therefore, to avoid loss of 
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fitness and survive, bacteria integrate and respond to external signals that indicate 
changing environments. 
 
 The external signals bacteria sense include abiotic factors, such as nutrient and 
oxygen levels. In this way, bacteria can sense changes in these resources as a proxy for 
the presence of competitors. For example, when Amycolatopsis sp. AA4 and 
Streptomyces coelicolor are grown together, A. sp. AA4 downregulates the expression of 
its own siderophore biosynthesis genes and steals the siderophores produced by S. 
coelicolor. Subsequently, S. coelicolor induces expression of its siderophore 
biosynthesis genes to produce enough siderophores to capture the iron it requires (17). 
Bacteria also sense biotic factors that indicate the presence of microbial competitors. 
These factors include specialized metabolites. For instance, as populations of 
Vibrionales bacteria SWAT-3 grow they release extracellular metabolites, including the 
antibiotic andrimid, into their surrounding environment. When Vibrio cholerae is 
exposed to a gradient of andrimid, repulsive motility is induced and V. cholerae escapes 
competition (139). Finally, some bacteria are able to directly sense competitors by 
monitoring the integrity of their own cell envelopes. Such as the case of Pseudomonas 
aeruginosa, which responds to type VI secretion system-mediated attacks by directing 
the assembly and trigger of its own type VI secretion system directionally towards the 
offending competitor (116). As illustrated by these examples and others the ability to 
sense and respond to competitors and changing environmental conditions is essential for 
survival. 
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 Two-component signaling (TCS) systems are among the primary mechanisms 
through which bacteria sense and respond to their external environments (223). The 
typical TCS system is comprised histidine kinase, which is generally membrane-bound, 
and its cognate, cytoplasmic response regulator, which is usually a DNA-binding 
protein. When the histidine kinase senses its corresponding signal, it undergoes ATP-
dependent autophosphorylation on a conserved histidine residue. Next, this phosphate 
group is transferred onto an aspartic acid residue on the response regulator. After the 
phosphotransfer reaction, the response regulator changes its conformation, which affects 
its DNA-binding activity. The phosphorylated response regulator is a transcription factor 
and changes gene expression in response to the original signal (183). The Bacillus 
subtilis genome contains genes for 30 complete TCS pairs (223). Traditional laboratory 
approaches using genetic screens and mutational analyses have identified the signals and 
corresponding responses for many TCS signals. These TCS systems are responsible for 
sensing and maintaining metabolic homeostasis, nutrient uptake, and cell envelope 
structure, among other functions. However, many TCS system functions remain 
unknown because their corresponding deletion mutants have no phenotype under 
standard laboratory conditions. While many of these TCS systems are “non-essential” 
under laboratory conditions, their presence in the genome suggests this suite of signaling 
systems likely provides a selective advantage in a competitive environment. 
 
 The cell envelope is a common target for antibiotics and excessive damage to this 
important structure is lethal (237–239). Thus, it is important for bacterial cells to monitor 
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the condition of their envelopes in response to the environment and attack by other cells 
(240, 241). Accordingly, of the 30 complete TCS pairs encoded in the B. subtilis genome 
(223), currently ten are known to be involved in the regulation and maintenance of the 
membrane and/or cell wall and resistance to antibiotics that target these structures (193, 
221, 222, 241–250). Typically, identifying the signals sensed by TCS systems is 
difficult. Of particular interest are signals that indicate damage to cells, as these signals 
may represent new therapeutic targets that would allow circumvention of adaptive 
cellular responses. The identities of many TCS system signals have been genetically 
inferred, with fewer signals having been experimentally demonstrated. For example, it 
has been demonstrated that the histidine kinase PhoR senses intermediates of wall 
teichoic acid synthesis as a proxy for cellular phosphate levels (249) and the histidine 
kinase KinC senses potassium ion leakage (27). 
 
 Streptomyces sp. Mg1 (S. Mg1) produces a family of linear polyketides known as 
linearmycins (248). The linearmycins induce progressive lysis and degradation of B. 
subtilis cultured next to S. Mg1 (47, 248). We previously identified point mutations in 
the yfiJK, encoding a TCS system, responsible for causing B. subtilis to become 
linearmycin resistant (248). Deletion of the yfiJK operon had no effect on competitive 
outcome when B. subtilis was cultured with S. Mg1, suggesting that the point mutations 
were gain-of-function. Indeed, we found that strains of B. subtilis with the yfiJK point 
mutations increased expression of the yfiLMN operon, encoding an ATP-binding cassette 
(ABC) transporter necessary for linearmycin resistance. We also observe that the 
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linearmycin resistant mutants form biofilm-like colonies on rich media, suggesting that 
the YfiJK system promotes biofilm formation. 
 
 In the present study, we investigated how B. subtilis linearmycin resistant 
mutants form biofilms. To investigate this phenotype, we started by reevaluating the 
genes in the YfiK regulon. We find that YfiK only regulates the expression of the 
yfiLMN operon. We show that the biofilm phenotype is dependent upon yfiM and yfiN 
but not yfiL. Using transposon mutagenesis, we identified additional genes that are not 
differentially regulated in linearmycin resistant mutants but are required for biofilm 
formation. Next, we sought to identify signals that the YfiJK-LMN system senses. We 
used a transcriptional fusion of the yfiLMN promoter to lacZ as a reporter for YfiJK 
activity. We show that B. subtilis responds to S. Mg1 during competition by inducing 
expression of the yfiLMN operon. Finally, we show that activation of the yfiLMN 
promoter is dependent upon linearmycins, which are sensed by YfiJ. Together, our data 
indicate that B. subtilis responds to competition with S. Mg1 by specifically regulating 
expression of a linearmycin resistance transporter, which also affects colony 
morphology. Our results provide new insight into the function of TCS systems and ABC 
transporters in B. subtilis and suggest that concerted activation of specific resistance and 
biofilm functions may promote B. subtilis fitness when faced with competitive challenge 
by S. Mg1. 
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Results 
yfiJK complementation configuration influences colony phenotypes 
 In our previous study, we identified gain-of-function point mutations within the 
yfiJK operon that were responsible for causing B. subtilis to become resistant to 
linearmycins (248) (Figure 12A). Nine of these point mutations occurred within yfiJ, 
encoding a histidine kinase. We previously confirmed the yfiJ alleles by complementing 
a ΔyfiJ deletion strain at the ectopic lacA locus with monocistronic yfiJ under control of 
its native promoter and a plasmid-derived intrinsic terminator (Figure 12B). We also 
identified a single point mutation in yfiK, which encodes the cognate response regulator. 
Both open reading frames are part of a single transcript, as the yfiJ stop and yfiK start 
codons overlap and there are no putative promoter sequences for yfiK internal to the yfiJ 
sequence (Figure 12B). In addition, global expression profiles of B. subtilis confirm that 
yfiJ and yfiK are part of a bicistronic mRNA (251). Therefore, to test our yfiK allele, we 
complemented a ΔyfiJK deletion strain with bicistronic yfiJK at the ectopic amyE locus 
under the control of the native promoter and intrinsic terminator (Figure 12B). When 
complementing their respective deletion strains all identified point mutations resulted in 
linearmycin resistance, regardless of complementation configuration. 
 
We noticed phenotypic variation for the yfiJ
A152E
 allele depending on the 
complementation configuration. When we complemented the ΔyfiJ deletion strain with 
monocistronic yfiJ
A152E
, the B. subtilis colony reproducibly spreads out over the agar 
surface when cultured next to S. Mg1 (Figure 12A). However, when we complemented 
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the ΔyfiJK deletion strain with the bicistronic yfiJA152EK, the B. subtilis colony did not 
spread in response to S. Mg1. However, the bicistronic yfiJ
A152E
K complement was 
linearmycin resistant and developed abnormal morphology (Figure 12A). We 
hypothesized the differences in phenotype observed for the two strain configurations 
may result from effects of the complementation configuration. For example, the 
expression levels from the complementation loci (amyE vs. lacA), the relative strength of 
the native (-9.30 kcal/mol) and plasmid-derived (-13.20 kcal/mol) intrinsic terminators 
we used, or simply disruption of regulatory functions dependent on the bicistronic 
arrangement of yfiJK could explain the differences between the yfiJ
A152E
 monocistronic 
and yfiJ
A152E
K bicistronic complements. Though we currently do not know what 
factor(s) are responsible for the phenotypic variation we observe, we wanted to 
determine if complementation configuration affects YfiJK signaling. 
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Figure 12. yfiJ complementation configuration influences competitive outcomes 
with S. Mg1 
 
(A) Wild type S. Mg1 (PDS0543) colonies (left) were spotted with B. subtilis colonies (right). The 
different genotypes of the B. subtilis colonies are labeled on the right. The strains of B. subtilis with yfiJ
+
 
(PDS0571) and yfiJ
A152E
 (PDS0572) were complemented at the lacA locus as monocistrons with its native 
promoter and a plasmid-derived terminator. The strains of B. subtilis with yfiJK
+
 (PDS0627) and 
yfiJ
A152E
K (PDS0685) were complemented at the amyE locus with their native operon structure including 
the promoter and terminator. The labels on the right indicate complementation locus. The strains with 
wild-type yfiJ or yfiJK suffer lysis and colony degradation. Both strains with yfiJ
A152E
 alleles are resistant 
to linearmycin-induced lysis, but the yfiJ
A152E
 monocistron strain displays a motile response to S. Mg1 that 
is absent in the yfiJ
A152E
K strain. The photograph was taken after 72 h co-incubation on MYM agar. The 
photograph is representative of triplicate samples. Scale bar is 5 mm. (B) (top) The configuration for 
yfiJKLMN at the native chromosome locus. The overlapping stop codon in yfiJ and start codon in yfiK are 
marked with * and M, respectively. (middle) The monocistronic complementation construct for yfiJ 
inserted at lacA. (bottom) The bicistronic complementation construct for yfiJK inserted at amyE. Open-
reading frames are shown as block arrows, promoters are shown as arrows, and intrinsic terminators are 
shown as hairpins. Plasmid-derived terminators marked with a # symbol. The scale bar is 1 kb. erm
R
, 
erythromycin resistance cassette. spc
R
, spectinomycin resistance cassette. 
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The YfiJK system regulates a single operon 
Previously, we used RNA-seq to compare the transcriptomes of the yfiJ
A152E
K 
and the yfiJK
+
 bicistronic complement strains. We found that expression of only the 
downstream yfiLMN operon was significantly upregulated (248) (Figure A7A). We 
identified a single active promoter within 150 bp upstream of yfiL and predicted no 
promoter sequences within yfiL, yfiM, or yfiN (Figure 12B). Therefore, to identify 
differential regulatory effects of the yfiJ
A152E
 monocistronic and yfiJ
A152E
K bicistronic 
complements, we used quantitative reverse transcription PCR (qRT-PCR) to compare 
the relative fold expression of yfiL between the strains. In the yfiJ
A152E
 monocistronic 
complement, we found that the expression of yfiL was ~135 fold higher than yfiJ
+
. For 
comparison, the expression of yfiL in the yfiJ
A152E
K bicistronic complement was ~20 fold 
higher than yfiJK
+
 (248). This suggests that the increased colony spreading exhibited by 
the monocistronic complement may be due, in part, to increased expression of the 
yfiLMN operon.  
 
Given our interest in understanding the downstream functions of YfiJK, we 
decided to use the monocistronic complements as our strain background for all following 
experiments. The results from both colony morphology assays and qRT-PCR for yfiL 
demonstrated that this strain background would enhance the contrast between expression 
differences from the wild-type yfiJ
+
 and mutant yfiJ
A152E
 complement strains. In addition 
to the yfiLMN operon, we identified the gene des and the yvfRS operon as significantly 
downregulated by YfiK (248) (Figure A7A). Because yfiL fold expression was much 
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higher in the monocistronic complement, we returned to our previous transcriptomic 
data to determine if expression of other genes, putatively repressed by YfiK, might be 
more extremely downregulated when comparing expression levels from the yfiJ
A152E
 and 
yfiJ
+
 monocistronic complements. However, using qRT-PCR we found no change in 
yvfS expression and increased expression of des, which is inconsistent with our previous 
results (Figure A8). Furthermore, artificial overexpression of des from a xylose-
inducible promoter had no impact on linearmycin resistance or colony morphology in 
yfiJK
+
 or yfiJ
A152E
K bicistronic complements (Figure A9). All taken together, given the 
magnitude of the difference of yfiL expression compared to des and yvfS, these results 
suggest that the yfiLMN operon is the only target directly regulated by YfiK. 
 
 Expression of the yfiLMN operon leads to biofilm formation 
 In monoculture, strains with the yfiJ
A152E
 allele develop colonies with a rough 
texture and a characteristic circular wrinkle in the center of the colony. In contrast, 
strains expressing a wild-type yfiJ
+
 allele develop relatively flat and featureless colonies 
(Figure 13). We reasoned that production of the YfiLMN ABC transporter would be 
responsible promoting biofilm formation. To test this hypothesis, we constructed a 
deletion of the yfiLMN operon in both the yfiJ
+
 and yfiJ
A152E
 strain backgrounds. In 
addition to rendering B. subtilis sensitive to linearmycin, the yfiJ
A152E
 ∆yfiLMN strain 
forms a colony that is indistinguishable from the wild type (Figure 13,Table 5). When 
we complemented the yfiLMN deletion with a constitutively expressed copy of the 
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yfiLMN operon from the Pspac(C) promoter, both resistance and biofilm formation were 
restored, regardless of yfiJ allele (Figure 13, Table 5). 
 
 
 
 
 
 
Figure 13. The biofilm morphology of linearmycin resistant mutants is dependent 
upon yfiLMN 
 
The yfiJ allele is indicated on the top and the yfiLMN status is indicated on the right. The B. subtilis yfiJ
+
 
strain (PDS0571) develops as a smooth colony but the yfiJ
A152E
 strain (PDS0572) develops a biofilm 
structure. Introduction of the ΔyfiLMN deletion has no phenotypic effect on a yfiJ+ strain (PDS0798) and 
causes the yfiJ
A152E
 strain (PDS0799) to develop as a smooth colony. Complementation of the ΔyfiLMN 
deletion with constitutively expressed yfiLMN (Pspac(c)-yfiLMN) results in both the yfiJ
+
 strain (PDS0801) 
and the yfiJ
A152E
 strain (PDS0802) developing as biofilms. The photograph was taken after 48 h incubation 
on MYM agar. The photograph is representative of duplicate samples. Scale bar is 5 mm. 
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Table 5. YfiLMN functions in linearmycin resistance and biofilm development 
 
 
Linearmycin Resistance Biofilm Development 
 
yfiJ
+
 yfiJ
A152E
 yfiJ
+
 yfiJ
A152E
 
yfiLMN
+
 - + - + 
ΔyfiLMN - - - - 
ΔyfiLMN +  
Pspac(c)-yfiLMN 
+ + + + 
ΔyfiL - - - + 
ΔyfiM - - - - 
ΔyfiN - - - - 
 
Wild-type alleles are designated with a superscript 
+
 symbol. The Pspac(c)-yfiLMN strains constitutively 
express yfiLMN regardless of yfiJ allele. The + and - symbols indicate presence or absence, respectively, 
of linearmycin resistance in co-culture with S. Mg1 or biofilm formation in monoculture on MYM media. 
 
 
 
 
We asked if a functional ABC transporter is necessary for both linearmycin 
resistance and biofilm formation. ABC transporters are typically comprised of two 
copies of a cytoplasmic nucleotide-binding domain protein, which provides energy 
through ATP hydrolysis, and two membrane-spanning domains that form the pore (252). 
In the case of YfiLMN, the nucleotide-binding domain is encoded by yfiL and the 
membrane-spanning domains are encoded by yfiM and yfiN (192). We constructed 
strains with single deletions of yfiL, yfiM, and yfiN. Surprisingly, the ΔyfiL strain was 
still able to form a biofilm, whereas the ΔyfiM and ΔyfiN single deletion mutant colonies 
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developed wild-type, non-biofilm morphologies (Table 5). While the ΔyfiL strain was 
still able to form a biofilm, it was sensitive to lysis when cultured with S. Mg1 (Table 5). 
This observation indicates that biofilm formation and linearmycin resistance are 
separable phenotypes, and that resistance likely requires a functional ABC transporter 
while biofilm formation does not. Consistent with our previous results, deletion of genes 
encoding important developmental regulators and structural components of biofilms had 
no effect on linearmycin resistance (248). Further, the wrinkled morphology of the 
yfiJ
A152E
 strains is reminiscent to that of P. aeruginosa mutants that are unable to 
produce the alternative electron acceptor phenazine. In phenazine-deficient mutants, 
wrinkling increases surface area but can be suppressed by supplementation with an 
alternative electron acceptor, such as nitrate (253). We hypothesized that overexpression 
of the yfiLMN operon may similarly affect redox homeostasis in B. subtilis. However, 
while we found nitrate supplementation caused B. subtilis to form smaller colonies, the 
yfiJ
A152E
 strain remained wrinkled indicating that biofilm formation is not likely caused 
by redox stress (Figure A10). 
 
Transposon mutagenesis identifies additional genes involved in YfiLMN-mediated 
biofilm formation 
 Expression of the yfiLMN operon alone was sufficient to cause B. subtilis to form 
biofilms (Figure 13, Table 5). This observation is particularly provocative because 
canonical B. subtilis biofilm development requires numerous changes in gene expression 
(197). Therefore, we asked how YfiLMN causes biofilm formation. Based on protein 
 87 
 
sequence alignments, YfiLMN belongs to the class of ABC exporters (192). However, 
based on the ability of the yfiJ
A152E
 ΔyfiL strain to form biofilms (Table 5), active 
transport is likely not required for this process. Therefore, we sought to use transposon 
mutagenesis to identify genes whose products are necessary for the biofilm formation 
but are not transcriptionally regulated by YfiK. 
 
 We introduced pMarA, a transposon mutagenesis plasmid (227) into the yfiJ
A152E 
strain background. Next, we screened colonies for aberrant morphology, when compared 
to the parental yfiJ
A152E
 strain.  In total we screened 13,577 colonies. Initially we 
identified 97 isolates with abnormal colony morphology (0.71% of total colonies 
screened). Of the 97 isolates, 19 (0.14% total) were of particular interest because, the 
colonies developed non-biofilm morphologies typical of yfiJ
+
 strains. To confirm linkage 
to the transposon insertion, we prepared SPP1 phage lysates from the 19 isolates and 
transduced a fresh yfiJ
A152E
 strain. The non-biofilm morphology was linked in 11 
transposon-mutagenized strains (0.08% total). We extracted genomic DNA from the 11 
linked transposon mutants and identified the position of each transposon insertion (Table 
6). 
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Table 6. Transposon insertion loci identified in morphology screen 
 
Insertion Position* Identity Gene Product Annotated Function 
76954(-) IGRhprT-ftsH hprT: hypoxanthine 
phosphoribosyltransferase 
 
ftsH: ATP-dependent metalloprotease 
purine salvage and interconversion, 
control of ftsH expression 
 
cell-division protein and general stress 
protein (class III heat-shock) 
423837(+) gerKB subunit of GerK germination receptor spore germination 
1525015(+)† IGRrpoY-yrkA rpoY: RNA polymerase ε subunit 
 
yrkA: putative membrane associated 
protein 
control of RNA polymerase activity 
 
unknown 
1866388(-) IGRymaF-miaA ymaF: unknown 
 
miaA: tRNA 
isopentenylpyrophosphate transferase 
unknown 
 
tRNA modification 
 
 
2300897(+)‡ ilvD dihydroxy-acid dehydratase  biosynthesis of branched-chain amino 
acids 
2328299(+) ypvA similar to ATP-dependent helicase unknown 
2625166(+) dnaJ heat-shock protein (activation of 
DnaK) 
protein quality control 
2627755(+) dnaK class I heat-shock protein (molecular 
chaperone) 
protein quality control 
2729794(+) azlB Lrp family repressor of the azlBCD-
brnQ-yrdK operon 
regulation of branched-chain amino 
acid transport 
2887777(+) IGRtig-ysoA tig: trigger factor (prolyl isomerase) 
 
ysoA: putative hydrolase 
nascent polypeptide folding 
 
unknown 
3856278(+) BSU_MISC_RNA_
57 
T-box upstream of thrZ regulation of thrZ expression 
 
*
Insertion nucleotide number and strand orientation is with respect to a sequenced genome of B. subtilis 
(GenBank accession: AL009126.3). 
†
This insertion was identified in two independent isolates. 
‡
This 
insertion has a phenotype in yfiJ
A152E
 but not yfiJ
+
 but does not lead to non-biofilm colony morphology. 
IGR, intergenic region 
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The gene functions identified in the screen do not fall into any known B. subtilis 
colony development pathways. However, we note a pattern for transposon insertions in 
and near genes associated with protein folding and quality control. We identified 
transposon insertions in dnaJ, dnaK, in the intergenic region between hprT and ftsH, and 
upstream of tig (Table 6). DnaJ and DnaK are components of a molecular chaperone 
complex involved in class I heat shock response (254, 255). FtsH is a membrane-
anchored metalloprotease with diverse functions that include biofilm formation, heat 
shock response and chaperone activity (256–258). Tig is a ribosome-associated 
chaperone that promotes the proper folding of nascent polypeptides (259). The 
transposon insertions we identified in dnaJ and dnaK occur near the 3′ end and 5′ of the 
coding sequences, respectively, and likely disrupt the function of both proteins. It is 
known that the expression of ftsH is regulated by a complex formed by HprT and TilS 
(260). Therefore the transposon insertion may have polar effects on ftsH expression. 
Likewise, the transposon insertion upstream of tig may influence tig expression, which 
could lead to a change in biofilm formation through loss of chaperone activity. 
 
 We also identified branched chain amino acids as a possible biofilm-related 
function. First, we identified an insertion in azlB, which encodes a Lrp family repressor 
of azlBCD-brnQ-yrdK operon. This operon encodes genes involved in transport of 
branched chain amino acids (261). Second, we also identified a transposon insertion in 
ilvD, which encodes a dihydroxy-acid dehydratase involved in branched chain amino 
acid biosynthesis (262). Disruption of ilvD in a yfiJ
A152E
 background results in colonies 
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with lobate edges but otherwise had no visible phenotype in a yfiJ
+
 background (Figure 
A11). In addition to protein synthesis, B. subtilis uses branched chain amino acids as 
precursors for anteiso-branched-chain fatty acid biosynthesis. Supplementation of 
isoleucine into culture medium can cause B. subtilis to produce more anteiso-branched-
chain fatty acids (246), which influences membrane fluidity and may affect membrane 
protein dynamics. However, we found that isoleucine supplementation had no effect on 
either yfiJ
+
 or yfiJ
A152E
 strains (Figure A12). Additional characterization is required to 
determine how alzB, ilvD, and the other identified transposon insertions influence 
YfiLMN-mediated biofilm formation. 
 
The YfiJK system responds to linearmycins 
 We were interested in identifying the signal(s) that naturally activate the YfiJK 
system and lead to expression of the yfiLMN operon. To identify patterns of yfiLMN 
operon expression, we first analyzed results from a large scale transcriptional analysis of 
B. subtilis grown under 269 different conditions (251). In that study, under all conditions 
tested expression of the yfiLMN operon was low and did not appreciably change (Figure 
A7B-C). These transcriptional profiling experiments suggest that the YfiJK system is not 
activated under monoculture growth conditions. Because activating yfiJK mutations 
caused B. subtilis to become linearmycin resistant due to expression of the yfiLMN 
operon (248), we reasoned that YfiJ may sense linearmycins and become activated 
during competition with S. Mg1. To test this hypothesis, we cultured a B. subtilis strain 
with a transcriptional fusion of the yfiLMN promoter to lacZ (PyfiLMN-lacZ) with S. Mg1. 
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We found that the PyfiLMN-lacZ reporter was only active in the portion of the colony 
immediately adjacent to S. Mg1 (Figure 14A). To determine if the YfiJK system 
responds to linearmycins, we cultured the reporter strain with S. Mg1 ΔlnyI, a strain that 
is unable to produce linearmycins (Hoefler BC, Stubbendieck RM, Josyula NK, Moisan 
SM, Schulze EM, and Straight PD; in preparation). We found that the PyfiLMN-lacZ was 
not induced by S. Mg1 ΔlnyI (Figure 14A). As a direct test that the YfiJK system 
responds to linearmycins, we spotted isolated linearmycins on top of a pre-grown B. 
subtilis colony. Over the following day, we observed that the B. subtilis colony was 
lysed from the inside out. We observed strong activation of the reporter on the periphery 
of the lysed region of the colony (Figure 14B). Together these results demonstrate that 
the YfiJK system responds to linearmycins directly and not some other factor produced 
by S. Mg1.  
 
Expression of the yfiLMN operon is induced by multiple polyenes 
A characteristic feature of the linearmycin family is the presence of multiple 
conjugated double bonds (172, 173). The polyene moiety is also present in several 
structurally related molecules that target the cytoplasmic membrane of fungi. These 
polyene antibiotics interact with ergosterol, which leads to membrane permeabilization 
and cell death (177–180). Because YfiJ is a membrane-anchored histidine kinase, we 
hypothesized that linearmycins may be sensed directly or as a secondary consequence of 
perturbation to the B. subtilis membrane. Therefore, we first asked if other polyenes 
activate YfiJK signaling or if activation is due to lytic stresses. First, we tested a linear  
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Figure 14. YfiJK signaling is activated by linearmycins and other polyenes 
 
(A) A strain of B. subtilis (right) with a transcriptional fusion of lacZ to the yfiLMN promoter (PyfiLMN-
lacZ) (PDS0838) was cultured with either S. Mg1 (left) wild type (WT) (PDS0543) or ΔlnyI (PDS0755), 
which does not produce linearmycins. The B. subtilis colony cultured with wild type S. Mg1 suffers lysis 
and colony degradation in addition to activation of the PyfiLMN-lacZ reporter. The B. subtilis colony cultured 
with S. Mg1 ΔlnyI is not lysed and does not activate the reporter. The photograph was taken after 72 h co-
incubation of MYM agar with X-gal. The photograph is representative of quadruplicate samples. (B) The 
indicated molecules were spotted on top of pre-grown B. subtilis colonies. Exposure to linearmycins 
caused the B. subtilis colony to lyse inside-out and activate the PyfiLMN-lacZ reporter on the periphery of the 
lysed region. Likewise, ECO-02301 also lyses B. subtilis and activates the PyfiLMN-lacZ reporter. 
Amphotericin B and nystatin activate the PyfiLMN-lacZ reporter without causing lysis. Daptomycin lyses B. 
subtilis without activating the PyfiLMN-lacZ reporter. The photographs were taken after B. subtilis colonies 
were exposed to the molecules for 24 h. The B. subtilis colonies were photographed from the bottom. The 
brightness and contrast were evenly adjusted across the panels to better show the blue color on the 
amphotericin B and nystatin-treated colonies. Scale bar is 5 mm. 
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polyene ECO-02301 that also causes lysis of B. subtilis (176, 248). Similar to 
linearmycin exposure, we observed that ECO-02301 lyses B. subtilis and activates the 
PyfiLMN-lacZ reporter on the periphery of the lysed region (Figure 14B). However, 
activation of the PyfiLMN-lacZ reporter by ECO-02301 was much weaker than activation 
by linearmycins. Next, we tested the cyclic polyenes amphotericin B and nystatin. While 
the cyclic polyenes do not lyse B. subtilis, they do weakly activate the PyfiLMN-lacZ 
reporter and demonstrate that activation of YfiJK signaling is not dependent upon lysis 
(Figure 14B). As a control, we also tested daptomycin, a structurally unrelated 
lipopeptide that lyses B. subtilis (248, 263). In contrast to the polyenes, lytic 
concentrations of daptomycin do not activate the PyfiLMN-lacZ reporter (Figure 14B).  
 
We observed that the strongest activation of the PyfiLMN-lacZ reporter was caused 
by linearmycin exposure. We spotted 15 µg of amphotericin B (~16 nanomol), 
daptomycin (~9 nanomol), ECO-02301 (~12 nanomol), and nystatin (~16 nanomol) onto 
the B. subtilis colonies. Based on HPLC measurements, we estimate that we spotted 
between 3 – 6 µg of linearmycins (~3 – 5 nanomol). This estimation suggests that YfiJK 
signaling is most strongly activated specifically by linearmycins. Intriguingly, we 
previously found that a linearmycin resistant mutant was only weakly cross resistant to 
ECO-02301, despite their similar structures (248). Taken together, our results indicate 
that linearmycins and not lytic membrane stress stimulates YfiJK signaling. We note that 
exposure to amphotericin B and nystatin can cause potassium ion leakage in B. subtilis 
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(27). Therefore, it is possible that YfiJK signaling is activated by other membrane 
perturbations induced by polyene antibiotics. 
 
 Transposon mutagenesis suggests linearmycins are directly sensed 
 The known mechanisms for polyene sensing are indirect. For instance, in the 
budding yeast Saccharomyces cerevisiae, nystatin is sensed by SLN1, which is an 
osmosensing histidine kinase that senses changes in turgor pressure and detachment of 
the cytoplasmic membrane from the cell wall (264). Likewise, in B. subtilis nystatin is 
sensed as an effect of induced potassium leakage from the cell by the histidine kinase 
KinC (27). As a first approach to ask if linearmycins are indirectly sensed we used 
transposon mutagenesis. Specifically we asked if we could identify a mutant that 
activates the PyfiLMN-lacZ reporter in the absence of an inducing polyene. We obtained 
four isolates (0.02% total) with spontaneous gain of blue color from a screen of 18,002 
transposon-mutagenized colonies. After phage transduction we retested transductants for 
PyfiLMN-lacZ reporter activation. We found that 2/3 transductants (0.01% total) were 
constitutively blue. For one isolate we never recovered transductants. In both positive 
transductants, we found that transposon insertion disrupted lacR. LacR is a 
transcriptional repressor for expression of lacA, which encodes an endogenous β-
galactosidase. Thus, the blue color in these transductants resulted constitutive lacA 
expression and not activation of the PyfiLMN-lacZ reporter construct (265). Assuming a 
Poisson distribution, we calculated the probability of screen saturation to be ~98.3%. 
Though inconclusive, the results and density of this transposon screen suggest that B. 
subtilis either senses linearmycin directly or that insertion mutants cannot reproduce the 
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effects of linearmycin exposure. To address these possibilities we first needed to 
determine the identity of the linearmycin sensor. 
 
YfiLMN is not required for B. subtilis to respond to linearmycins 
 YfiJ has no canonical PAS sensing domains, which are often found in histidine 
kinases (266). Protein domain analysis predicted five to six transmembrane helices, with 
no substantial extracellular domain (≤ 17 residues) (Figure A14A). Otherwise, no 
apparent sensing domains were detected. We previously reported similarities between 
the YfiJK-LMN system and peptide sensing and detoxification (PSD) modules encoded 
in the B. subtilis genome. For instance, the genetic context for yfiJKLMN, with TCS 
system and related ABC transporter functions encoded side-by-side is identical to the 
organization of the PSD modules (182, 193) (Figure 12B). The bacitracin sensing and 
detoxification system BceAB-RS is currently the best characterized PSD system (222, 
267–274). Similar to YfiJ, the histidine kinase BceS lacks PAS domains or a 
recognizable extracellular sensor sequence (Figure A14B). Instead, the ABC transporter 
BceAB is responsible for both sensing and detoxifying peptide antibiotics (271). 
Therefore ΔbceAB strains are unable to respond to bacitracin or induce expression of a 
PbceA-lacZ transcriptional reporter (268).  
 
Given the structural and genetic context similarities between YfiJ and BceS, we 
wanted to test if YfiLMN is required for B. subtilis to respond to linearmycins. We 
cultured ΔyfiLMN strains with S. Mg1 and found that the PyfiLMN-lacZ reporter was still 
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activated during competition with S. Mg1 (Table 7). Thus, unlike the bacitracin sensing 
system, YfiLMN does not act as the linearmycin sensor for B. subtilis. Unexpectedly, we 
found that the PyfiLMN-lacZ reporter was constitutively active in the yfiJ
+
 ΔyfiLMN strain 
during monoculture but the yfiJ
A152E
 ΔyfiLMN strain responded identically to the yfiJ+ 
strain (Table 7). We speculate that YfiLMN may have an additional regulatory function 
with respect to controlling activation of YfiJK signaling and the A152E substitution may 
affect this regulatory function.  
 
 
 
Table 7. The YfiJ TMD is required for linearmycin sensing 
 
 
Activation of PyfiLMN-lacZ 
Genotype -S. Mg1 +S. Mg1 
yfiJ
+
 - + 
yfiJ
A152E
 + + 
yfiJ
+ ΔyfiLMN + + 
yfiJ
A152E ΔyfiLMN - + 
yfiJ
ΔTMD
 - - 
yfiJ
ΔTMD, A152E
 - - 
 
Activation of PbceA-lacZ 
Genotype -S. Mg1 +S. Mg1 
yfiJ
TMD
-bceS
cyto
 - - 
yfiJ
TMD-linker
-bceS
cyto
 TBD TBD 
 
Wild-type alleles are designated with a superscript 
+
 symbol. The + and - symbols indicate presence or 
absence, respectively, of blue color as an indication of reporter activation. TBD, to be determined.  
 97 
 
YfiJ requires the transmembrane domain for B. subtilis to respond to linearmycins 
 The next most feasible identity of the linearmycin sensor was YfiJ. Specifically 
we hypothesized that the transmembrane domain in YfiJ (YfiJ
TMD
) is responsible for 
sensing linearmycins. We generated a truncation of yfiJ by deleting the sequence that 
encodes the transmembrane helices (yfiJ
ΔTMD
). We cultured yfiJ
ΔTMD
 with S. Mg1 and 
found that there was no activation of the PyfiLMN-lacZ reporter (Table 7). Unexpectedly, 
when we cultured a yfiJ
ΔTMD, A152E
 strain with S. Mg1 there was also no activation of the 
PyfiLMN-lacZ reporter (Table 7). As yfiJ
A152E
 strains constitutively express the yfiLMN 
operon, even in the absence of linearmycins, we hypothesize that membrane anchoring 
by the TMD is required for proper folding of YfiJ or additional regulatory functions such 
as phosphorylation of YfiK. 
 
 As the results of the TMD truncation were inconclusive we sought an alternative 
means to determine if the YfiJ
TMD
 senses linearmycins. Chimeras are a powerful tool to 
determine which protein domains in histidine kinases are responsible for sensing and 
responding to external stimuli (e.g. 27, 264, 275–279). Therefore we generated a 
chimeric histidine kinase consisting of the YfiJ
TMD
 fused to the cytoplasmic domain of 
BceS (BceS
Cyto
). If the YfiJ
TMD
 senses linearmycins, we hypothesized that linearmycin 
exposure would result in the YfiJ
TMD
-BceS
Cyto
 chimera phosphorylating BceR instead of 
YfiK. To test the output of the chimeric YfiJ
TMD
-BceS
Cyto
, we generated a transcriptional 
fusion of the bceA promoter to lacZ (PbceA-lacZ) (222). We cultured a strain encoding 
both yfiJ
TMD
-bceS
cyto
 and the PbceA-lacZ reporter with S. Mg1. However, we found that 
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competition with S. Mg1 did not activate the PbceA-lacZ reporter (Table 7).  Currently, we 
are building a construct that includes the YfiJ
TMD
 and cytoplasmic linker fused to the 
BceS dimerization and phosphotransfer and ATP-binding domains. We will test this 
construct for activation of the PbceA-lacZ reporter during competition with S. Mg1. 
 
Nystatin exposure provides subsequent protection against linearmycins 
 We wanted to determine if there are functional consequences for activation of 
YfiJK signaling in response to polyenes other than linearmycins. We hypothesized that if 
yfiLMN expression is induced by polyenes then B. subtilis should become more resistant 
to subsequent linearmycin exposure. We pre-cultured wild type B. subtilis in increasing 
concentrations of nystatin and then exposed cells to serial dilutions of linearmycins. We 
found that as the pre-culture nystatin concentration increased, there was a concurrent 
decrease in B. subtilis lysis by linearmycins (Figure A13). We verified that the increased 
linearmycin resistance was due to YfiLMN by repeating the experiment with an isogenic 
ΔyfiLMN strain. Without pre-culture in nystatin, we observed no differences in lysis 
when comparing the yfiJ
+
 and yfiJ
+
 ΔyfiLMN strains (Figure 15A). As expected, when 
we cultured yfiJ
+
 B. subtilis in nystatin we observed increased linearmycin resistance. 
Unexpectedly, pre-culture in nystatin also protected the yfiJ
+
 ΔyfiLMN strain from 
linearmycins. However, this linearmycin protection was reduced in comparison to yfiJ
+
 
strain (Figure 15B). Nystatin alone can protect B. subtilis from linearmycin but 
expression of the yfiLMN operon by nystatin pre-culture contributes more protection 
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against linearmycin. Currently, the YfiLMN-independent mechanism of nystatin-
mediated linearmycin protection is unknown. 
 
 
 
 
 
Figure 15. Preconditioning B. subtilis in nystatin enhances linearmycin resistance 
 
Bacillus subtilis yfiJ
+
 (PDS0571) and yfiJ
+
 ΔyfiLMN (PDS0798) were preconditioned in (A) 0 or (B) 100 
µg/mL nystatin then embedded in a soft agar overlay at equal cell density and spread over a MYM plate 
with the same concentration of nystatin. Two-fold serial dilutions of linearmycins were plated on top of 
the agar overlay. After 18 h incubation, the plates were photographed. Without the addition of nystatin, the 
lysis profiles are similar between the yfiJ
+
 and the yfiJ
+
 ΔyfiLMN. However, when B. subtilis was 
conditioned with nystatin both strains were more resistant to linearmycin but the yfiJ
+
 strain is more 
resistant than the yfiJ
+
 ΔyfiLMN strain. The numbers on the left indicate the dilution factor [(1/2)n] for each 
panel. 
 
 100 
 
Nystatin and KinC influence YfiLMN-mediated colony phenotypes 
 YfiJK signaling is activated by linearmycins and other polyenes. In addition, we 
showed that nystatin induces expression of the yfiLMN operon. Here, we return to our 
observation that expression of the yfiLMN operon leads to biofilm formation. We wanted 
to test if nystatin would induce YfiLMN-mediated morphological changes in B. subtilis. 
We cultured yfiJ
+
 and yfiJ
A152E
 strains with and without nystatin. As expected, without 
nystatin we observed that the yfiJ
A152E
 strain forms a biofilm whereas the yfiJ
+
 strain 
does not (Figure 16). However, when we cultured yfiJ
+
 with nystatin (100 µg/mL), we 
observed biofilm formation. This yfiJ
+
 biofilm was indistinguishable to a biofilm formed 
by yfiJ
A152E
 without nystatin supplementation. We tested the YfiLMN dependence of 
nystatin-induced biofilm formation by repeating the experiment with ΔyfiLMN strains. 
We found that a yfiJ
+
 ΔyfiLMN strain only weakly formed biofilms at the highest 
concentration of nystatin. This observation suggests that nystatin activates expression of 
the yfiLMN operon and leads to biofilm formation. 
 
 We wanted to determine if KinC was required for nystatin-induced YfiLMN-
mediated biofilm formation. We found that a yfiJ
+
 ΔkinC strain is mucoid, consistent 
with defects in biofilm production (27, 258). Intriguingly, the yfiJ
A152E
 ΔkinC strain 
formed a colony that closely resembled a yfiJ
+
 colony (Figure 16). Similarly, we found  
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Figure 16. KinC is required for YfiLMN-mediated biofilm formation 
 
The allele of yfiJ is indicated on the top. The yfiLMN and kinC status is indicated to the right. Without 
nystatin, the yfiJ
+
 B. subtilis strain (PDS0571) produces a wild-type colony. At the highest concentration 
of nystatin, the yfiJ
+
 strain forms a biofilm but the yfiJ
+
 ΔkinC strain (PDS0914) does not. Without 
nystatin supplementation, the yfiJ
A152E
 strain (PDS0572) forms a biofilm but the yfiJ
A152E
 ΔkinC strain 
(PDS0915) does not. As the nystatin concentration increases the yfiJ
A152E
 strain begins to spread over the 
plate in a yfiLMN-dependent manner. Both ΔyfiLMN strains only form hints of a biofilm at the highest 
nystatin concentration. The photographs were taken after 48 h incubation on MYM agar with the nystatin 
concentration in µg/mL indicated under each panel. The photographs are representative of duplicate 
samples. Scale bar is 5 mm. 
 
 
 
 
that at the highest nystatin concentrations that induce biofilm formation in yfiJ
+
, the yfiJ
+
 
ΔkinC strain was unable to form a biofilm. Taken together, these results indicate that 
kinC is required for biofilm formation. The addition of nystatin caused the yfiJ
A152E
 
strain to develop a new morphology. The yfiJ
A152E
 colonies flattened and spread out in a 
concentration-dependent manner. However, at the highest nystatin concentration, the 
ΔkinC deletion had only a small effect on the spreading morphology (Figure 16). As 
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both ΔkinC and ΔyfiLMN strains were unable to form biofilms under permissive media 
conditions or genetic backgrounds, we conclude that both gene products are required for 
YfiLMN-mediated biofilm formation.  
 
Discussion 
 In this study, we used a model system to determine how one organism senses a 
competitor and elicits an appropriate response to bacterial competition. Here, we showed 
that the transmembrane domain of the histidine kinase YfiJ senses linearmycins 
produced by S. Mg1 and other polyenes. YfiJ then phosphorylates its cognate response 
regulator, which activates expression of the yfiLMN operon.  yfiL, yfiM, and yfiN encode 
components of a linearmycin resistance ABC transporter that also induces biofilm 
formation. Further, we found that yfiM and yfiN but not yfiL are required for the biofilm 
phenotype of linearmycin resistant B. subtilis mutants. We identified other genes that are 
also required for YfiLMN-mediated biofilm formation including several chaperone-
encoding genes. We also determine that kinC is required for YfiLMN-mediated biofilm 
formation. 
 
 In addition to YfiK acting as a transcriptional activator of the yfiLMN operon, we 
previously reported des and the yvfRS operon as putative candidates for repression by 
YfiK (Figure A7) (248). In the present study we took advantage of an observation that B. 
subtilis strains complemented with monocistronic yfiJ
A152E
 exhibited a more extreme 
phenotype than strains complemented with bicistronic yfiJ
A152E
K (Figure 12). In our 
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previous study we focused on the latter strains for transcriptional analysis. Using the 
monocistronic complements, we determined that the YfiK only regulates yfiLMN 
operon, which is controlled by a single promoter. 
 
We were interested in determining what factors cause linearmycin resistant B. 
subtilis to form biofilms. Because YfiK only regulates the yfiLMN operon, we targeted 
this operon to determine its effects on biofilm formation. We deleted the yfiLMN operon 
in a yfiJ
A152E
 strain and found that the resulting colonies were indistinguishable from 
wild type. Further, we found that constitutive expression of the yfiLMN operon caused 
yfiJ
+
 strains to form biofilms (Figure 13). We found that that yfiM and yfiN were required 
for the yfiJ
A152E
 mutant to develop as a biofilm but yfiL was not. However, all three 
genes yfiL, yfiM, and yfiN were required for linearmycin resistance (Table 5). Taken 
together, the yfiLMN operon encodes a multifunctional ABC transporter that is involved 
in both biofilm formation and linearmycin resistance functions. This is in contrast to 
known ABC transporters that function solely in antibiotic resistance and to conventional 
B. subtilis biofilm development, which requires transcriptional regulation of many genes 
to affect colony development (197).  
 
We hypothesize that the two functions of YfiLMN may result from the assembly 
of different hetero-oligomeric ABC transporter protein complexes. In the cytoplasm, the 
NBDs of ABC transporters form soluble dimers, which are thought to act as an initiation 
step in ABC transporter complex assembly (280). Certainly, incorporation of the NBDs 
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is necessary for proper ABC transporter function. The yfiJ
A152E
 ΔyfiL strain formed a 
biofilm but became sensitive to lysis by S. Mg1 (Table 5). This observation confirms 
that linearmycin resistance requires active ATP hydrolysis. However, in E. coli the 
maltose ABC transporter MalFGK2 can form from multiple assembly pathways. All 
possible intermediate pairwise combinations of MalK (NBD), MalF (MSD), and MalG 
(MSD) were observed in vivo and found to be stable. This includes heterodimeric 
MalFG dimers (281). Further, MalFG dimers have been purified from E. coli and 
reassembled with MalK2 in vitro to form functional ABC transporter complexes (282). 
Together, this suggests that ABC transporter complexes can form from convergent 
assembly pathways of different dimer composition (281). The yfiJ
A152E
 mutant expresses 
the yfiLMN operon ~135-fold over wild type (Figure A8). Perhaps these higher 
expression levels of yfiM and yfiN ultimately result in stable YfiMN heterodimers 
forming in the membrane. Though YfiMN heterodimers lack YfiL and ATPase activity, 
the heterodimer may facilitate biofilm formation as a secondary effect of membrane 
perturbation. Alternatively, formation of excess YfiLMN or YfiMN complexes in the 
membrane may generate pores that promote potassium ion leakage and trigger biofilm 
formation (27). In support of the latter model, we found that kinC is necessary for 
YfiLMN-mediated biofilm formation (Figure 16).  
 
As an alternative approach to understanding the biofilm phenotype of YfiLMN, 
we used transposon mutagenesis and identified yfiJ
A152E
 mutants that failed to form 
biofilms. In 4/11 transposon mutants that we identified, there were transposon insertions 
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associated with genes encoding chaperone and protein quality control systems. 
Currently, we do not know how the YfiLMN transporter complex is formed. However, 
for the MalFGK2 ABC transporter complex, MalK acts as a chaperone for assembly of 
MalFG (282, 283). Therefore, it is not unprecedented that the MSDs YfiM and YfiN 
may require chaperone activity to properly fold. We speculate that during 
overexpression of yfiLMN in yfiJ
A152E
 strains chaperones promote the assembly of 
YfiMN complexes and lead to biofilm formation. We note that all transposon-
mutagenized strains that we identified were linearmycin resistant, which indicates that 
some chaperone systems must be dispensable for assembly of functional YfiLMN. More 
work is required to determine how the YfiLMN transporter complex is naturally formed 
and if chaperones are required for its formation. 
 
Using bacterial co-culture, we demonstrated that B. subtilis induces expression of 
the yfiLMN operon in response to S. Mg1. In particular, using a linearmycin biosynthesis 
deficient mutant and isolated linearmycins, we confirm that the YfiJK system responds 
to linearmycins (Figure 14A). With truncated variants of YfiJ, we show that the YfiJ 
transmembrane domain is required for activation of YfiJK signaling. As we currently do 
not know the mechanism of linearmycin-induced lysis of B. subtilis, we cannot rule out 
that linearmycin is sensed as a similar secondary effect. However, B. subtilis is similarly 
lysed by both linearmycins and daptomycin but does not induce yfiLMN expression in 
response to daptomycin (Figure 14B). Further, we were unable to identify any 
transposon mutants that spontaneously activated YfiJ signaling. Consequently, we 
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hypothesize that YfiJ act as a direct linearmycin sensor. Therefore, we rename 
yfiJKLMN to lnrJKLMN for linearmycin sensing and resistance. 
 
Here we expand our understanding of a model system to include transcriptional 
regulation and biofilm formation as a response to bacterial competition. As we better 
understand model systems for interspecies interactions in the laboratory, we begin to 
piece together the rich and multifaceted suite of functions that bacteria use to survive 
and compete in the environment. By incorporating this information into models of 
bacterial communities, we will gain a more thorough understanding of community 
dynamics and their influence on the environment at large. 
 
Materials and methods 
Bacterial strains, media, and primers 
 The strains of B. subtilis used in this study are listed in Table A5. For general 
propagation and manipulation, we inoculated B. subtilis and E. coli strains in lysogeny 
broth (LB) [1% tryptone (Bacto), 0.5% yeast extract (BBL), 0.5% sodium chloride 
(Sigma)] or on LB agar plates [with 1.5% agar (Bacto)]. We maintained S. Mg1 strains 
as spore suspensions in water at 4 °C. All experiments used MYM [0.4% malt extract 
(Bacto), 0.4% yeast extract (BBL), 0.4% D-(+)-maltose monohydrate (Sigma), 1.5% 
agar (Bacto)]. We supplemented chloramphenicol (5 µg/mL), kanamycin (5 µg/mL), 
MLS (1 μg/mL erythromycin, 25 μg/mL lincomycin), and 5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside (X-gal) (40 µg/mL) into media as needed. All primers are listed 
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in Table A6. We used Escherichia coli XL-1 blue or DH5ɑ for plasmid maintenance and 
manipulation. We prepared B. subtilis genetic manipulations in the 168, PY79, or 
NCIB3610 ΔcomI (284) strain backgrounds with one-step transformation. We used 
phage SPP1 to transduce our genetic manipulations into the NCIB3610 strain 
background as previously described (224). 
 
Lysis co-culture assays 
We performed all lysis co-culture assays as previously described (248). 
 
RNA extraction and qRT-PCR 
 After 24 h of growth we scraped lawns of B. subtilis into RNAprotect Bacteria 
Reagent (Qiagen). We lysed 200 μL of fixed cells using lysozyme and Proteinase K 
digestion for 45 min at ambient temperature while vortexing. To extract RNA we used 
TRIreagent (Sigma) and standard procedures. We removed trace DNA from RNA 
samples using a Turbo DNA-free kit (Applied Biosystems). We performed qRT-PCR as 
previously described (248). All primers used for qRT-PCR are listed in Table A7. 
 
Construction of yfiLMN, yfiL, yfiM, and yfiN deletion strains 
To generate a yfiLMN deletion strain, we used long-flanking homology PCR. We 
used primers 11 and 75 to amplify an upstream sequence of yfiL, primers 79 and 155 to 
amplify a downstream sequence of yfiN, and primers 153 and 154 to amplify the MLS-
resistance cassette from strain BKE08290. We mixed the three products together and 
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used primers 11 and 79 to amplify a LFH PCR product. We transformed the product 
directly into PDS0559 (ΔyfiJ) to generate PDS0795. We transduced the linked ΔyfiJ 
ΔyfiLMN::mls into wild type B. subtilis NCIB3610 (PDS0742) to generate strain 
PDS0796. We transduced pDR244 into PDS0796 to generate strain PDS0797 with 
markerless deletions ΔyfiJ ΔyfiLMN. To generate single deletions of yfiL, yfiM, and 
yfiN, we used primers 21 and 81 to amplify DNA containing the given deletions marked 
with a mls resistance cassette from strains BKE08310, BKE08320, and BKE08330, 
respectively. The PCR products were directly transformed into PDS0559 to generate 
ΔyfiJ ΔyfiL::mls (PDS0788), ΔyfiJ ΔyfiM::mls (PDS0810), and ΔyfiJ ΔyfiN::mls 
(PDS0811) strains. As above, we transduced the mls marked deletions into PDS0742 and 
used pDR244 to generate markerless deletions ΔyfiJ ΔyfiL (PDS0789), ΔyfiJ ΔyfiM 
(PDS0814), and ΔyfiJ ΔyfiN (PDS0815). To complement the yfiJ deletions, we 
transduced lacA::yfiJ
+
 (mls) or lacA::yfiJ
A152E
 (mls) from PDS0562 and PDS0563, 
respectively. 
 
In vivo transposon mutagenesis 
We used plasmid pMarA for in vivo transposon mutagenesis of B. subtilis. The 
pMarA plasmid contains a Mariner element under control of the housekeeping sigma 
factor σA and a temperature-sensitive origin of replication (227). For our morphology 
screen, we transduced pMarA into PDS0572. For the spontaneous activation of PyfiLMN-
lacZ screen, we transduced pMarA into PDS0838. We selected transductants on 
kanamycin and MLS. We inoculated single colonies overnight in LB at 30 °C with both 
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antibiotics. After overnight growth, we diluted the cultures to OD600 = 0.08 and grew the 
cultures to OD600 = 0.3-0.4 at 30 °C, only under kanamycin selection. Afterwards, we 
raised the temperature to 42 °C to restrict pMarA replication. When the cultures reached 
OD600 = 1, we mixed 500 µL culture aliquots with 500 µL of 50% glycerol and froze the 
transposon libraries at -80 °C. 
 
Colony morphology screen 
To screen for B. subtilis mutants with altered colony morphology, we thawed an 
aliquot of the transposon library, serially diluted 100 µL 10
-5
 in LB, and plated 100-150 
µL onto MYM plates containing kanamycin. After 2 d of growth, we screened the plates 
for colonies with altered morphology. Each plate, on average, contained ~38 colonies. At 
this stage, we considered colonies with abnormal morphology to have “passed” the first 
stage of the screen. We passaged each isolate on LB plates containing kanamycin. To 
verify altered morphology, we plated the isolates for single colonies on MYM plates. As 
before, after 2 d of growth we observed the isolates. At this stage, we classified isolates 
that retained altered morphology as passing the second stage of the screen. We prepared 
SPP1 phage lysates on the second stage isolates and transduced the transposon insertions 
into yfiJ
+
 (PDS0571) and yfiJ
A152E
 (PDS0572) strain backgrounds. To pass the third and 
final stage of the screen, the abnormal morphology and kanamycin resistance markers 
must be linked through transduction. We extracted genomic DNA from the third stage 
transductants for insertion loci identification (see below). 
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Construction of PyfiLMN- and PbceA-lacZ transcriptional reporters 
We used the PePPER webserver (285) to predict promoter sequences for yfiL, 
yfiM, and yfiN. We identified a single putative promoter that overlaps the stop codon and 
the predicted rho-independent terminator downstream of yfiK. Using primers 173 and 
174 we amplified a 200 bp DNA sequence containing the putative yfiLMN promoter with 
EcoRI and HindIII restriction sites. Similarly, we used primers 180 and 181 to amplify 
PbceA with EcoRI and HindIII restriction sites (286). To generate transcriptional fusions 
to lacZ we digested our PCR products and plasmid pDG1661 (amyE::RBSspoVG-lacZ cat 
spc bla) (287) with EcoRI and HindIII. We ligated the digested products together using 
T4 DNA Ligase. We confirmed plasmid construction by restriction digest. We 
transformed the PyiLMN-lacZ plasmid into DS7817 to generate PDS0838 in the NCIB 
3610 strain background. We used SPP1 phage lysates from PDS0838 to introduce the 
PyiLMN-lacZ reporter construct into other strain backgrounds. We transformed the PbceA-
lacZ plasmid into PDS0559 to generate PDS0917. We used SPP1 phage lysates from 
PDS0917 to introduce the PbceA-lacZ reporter construct into PDS0555 and generate 
PDS0918 in the NCIB 3610 strain background. 
 
Linearmycin and polyene assays 
To test linearmycins and other polyenes for activation of the PyfiLMN-lacZ 
reporter, we first diluted an overnight culture of PDS0838 to OD600 = 0.08 then grew the 
culture back to OD600 = 1 at 37 °C. We spotted 2 µL spots of the culture onto MYM 
plates containing X-gal and incubated the plates for 18 h at 30 °C. To test polyenes we 
spotted 3 µL containing 15 µg of amphotericin B, ECO-02301, or nystatin onto the pre-
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grown colony and allowed the spot to dry before returning the plate to the incubator. 
Likewise, we spotted 15 µg of daptomycin. We isolated linearmycins from S. Mg1 and 
spotted a fraction onto a B. subtilis colony as above. 
 
Constitutive activation of PyfiLMN-lacZ screen 
 To screen for mutants with constitutive activation of the PyfiLMN-lacZ reporter, we 
thawed an aliquot of our transposon library, serially diluted 100 µL 10
-4
 in LB, and 
plated 150 µL onto MYM plates containing kanamycin and X-gal. After 2 d of growth, 
we screened the plates for colonies with blue color. Each plate, on average, contained 
~120 colonies. We passaged each blue isolate on MYM plates containing kanamycin and 
X-gal. After 2 d of growth, we scored the passaged isolates for the presence of blue 
color. We prepared SPP1 phage lysates from each positive isolate and transduced the 
transposon insertions into the fresh PDS0838 strain background. We extracted genomic 
DNA from the blue transductants for insertion loci identification (see below). 
 
Identification of transposon insertion loci 
 TnYLB-1-insertion loci from pMarA were identified using degenerate primer 
PCR, inverse PCR, or single primer PCR. For degenerate primer PCR we used primers 
oIPCR-2 and Degen3 with the following cycling conditions: 98 °C for 5 min, followed 
by 25 cycles of 98 °C for 45 s, 60 °C for 45 s (decreasing by 0.5 °C/cycle), and 72 °C for 
2 min. Next, we used 25 cycles of 98 °C for 45 s, 50 °C for 45 s, and 72 °C for 2 min. 
For inverse PCR we digested 5 µg of genomic DNA with AluI, Taq
ɑ
I, or Sau3AI. We 
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ligated the digested DNA using T4 DNA ligase for 16 h at 16 °C at a DNA concentration 
of 5 ng/µL. We used the outward facing primers oIPCR-1 and oIPCR-2 to amplify a 
linear product from the ligated circular DNA using Phusion polymerase with the 
following cycling conditions: 98 °C for 2 min, followed by 30 cycles of 98 °C for 10 s, 
57 °C for 20 s, and 72 °C for 15 sec. For insertion loci that could not be identified by 
either degenerate or inverse PCR, we used single primer PCR. For single primer PCR we 
used primer oIPCR-2 with the following conditions to generate single stranded DNA: 98 
°C for 2 min, followed by 30 cycles of 98 °C for 30 s, 57 °C for 10 s, and 72 °C for 2 
min. Subsequently, we used 20 cycles of 98 °C for 30 s, 30 °C for 10 s, and 72 °C for 2 
min, which allows for inward facing non-specific primer pairing. Finally, we used 30 
cycles of 98 °C for 30 s, 57 °C for 10 s, and 72 °C for 2 min with a final extension of 2 
min. We confirmed the presence of PCR products on 1% agarose gels and purified 
products before sequencing. All sequencing was performed using nested primer oIPCR-
3. In all cases we clearly identified the boundary between the insertion element and 
genomic sequence. 
 
Construction of yfiJ
ΔTMD
 truncation and yfiJ
TMD
-bceS
Cyto
 strains 
We amplified the yfiJ promoter (PyfiJ) using primers 46 and 60, which includes a 
BamHI restriction site on the 5′ end. We used TMHMM (288) and Phobius (289) to 
predict the transmembrane helices in YfiJ, respectively. In both cases, predictions 
indicate that the transmembrane domain of YfiJ ends at residue 146. To generate a 
variant of yfiJ with a transmembrane domain truncation, we amplified yfiJ from codon 
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146 onward using primers 62 and 26. The forward primer includes an in frame ATG to 
serve as the start codon. The reverse primer contains an EcoRI restriction site on the 3′ 
end. Subsequently, we used joining PCR to fuse the PyfiJ and yfiJ
ΔTMD
 fragments 
together. Briefly, we mixed the two DNA fragments together in an equimolar ratio in a 
standard PCR mix without primers for 10 cycles of amplification. Next, we added 
primers 46 and 26 and continued amplification for 30 cycles. We digested the fusion 
PCR product and the plasmid pDR183 (lacA::mls bla) (290) with BamHI and EcoRI. We 
ligated the digested products together using T4 DNA Ligase. To generate the yfiJ
ΔTMD, 
A152E
 allele, we used PCR-mediated site-directed mutagenesis with primers 92 and 93. 
We verified both constructs with Sanger sequencing. We transformed both plasmids into 
PDS0559 to generate PDS0910 and PDS0911, respectively. We used SPP1 phage 
transduction to introduce the constructs into PDS0909 and generate strains PDS0912 and 
PDS0913 in the NCIB 3610 strain background. 
 
To construct the yfiJ
TMD
-bceS
Cyto
 chimera, we first amplified PyfiJ and the first 
146 codons of yfiJ using primers 175 and 176. Next, we amplified the cytoplasmic 
portion of bceS using primers 177 and 178. We used joining PCR as above to generate a 
yfiJ
TMD
-bceS
Cyto
 fusion fragment with SacI and SacII restriction sites. We digested the 
fusion PCR product and pDR183 with SacI and SacII. We ligated the digested products 
together using T4 DNA Ligase. We confirmed plasmid construction by restriction digest. 
We transformed the plasmid into PDS0559 to generate PDS0919. We used SPP1 phage 
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transduction to introduce the construct into PDS0918 to generate PDS0920 in the NCIB 
3610 strain background. 
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CHAPTER IV  
GROWTH PHASE-DEPENDENT REGULATION OF LINEARMYCIN 
BIOSYNTHESIS: EVIDENCE FOR AN AUTOLYTIC MECHANISM OF 
EXTRACELLULAR VESICLE BIOGENESIS 
 
Summary 
 In addition to their primary metabolism, bacteria and other microbes produce 
numerous specialized metabolites. The structures of specialized metabolites differ as 
widely as their biological functions. These functions include roles in competition, 
development, nutrient acquisition, and stress response. Streptomyces sp. Mg1 (S. Mg1) 
produces linearmycins, which are polyketides responsible for the lysis and degradation 
of competitor Bacillus subtilis in co-culture. Mutants of S. Mg1 that are unable to 
produce linearmycins have defects in extracellular vesicle production, suggesting that 
linearmycin biosynthesis is integrated with extracellular vesicle production. Here, we 
determined the pattern of expression for the linearmycin lny biosynthetic gene cluster 
and linearmycin biosynthesis over the S. Mg1 growth curve. We find that both lny gene 
expression and linearmycin biosynthesis are growth phase regulated. We also observe 
that the morphology of extracellular vesicles isolated from stationary phase S. Mg1 is 
consistent with an autolytic origin. As the linearmycin biosynthesis mutant is unable to 
produce extracellular vesicles, our results implicate linearmycins as inducers of autolysis 
that leads to extracellular vesicle production. We also find that surfactin, a specialized 
metabolite produced by B. subtilis, enhances the lytic activity of extracellular vesicles 
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produced by S. Mg1. Together, our findings suggest that linearmycin-mediated autolysis 
is responsible for releasing linearmycin-laden vesicles from S. Mg1 and surfactin-
mediated lysis is responsible for enhancing the activity of those same vesicles against B. 
subtilis. 
 
Introduction 
The capacity to engage in specialized metabolism is an attribute that is widely 
dispersed within the microbial world. Though once considered “secondary”, many 
specialized metabolites play critical roles in bacterial competition, defense, 
development, physiology, signaling, and survival (5–10, 153). Our understanding of the 
functions of specialized metabolites is disproportionately focused on molecules with 
antibiotic activity. Though many specialized metabolites may intrinsically function as 
antibiotics, antibiotic activity in and of itself may a consequence when these molecules 
are divorced from their natural context and concentrations (7). To understand the 
ecological and physiological functions of specialized metabolites, we need to consider 
specialized metabolism within the context of the producing organism and its 
extracellular environment. 
 
In our laboratory, we use models of bacterial interspecies interactions to identify 
specialized metabolites and their roles in competition. One particular model we use 
consists of two soil bacteria: Bacillus subtilis and Streptomyces sp. Mg1 (S. Mg1). When 
colonies of B. subtilis and S. Mg1 are cultured together on an agar surface, the B. subtilis 
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colony undergoes progressive degradation with concurrent cellular lysis (47). We 
identified linearmycins A and B as the causative agents of this lytic degradative activity 
(248). Linearmycins are long, linear polyketides with reported antibacterial and 
antifungal activities (172, 173). We identified the ~180 kb, type I polyketide synthase 
(PKS) lny gene cluster responsible for encoding the linearmycin biosynthesis machinery 
using the sequenced genome of S. Mg1 (171). Using mass spectral molecular 
networking, we have identified over 50 additional linearmycin variants (which we 
collectively refer to as “linearmycins”). From the S. Mg1 genome we identified the lnyI 
gene, which encodes the acyltransferase responsible for loading the starter unit onto the 
first PKS module (291). We found that deletion of lnyI results in loss of production of all 
linearmycins, and B. subtilis is not lysed by this deletion mutant. Intriguingly, the ΔlnyI 
strain also has a defect in the production of extracellular vesicles (EVs). We found that 
the linearmycins co-migrate with EVs during isolation, indicating that linearmycins may 
be a constituent or cargo of S. Mg1 EVs (Hoefler BC, Stubbendieck RM, Josyula NK, 
Moisan SM, Schulze EM, and Straight PD; in preparation). 
 
Here we report the relationship between growth phase, lny gene expression, and 
linearmycin biosynthesis in S. Mg1. We find that expression of the lny gene cluster is 
dependent upon growth phase, reaching peak expression after a period of growth arrest. 
Thereupon, we find the highest concentrations of linearmycins within the cell-free 
supernatants associated with EVs. We show that linearmycins continue to accumulate in 
the EV fractions well past the transition into stationary phase. The morphology of EVs 
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isolated from stationary phase cultures is consistent with biogenesis resulting from 
cellular autolysis. Strikingly, we did not observe morphologically similar EVs from the 
ΔlnyI strain. Our results suggest a role for linearmycins in programmed cell death of S. 
Mg1, which results in EV release. We also find that surfactin, produced by B. subtilis, 
enhances the lytic activity of EVs isolated from S. Mg1 and indicates a new competitive 
interface for these specialized metabolites. 
 
Results 
Growth phase, lny gene expression, and linearmycin biosynthesis are coordinated 
processes 
 We hypothesized that S. Mg1 coordinates linearmycin biosynthesis with 
production of EVs over the course of its life cycle. We inoculated cultures with S. Mg1 
spores and measure the growth of S. Mg1 over time. At specified time points, we 
collected the cell mycelium for growth measurement and RNA extraction, and the 
culture supernatant for EV isolation. As a control, we also inoculated a set of cultures 
with S. Mg1 ΔlnyI, which does not produce linearmycins and has an EV production 
defect (Hoefler BC, Stubbendieck RM, Josyula NK, Moisan SM, Schulze EM, and 
Straight PD; in preparation). The growth curve of S. Mg1 is similar to growth curves 
obtained from other streptomycetes grown in rich media (e.g. 292, 293). Over the first 
12 h, there is little to no growth, which is consistent with spore germination. Following 
germination, the cultures grow for an additional 12 h, before growth pauses for the next 
48 h. A pause period is characteristic for streptomycetes grown in rich media (e.g. 292, 
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293). When growth resumes, the S. Mg1 culture grows for an additional 24 h before 
reaching a plateau, indicating the entrance to stationary phase. We do not observe any 
significant differences in growth between the wild type and ΔlnyI strains of S. Mg1 
(Figure 17). 
 
 
 
 
 
 
 
 
Figure 17. Growth curve of S. Mg1 in liquid MYM7 media 
 
Growth curve of S. Mg1 wild type and ΔlnyI mutant measured by diphenylamine colorimetric assay. Each 
time point was measured ≥ 3 times and the error bars represent the standard deviation of the 
measurements. 
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We chose to monitor expression of lnyHA and lnyHI as representatives of the lny 
biosynthetic gene cluster. lnyHA and lnyHI encode the first and last PKS, respectively, 
with nearly ~117 kb of sequence between the two open-reading frames (171). We 
extracted RNA from each post-germination time point, synthesized cDNA, and used 
quantitative PCR to measure relative gene expression, normalized to the 24 h time point. 
We found that the expression of lnyHA and lnyHI increased over time and peaked at 48 
h, coincident with the end of the pause period (Figure 18). Afterwards, expression levels 
decreased to near the initial level. Note, we synthesized cDNA from equal inputs of 
RNA and we report expression levels without reference to an internal housekeeping 
gene. Typically for Streptomyces, the hrdB gene is used as an internal control for 
expression normalization (294). We found that normalization of lny expression to hrdB 
maintains the same pattern of expression, except at 96 h where lny expression is inflated 
(Figure A15). The hrdB gene encodes the primary σ factor and its expression decreases 
during the transition to stationary phase (Figure A16) (295, 296). Therefore, the 
expression inflation observed at 96 h is likely a normalization artifact. 
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Figure 18. Expression of lny gene cluster during S. Mg1 growth 
 
qRT-PCR was used to determine the relative fold expression in wild type S. Mg1 of the first (lnyHA) and 
last (lnyHI) PKS-encoding open-reading frame in the lny biosynthetic gene cluster. The error bars 
represent the standard deviation of the fold difference. 
 
 
 
We wanted to determine how EV production is controlled over the course of S. 
Mg1 growth and its relation to lny gene expression. At each time point, we isolated EVs 
from cell-free supernatants using ultracentrifugation. We resuspended crude pellets 
containing EVs with other membranous debris and used differential gradient 
ultracentrifugation to separate the EVs from the other material. We isolated fractions 
from the top (Fraction 1) to the bottom (Fraction 10) of the density gradient. We 
observed a yellow-pigmented band (Fractions 5 and 6) present in samples derived from 
wild type S. Mg1 but absent in the ∆lnyI strain. Note that purified linearmycins are also 
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yellow due to the presence of the polyene moiety (297). Thus, we hypothesized that 
fractions 5 and 6 contain the highest concentrations of linearmycins. 
 
Direct assay of fractions for vesicle number requires enumeration via electron 
microscopy from large numbers of biological replicates. Instead, based upon the 
presence of linearmycins and lysis of B. subtilis, we developed an indirect assay for EVs. 
We reasoned that measurement of the linearmycins content in EVs could serve as a 
proxy for EV number. To test fractions for lytic activity, we spotted each fraction onto a 
high-density lawn of B. subtilis embedded in agar. After incubation, we visualized lysis 
as clear zones in an otherwise opaque lawn. We observed lytic activity from wild type S. 
Mg1 in the 24 h sample and all subsequent time points. As expected, no lytic activity 
was ever observed from the ΔlnyI strain. From the 24 h sample, we observed that 
fractions 5 and 6 had the highest lytic activity. This finding accords with our observation 
of the yellow-pigmented band in these fractions. We also observed some, albeit lower, 
activity in fractions 4, 7, 8, 9, and 10 (Figure 19). At subsequent time points, the 
fractions were saturated with lytic activity, which enabled us to measure the relative 
activity at each time. Because fractions 5 and 6 contained the most activity, we chose 
these fractions as our focus for subsequent analysis. 
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Figure 19. Plate assay used to detect the presence of linearmycins in extracellular 
vesicle fractions 
 
Example activity assay used to detect the presence of linearmycin-containing vesicles from a culture of S. 
Mg1 grown for 24 h. Lysis is indicated by a zone of clearing when 3 μL of a vesicle fraction was spotted 
onto a high-density lawn of B. subtilis. Fraction number is indicated above each panel and ranges from 0% 
to 50% iodixanol in a continuous gradient. Fractions 5 and 6 were the most active and used for subsequent 
experiments. 
 
 
 
 
We detected linearmycin content in the vesicle fractions using HPLC and by 
monitoring the UV absorbance at 333 nm (248). We observed no signal in the 12 h 
sample, consistent with an absence of lytic activity (Figure 20). We observed increasing 
linearmycin content over time. Intriguingly, we observed the largest increase in 
linearmycins between 48 and 72 h (Figure 20). This is the same period of time when S. 
Mg1 reinitiates growth after the pause period (Figure 17). The increase in linearmycin 
content is also concurrent with the peak in expression from the lny gene cluster (Figure 
18). Taken together, this suggests that S. Mg1 constantly synthesizes linearmycins and 
produces EVs during its growth but that the total output regulated by the growth phase. 
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Figure 20. Detection of linearmycins in extracellular vesicle fractions by HPLC 
 
Equal volumes of fractions 5 and 6 were pooled and extracted with methanol before injection onto an 
HPLC. Linearmycins were monitored by absorbance at 333 nm. 
 
 
 
 
To quantitate lytic activity in the EV fractions, we returned to our plate assay. 
We spotted serial dilutions of pooled EV fractions 5 and 6 onto B. subtilis lawns, as 
above. At lower dilution factors, the EVs caused total lysis of B. subtilis. As we diluted 
the vesicles, we observed that the extent of lysis diminished as evidenced by the 
increased haziness of the lysed spots. For the earlier time points we diluted lytic activity 
below detectable levels. We measured the mean pixel intensity (MPI) of each lysed spot 
as a quantitative measure of B. subtilis lysis. There was a linear relationship between the 
dilution factor and the normalized MPIs of each lysed spot (Figure 21). Using this linear 
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relationship, we calculated the half maximal lytic concentration (LC50) for pooled EV 
fractions extracted at each time point (Table 8). We also report fold lytic activity relative 
to the 24 h samples (Figure 22). As expected, the lytic activity measurements are in 
agreement with the linearmycin quantification by HPLC (Figure 20). Coincident with 
the end of the growth pause period, lytic activity rapidly increases. 
 
 
 
 
 
 
 
Figure 21. Measurement of LC50 values from extracellular vesicle fractions 
 
Serial dilutions of pooled EV fractions isolated from S. Mg1 at specified time points were plated against 
lawns of B. subtilis. After 18 h of incubation, the plates were scanned. The MPI of each lysed spot was 
determined using ImageJ, normalized to MPI of the undiluted EV spot, and plotted against the dilution 
factor. The LC50 value is calculated from where each line crosses 50% MPI. 
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Table 8. LC50 measurements for EV fractions 
 
Time Point (h) LC50 
24 10.5 
36 33.7 
48 40.6 
72 287.1 
96 417.8 
 
 
 
 
 
Figure 22. Relative lytic activity of pooled extracellular vesicle fractions 
 
Visualization of the values in Table 8. LC50 values were normalized to the 24 h sample and reported as 
relative lytic activity. 
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Stationary phase EV morphology is distinct 
 The growth of S. Mg1 halts between 72 and 96 h (Figure 17). Concurrently, the 
expression of hrdB decreases (Figure A16), indicating that the culture is entering 
stationary phase. However, though the culture did not grow, we observed an increase in 
the lytic activity between 72 and 96 h (Figure 22, Table 8). To better understand this 
apparent discrepancy, we used electron microscopy and observed pooled EV fractions 
from wild type S. Mg1 isolated at both 72 and 96 h. From the 72 h sample, we observe a 
number of spherical vesicles that are morphologically consistent with vesicles previously 
isolated from S. Mg1 in our laboratory (Figure 23). However, the morphology of 
vesicles we isolated at 96 h is different. These vesicles are not uniform in size. Further, 
many of the vesicles are not spherical but are chained, clustered, or elongated in 
appearance (Figure 24). As a control, we examined equivalent fractions isolated from the 
ΔlnyI strain and found few vesicles, consistent with our previous results (Hoefler BC, 
Stubbendieck RM, Josyula NK, Moisan SM, Schulze EM, and Straight PD; in 
preparation). 
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Figure 23. Electron micrographs of extracellular vesicle fractions isolated from S. 
Mg1 cultured for 72 h 
 
Fractions 5 and 6 were pooled together and imaged using electron microscopy with negative staining. 
Spherical EVs are present in the wild-type sample (A-B) and mostly absent in the ∆lnyI mutant (C-D). The 
scale bar is 0.2 µm. 
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Figure 24. Electron micrographs of extracellular vesicle fractions isolated from S. 
Mg1 cultured for 96 h 
 
Fractions 5 and 6 were pooled together and imaged using electron microscopy with negative staining. EVs 
with varying morphology including chains, clusters, and spheres are present in the wild-type sample (A-B) 
and mostly absent in the ∆lnyI mutant (C-D). The scale bar is 0.2 µm. 
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Surfactin enhances linearmycin sensitivity of B. subtilis 
The focus of the current study has been to understand the control of linearmycin 
biosynthesis and EV production by S. Mg1. Among Gram-positive bacteria, EV 
production is not limited to the streptomycetes. Strains of B. subtilis are also reported to 
produce EVs (79). Biogenesis of EVs from B. subtilis has primarily been studied in 
laboratory strains or mutants that are unable to produce surfactin. This is because 
surfactin, a lipopeptide surfactant, self-produced lyses vesicles from B. subtilis (79). 
Therefore, we asked if surfactin would destabilize EVs from S. Mg1 and influence their 
lytic activity toward B. subtilis. We applied serial dilutions of S. Mg1 EVs onto high 
density, embedded lawns of B. subtilis wild type and ΔsrfAA, which is unable to produce 
surfactin (39). We found that the ΔsrfAA strain is largely resistant to lysis by S. Mg1 
EVs (Figure 25A). However, when we pretreated the EVs with purified surfactin, then 
their lytic activity towards the ΔsrfAA strain was restored and even enhanced (Figure 
25B). We speculate that disruption of linearmycin-laden vesicles by surfactin increases 
their lytic activity due to increased solubilization of linearmycins. 
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Figure 25. Surfactin enhances linearmycins sensitivity of B. subtilis 
 
(A) High-density lawns of both wild type and ∆srfAA B. subtilis were treated with serial dilutions of 
pooled EV fractions 5 and 6 containing linearmycin from a culture of S. Mg1 grown for 24 h. Lysis is 
indicated by a zone of clearing. (B) High-density lawns of the ∆srfAA strain of B. subtilis were treated 
with serial dilutions of the same EV fractions from (A) but after pre-treatment with 2.5 mg/ml of surfactin 
before being spotted. The numbers on the left indicate the dilution factor [(1/2)
n
] for each panel. 
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Discussion 
In this study we identified growth phase-dependent regulation of lny biosynthetic 
gene cluster expression and linearmycin biosynthesis in S. Mg1. This study stemmed 
from previous work showing that S. Mg1 produces EVs and that linearmycins co-
migrate with vesicles as potential cargo (Hoefler BC, Stubbendieck RM, Josyula NK, 
Moisan SM, Schulze EM, and Straight PD; in preparation). Here we first correlated S. 
Mg1 growth phase with expression of the lny biosynthetic gene cluster and linearmycin 
production. We observed that expression of the lny gene cluster peaks at the end of the 
pause period, which is followed by an increase in linearmycin content isolated from cell-
free supernatants. We also noticed that after the transition of the S. Mg1 culture into 
stationary phase, there was a marked increase in lytic activity from EV fraction 
preparations. We also observed that the morphology of EVs isolated from stationary 
phase S. Mg1 cultures were markedly different from EVs isolated before stationary 
phase. The significance of the current work is in understanding how an organism 
controls production of a specialized metabolite that is involved in critical physiological 
processes (e.g. vesicle production) and bacterial competition. 
 
In nutrient rich liquid culture, streptomycete growth follows five phases: (i) 
germination, (ii) initial growth, (iii) pause, (iv) second growth, and (v) stationary and 
death phase (e.g. 292, 293). As expected, we find that S. Mg1 conforms to this growth 
regimen (Figure 17). We hypothesized that linearmycin biosynthesis, and therefore EV 
production, is associated with culture growth phase. Indeed, we found that expression of 
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the lny genes increases through the initial growth phase, peaks during the pause period, 
and diminishes during the second growth and stationary phases (Figure 18). In addition, 
we found that expression of lnyHI decreases at a faster rate than lnyHA. This is 
consistent with the presence of a major promoter that is responsible for driving 
expression of all downstream PKS-encoding genes, as is the case for the ~74 kb pks 
operon in B. subtilis (31). After the pause period, we observe that the linearmycin 
content of the cell-free supernatant increases ~5 fold as measured by both HPLC and 
lytic activity (Figure 20, Figure 22). Together our data suggest that expression of the lny 
biosynthetic gene cluster is followed by translation of the PKS assembly machinery 
during pause period and a subsequent burst of linearmycin biosynthesis. 
 
Streptomycetes are unique among bacteria due to their cell morphology and 
development. Like filamentous fungi, streptomycete growth initiates from spores. 
During germination a germ tube emerges from the spore to form the first hyphae. As the 
hyphae grows it lengthens and, at branch points, new hyphal growth is initiated (35). 
Given sufficient time to grow, streptomycetes become intertwined, and multinucleate 
mycelial mats. Similar to biofilms, access to nutrients and oxygen becomes limiting at 
increasing depths within the mycelium. The most interior cells in the mat starve and die 
over time (292, 298). Between 72 and 96 h, the expression of hrdB decreases, which 
indicates that the S. Mg1 culture has entered stationary phase (Figure A16). Concurrent 
with this transition is an apparent paradoxical increase in the lytic activity in cell-free 
supernatants without a concurrent increase in cell density (Figure 17, Figure 22). These 
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observations suggest that more EVs are produced after the culture reaches stationary 
phase. 
 
Little is known about the biogenesis of EVs from Gram-positive bacteria. One 
major challenge is reconciling the inherent difficulties in vesicle formation and release 
through the peptidoglycan cell wall (64). We propose that the increased lytic activity, 
and therefore EV production, is due to autolysis of S. Mg1 releasing vesiculated 
membranes. An autolytic mechanism for vesicle biogenesis circumvents the need for 
Gram-positive bacteria to use a controlled vesicle release system. Further, the 
multinucleate and filamentous growth mode of streptomycetes ensures that fitness costs 
for autolysis are low. We speculate that after 72 h the S. Mg1 culture enters death phase 
and increased numbers of EVs are released by autolysis. This mechanism is not 
unprecedented. Indeed, within biofilms of the Gram-negative bacteria Pseudomonas 
aeruginosa, explosive cell lysis produces EVs (63). Using electron microscopy, we 
observed vesicles from both 72 and 96 h cultures, representing early and late stationary 
phase time points. Unlike the 72 h vesicles, the 96 h vesicles vary widely in their 
morphologies (Figure 23, Figure 24). We propose that EV biogenesis results from 
autolysis and subsequent vesiculation of S. Mg1 membranes. In support of this model, 
cryo-electron microscopy of S. Mg1 revealed the presence of vesicles near cracked S. 
Mg1 filaments (Straight PD, unpublished data). In addition, the lipid composition of 
vesicles and the S. Mg1 cytoplasmic membrane are identical (Josyula NK, unpublished 
data). However, most intriguingly is that we observe very few, if any, vesicles from the 
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ΔlnyI strain. Presumably, these cells are also in stationary phase, but the ΔlnyI strain 
does not undergo a substantial degree of autolysis. Given the capacity of linearmycins to 
lyse B. subtilis, perhaps these molecules are also responsible for mediating programmed 
cell lysis in S. Mg1. By sacrificing some of its filamentous mass, S. Mg1 is able to 
release a competitive molecule and associated vehicle into an aqueous environment 
where the molecule would otherwise be relatively insoluble. Future work is necessary to 
determine if there is a differential extent of death that occurs within the mycelial mats of 
wild type and ΔlnyI strains of S. Mg1. 
 
Much of this study was focused on determining the dynamics of lny biosynthetic 
gene cluster expression linearmycin biosynthesis in monocultures of S. Mg1. However, 
our primary interest is in understanding how S. Mg1 uses EVs as agents for bacterial 
competition. In this study we did not directly co-culture S. Mg1 and B. subtilis together, 
but we observed that the efficacy of linearmycin-laden vesicles was largely diminished 
against a mutant of B. subtilis that is unable to produce surfactin. We also observed that 
treatment of vesicles with surfactin enhances the lytic activity of their linearmycin cargo 
against the B. subtilis ΔsrfAA strain (Figure 25B). Though the enhanced lysis may be due 
to a secondary effect of exogenous application of surfactin onto the ΔsrfAA strain (27, 
299). We propose a direct effect. Previous studies have shown that surfactin lyses natural 
vesicles produced by B. subtilis and Bacillus anthracis (79), artificial vesicles (300), and 
membranes (301). Therefore, we propose that surfactin directly interacts with vesicles 
produced by S. Mg1 and that vesicle lysis or solubilization of linearmycins by surfactin 
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is responsible for increased lytic activity. Surfactin is involved in multiple important 
functions for B. subtilis including biofilm formation, motility, and bacterial competition 
(27, 37, 38). By interacting with a critical metabolite produced by B. subtilis, 
linearmycin-laden vesicles may counteract selective pressures for B. subtilis to 
adaptively lose surfactin biosynthesis genes.  
 
In summary, the present study expands the interface of specialized metabolism, 
bacterial developmental physiology, and competitive functions. Beyond acting simply as 
antibiotics, many specialized metabolites function in crucial cellular processes. As 
mentioned above, surfactin is necessary for B. subtilis motility and biofilm formation 
(27, 37, 38). In addition, phenazines produced by P. aeruginosa are involved in redox 
balance and have roles in biofilm formation (6, 253, 302, 303). Autolysis is another 
process critical for bacterial development that intersects with specialized metabolism. 
For instance, during P. aeruginosa biofilm formation phenazine and pyocyanin 
contribute to hydrogen peroxide-mediated cell lysis and release of extracellular DNA, an 
important biofilm constituent (304, 305). Likewise, linearmycins may be responsible for 
autolysis of S. Mg1 and release of EVs. When taken out of their native context, many 
specialized metabolites act simply as inhibitory antibiotics. Only through careful 
consideration of the natural functions of these once “secondary” metabolites, we will 
uncover more interesting interfaces between bacterial development and specialized 
metabolism and garner new insight into bacterial physiology. 
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Materials and methods 
Bacterial strains and media 
The strains of S. Mg1 used in this study were wild type (PDS0543) or ΔlnyI::apr 
(PDS0755). The strains of B. subtilis used in this study were wild type (PDS0742) or 
ΔsrfAA::mls (PSK0049). We used MYM media [0.4% malt extract (Bacto), 0.4% yeast 
extract (BBL), 0.4% D-(+)-maltose monohydrate (Sigma)] for all experiments. For 
culturing S. Mg1, we buffered liquid MYM with 100 mM MOPS (Chem-Impex) and 5 
mM potassium phosphate at pH 7 (MYM7). 
 
Time course experiment 
To observe growth, lny biosynthetic gene cluster expression, and linearmycin 
biosynthesis over time, we inoculated independent 25 mL MYM7 cultures with a 100 µL 
suspension containing 5 x 10
7
 spores of S. Mg1 wild type or ΔlnyI. At 12, 24, 36, 48, 72, 
and 96 h we harvested one culture each of wild type and ΔlnyI. At the specified 
collection time, we shook the culture flask to resuspend the mycelia. We removed three 
1 mL aliquots from the culture. We centrifuged the aliquots at 21,130 x g for 10 min to 
pellet the mycelia, which we dried and stored at -20 °C for later growth measurements. 
After collecting aliquots for growth measurements, we centrifuged the remainder of the 
cultures at 12,000 x g for 10 min at 4 °C. We fixed the mycelial pellets with RNA-
protect Bacteria Reagent (Qiagen). We stored the fixed pellets at -80 °C for later RNA 
extraction. We immediately processed culture supernatants for vesicle purification, as 
described below. 
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S. Mg1 growth measurements 
The growth of S. Mg1 was determined using a diphenylamine colorimetric 
method (306). Briefly, we washed mycelial pellets twice with phosphate-buffered saline 
and resuspended each pellet in 1 mL of diphenylamine reagent [1.5% w/v 
diphenylamine, 1.5% v/v sulfuric acid, and 0.008% v/v aqueous acetaldehyde in glacial 
acetic acid]. We incubated the resuspended pellets at 60 °C for 1 h. After incubation, we 
centrifuged the samples at 21,130 x g for 5 min and measured the absorbance at 595 nm 
from 200 µL of the supernatant. We used ungerminated spores, at an identical density 
used to inoculate the cultures, to measure the 0 h time point. 
 
EV isolation and preparation 
To isolate EVs from culture supernatants, we first treated each supernatant with 
0.1 mg of DNase I for 15 min while rotating at ambient temperature. We removed cells 
and large debris by filtering the supernatant through a 0.22 µm PES filter. We 
ultracentrifuged the filtrate in a Beckman Type 45 Ti rotor at 235,000 x g at 4 °C for 3 h. 
We resuspended the crude pellets in 200 µL of a 50% w/v iodixanol solution in Buffer A 
[10 mM HEPES, 0.85% w/v NaCl, pH 7.4]. We overlaid the resuspended pellet with 
lower-density iodixanol solutions [50 (200 µL), 40 (400 µL), 30 (400 µL), 20 (400 µL), 
10 (400 µL), and 0% (100 µL) each in Buffer A] to form a step gradient (2.1 mL total). 
We ultracentrifuged the gradients to equilibrium in a TLS55 rotor at 120,000 x g at 4 °C 
for 16-18 h. Fractions (200 µL) were recovered from the top (fraction 1) to the bottom 
(fraction 10) of the tube and stored at 4 °C. 
 139 
 
Plate overlay lysis assay and LC50 measurement 
We adapted a previously described plate assay to assay EV fractions for lytic 
activity (248). Briefly, overnight cultures of B. subtilis were diluted to OD600 = 0.08 in 
25 mL of MYM. When the cultures reached stationary phase, we concentrated the cells 
to OD600 = 4 by centrifugation at 3220 x g for 5 min and resuspension in a reduced 
volume of MYM. For each plate, we mixed 1.5 mL of concentrated B. subtilis with 4.5 
mL of MYM agar (0.67% w/v agar) and spread the suspension evenly over a 25 mL 
MYM plate. Once the plates solidified, we spotted 3 µL of each vesicle fraction directly 
onto the overlay. After the spots dried, we incubated the plates at 30 °C. After 18 h we 
photographed or scanned the plates. 
 
 To compare lytic activity from vesicles extracted at different time points, we 
pooled equal volumes of EV fractions 5 and 6, made two-fold serial dilutions, and 
spotted each dilution onto plates. After incubation, we scanned the plates and measured 
the MPI of each lysed spot using ImageJ (307). We calculated the ratio of MPI of each 
lysed spot relative to the fully concentrated sample. This value was natural log-
transformed and plotted against the dilution factor. Data points whose MPI ratios were ≥ 
0.95 or ≤ 0.39 were not plotted because these values indicate assay saturation and 
background, respectively. For each EV preparation, the LC50 value was determined by 
calculating the dilution where the ratio of mean pixel intensity = 0.67, which represents 
the middle point between saturation and background intensity ratio. All linear 
regressions used 3 or 4 data points and the LC50 values were within the interpolable 
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range. All R
2
 values were ≥ 0.99. We report all values as fold difference compared to the 
24 h sample. 
 
Quantification of linearmycin from EV preparations 
To quantify linearmycins in EV fractions, we pooled 3 µL each of fractions 5 and 
6 and extracted linearmycins with 6 µL of methanol. We injected a 6 µL sample of 
extracted linearmycins onto an Agilent 1200 HPLC system with a Phenomenex Luna C18 
column (4.6 x 250 mm, 5 µm) and eluted with an ACN/20 mM ammonium acetate pH 5 
gradient running at 1 mL/min. The elution program was as follows: 1) 5 min at 40% 
ACN then 2) a gradient up to 50% ACN over 10 min then 3) a gradient up to 75% ACN 
over 5 min, and 4) a gradient diminishing to 40% ACN over 5 min (248). Peaks 
primarily consisting of linearmycins A and B were detected by UV absorbance at 333 
nm with retention times of 13 and 16 min, respectively. 
 
RNA extraction and cleanup 
We added five 3 mm glass beads and 2 mL of ice-cold lysis buffer [4 M 
guanidine thiocyanate, 25 mM trisodium citrate, 0.5% (w/v) sodium N-lauroyl 
sarcosinate, and 0.8% (v/v) β-mercaptoethanol) to each fixed mycelial pellet. After 2 
min of vortexing, we added 2 mL of TRI Reagent (Sigma-Aldrich) to each sample. We 
vortexed each sample with four cycles of 30 s on vortex and 30 s on ice. After the 
addition of chloroform, we extracted RNA following standard procedures. We removed 
DNA from the RNA samples using a Turbo DNA-free kit (Applied Biosystems). We did 
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not extract RNA from the 0 and 12 h time points because the starting biomass was too 
low. 
 
qRT-PCR of lny genes 
We reverse transcribed cDNA from 100 ng of total RNA using a High-Capacity 
RNA-to-cDNA Kit (Thermo Fisher Scientific). We performed quantitative PCR using a 
Sso Advanced Universal SYBR Green Supermix Kit (Bio-Rad) and a CFX96 Touch 
real-time PCR thermocycler (Bio-Rad) with the following cycling parameters: 
denaturation at 95 °C for 30 s; 40 cycles of denaturation at 95 °C for 15 s, annealing at 
58 °C for 30 s, and extension at 72 °C for 30 s; followed by a final melting curve from 
60 °C to 95 °C for 6 min. We amplified lnyHA and lnyHI, the first and last PKS-
encoding open-reading frames, respectively using the primers listed in Table A8. Each 
reaction was run in triplicate. Using LinReg (234), we calculated the primer efficiency 
and quantification cycle values. We report all values are as fold difference compared to 
the 24 h sample. 
 
Electron microscopy of EV fractions 
To remove iodixanol for electron microscopy, we pooled 100 µL each of 
fractions 5 and 6 and diluted the samples to 2.1 mL with Buffer A. We ultracentrifuged 
the diluted samples at 120,000 x g at 4 °C for ≥ 6 h. We resuspended the vesicle-
containing pellet in 30 µL of Buffer A. To image vesicles with EM, we adsorbed 3 µL of 
the resuspended vesicles onto freshly glow-discharged carbon-coated Formvar grids. We 
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washed the vesicles washed briefly with water and followed by a negative stain with 2% 
w/v ammonium molybdate. We imaged samples with a JEOL 1200 EX transmission 
electron microscope operated at an acceleration voltage of 100 kV. We collected 
electron micrographs at calibrated magnifications using a 3k slow-scan CCD camera 
(model 15C, SIA). We processed images using ImageJ (307). 
 
Surfactin EV lysis assay 
To test the effect of surfactin on vesicle preparations, we extracted vesicles from 
a 24 h old culture of S. Mg1. We pooled equal volumes of vesicle fractions 5 and 6, and 
made two-fold serial dilutions in Buffer A containing a 2.5 mg/mL mixture of surfactins 
in ethanol (Sigma). We assayed lysis as above. 
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CHAPTER V  
CONCLUSIONS AND FUTURE DIRECTIONS
3
 
 
Bacterial communities vary in their species composition, niches occupied, and 
influence on different environments. Based on these complexities, communities defy a 
single fundamental definition. Rather, they represent fascinating examples of interactive 
processes that differ with ecological scale. The complications in defining and 
characterizing communities are reflected in the early history of microbiology. In the late 
1800s Robert Koch revolutionized the field of microbiology by pioneering his methods 
to establish causality between a microorganism and disease (308). Even to this day 
Koch’s postulates remain the “gold standard” to associate microbes to disease or any 
other phenomenon of interest. Inspired by Koch’s reductionist approach, the vast 
majority of research over the past one hundred years has investigated the growth and 
physiology of microbes grown in pure culture. Studying single species of bacteria 
axenically was essential for birth of modern biochemistry and molecular biology and 
remains important to this day. However, even as early as the 1870s microbiologists 
including Louis Pasteur reported phenomena resulting from interactions of bacteria 
existing in multispecies communities (309). Bacteria are social organisms that interact 
extensively within and between species all while responding to external stimuli from 
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their environments. Indeed, the ability to perceive neighboring cells and the environment 
is often reflected in the content of bacterial genomes. Recently, the construction of 
Mycoplasma mycoides JCVI-syn3.0, a bacterium with a minimal genome containing 
only 531 kilobase pairs and 473 genes was reported (310). When compared to the 
genome of a natural, soil bacterium Myxococcus xanthus, which contains 9.14 megabase 
pairs and 7388 protein coding genes (52) the genome of M. mycoides JCVI-syn3.0 is 
miniscule. While JCVI-syn3.0 inhabits rich, complete media in the laboratory, M. 
xanthus competes in its environment and requires a large number of genes for signaling 
systems to interpret changing environmental conditions and the presence of competitors. 
In fact, many organisms, including two of our best studied model species Bacillus 
subtilis and Escherichia coli, contain large numbers of genes deemed “non-essential”. 
However, many of these genes may be absolutely critical to survival when bacteria are 
faced with competitors. As an old adage states: “no microbe is an island”. Thus, to truly 
understand a bacterial species it must be placed within its ecological context including 
the other members of its community. 
 
To understand a bacterial species, it must be placed into an ecological context, 
but doing so is challenging. Consequently, we use complementary biological and 
computational approaches to study bacterial communities. Commonly used 
computational approaches include metagenomic analysis and mathematical modeling. In 
typical metagenomic approaches, total DNA is isolated from environmental samples, 
sequenced, and different species are identified as determined by the sequence of their 
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ribosomal RNA genes (311–313). Metagenomic analyses have the potential to uncover 
the composition and connectivity of species in a bacterial community. However, by only 
using single snapshot binary comparisons of two community states, it is not possible to 
ascertain how members of the community interact. To infer interactions from 
metagenomic data it is necessary to following the composition of a community over a 
sufficiently long period of time with high temporal resolution (314, 315). In addition, 
inferences of interspecies interactions do not reveal the pertinent mechanistic details 
underlying interaction mechanisms. Likewise, mathematical models are used to predict 
bacterial community dynamics over time. In general, models attempt to capture many 
biological variables and place them into well-defined rules that govern how systems 
behave. Though models are incredibly powerful tools to investigate biological 
phenomena, they are limited by our current understanding of individual systems. By 
wedding models generated from metagenomic and mathematical approaches to 
complementary cultured-dependent experiments we gain deeper insights into the specific 
interactions that undergird community function 
 
Though a bacterial community may be comprised of large number of cells, 
bacteria likely interact at the scale of single cells or multicellular aggregates (100, 316–
319). The dynamics of the community at large are thus determined by interactions that 
occur between pairs of individual cells residing within the community. Using models of 
bacterial competition, often taking the form of macroscopic bacterial colonies competing 
on an agar plate, is a proven approach to address fundamental questions regarding 
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competitive mechanisms. Though artificial, by observing macroscopic colonies we gain 
insight into competitive mechanisms that bacteria use at single cell levels. For instance, 
Alexander Fleming’s famous laboratory observation that Penicillium chrysogenum 
inhibited Staphylococcus aureus growth may be one of the first examples of interference 
competition investigated by this method (320). The agar plate was subsequently adopted 
for screening antibiotic compounds and it remains an invaluable tool for investigating 
competition (19). The outcomes of competition on an agar plate are often manifested in 
visible phenotypes including developmental defects, growth inhibition, lysis, motility, 
and pigment production (e.g. 17, 22, 26, 28, 32, 120, 151, 154, 321–326) 
 
Our own experience using Bacillus subtilis and Streptomyces spp. in different 
formats reveals variable patterns and functions of bacterial competition. Importantly, 
changing the competitive dynamics between these organisms by using different species 
or mutants of Bacillus and Streptomyces, or changing plating formats has continued to 
uncover new mechanistic insights into functions of secreted enzymes and specialized 
metabolites in bacterial competition. For example the B. subtilis produced specialized 
metabolite bacillaene, originally identified as a translation inhibitor (29), is involved in a 
suite of functions with respect to different competitors. Bacillaene also inhibits the 
growth of Streptomyces avermitilis (327), interferes with production of pigmented 
prodigiosin Streptomyces coelicolor (30) and Streptomyces lividans (31), and is involved 
in defense against consumption by Myxococcus xanthus (44) and lysis by Streptomyces 
sp. strain Mg1 (S. Mg1) (47). Bacillus subtilis also produces surfactin, a lipopeptide 
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surfactant (27, 37, 38). Surfactin also inhibits sporulation of many Streptomyces species 
by antagonizing a morphogenetic peptide SapB, which is visually striking on an agar 
plate (39, 41). Imaging mass spectrometry of competitions between B. subtilis and S. 
Mg1 revealed that S. Mg1 produces a secreted hydrolase (SfhA) that specifically 
degrades surfactin and plipastatin produced by B. subtilis (40). Additionally, MALDI-
TOF-IMS of competitions between these same two organisms led to the identification of 
chalcomycin A produced by S. Mg1 and revealed patterns of many unknown specialized 
metabolites that may also be involved in competition (47). 
 
In this dissertation, I studied the interaction between S. Mg1 and B. subtilis that 
results in lysis of B. subtilis. First, I found that S. Mg1 produces linearmycins that cause 
lysis of B. subtilis (Chapter II). Using linearmycins, I identified mutants of B. subtilis 
that are spontaneously resistant to lysis. The linearmycin-resistant B. subtilis mutants 
revealed competitive functions for YfiJK, a previously uncharacterized two-component 
signaling system (Chapter II). I found genetic evidence that the histidine kinase YfiJ is a 
linearmycin sensor (Chapter III) and its cognate response regulator YfiK controls 
expression of the yfiLMN operon (Chapter II). We find that YfiLMN is an ATP-binding 
cassette transporter complex that is involved in linearmycin resistance and causes 
morphological changes in B. subtilis with regard colony development (Chapters II, III). 
Finally, I uncovered growth phase-dependent regulation of expression of the lny 
biosynthetic gene cluster and linearmycin biosynthesis in S. Mg1, consistent with an 
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autolytic model for extracellular vesicle biogenesis (Chapter IV).  In this final chapter, I 
will discuss the conclusions and highlight future directions of this research. 
 
Linearmycins are specialized metabolites involved in a suite of competitive 
functions 
Offensive and defensive roles for linearmycins in competition 
In this dissertation study I found that linearmycins are involved in multiple facets 
of bacterial competition. In particular, exposure to linearmycins causes subsequent lysis 
of B. subtilis (Chapter II). One interpretation of this observation is that S. Mg1 produces 
linearmycins as a means to lyse B. subtilis prey for consumption. However, though some 
species such as Streptomyces scabies are known plant pathogens (328), streptomycetes 
are typically considered to be saprophytic organisms (35). In addition, streptomycetes 
are mostly non-motile, unlike known predatory myxobacteria (53). An alternative 
interpretation is that linearmycins may function as a defense mechanism against motile 
competitors, such as B. subtilis. Coordinated antibiotic production and sporulation of 
streptomycetes are hypothesized to protect nutrients released by cannibalized substrate 
mycelium from motile competitors (165–167). Consistent with this defensive role, we 
have observed on agar plates that B. subtilis overruns the linearmycin biosynthesis 
deficient mutant S. Mg1 ΔlnyI (Figure A17). Finally, it is possible that the distinction 
between the offensive and defensive properties of linearmycins is simply due to 
constraints in our laboratory models. A provocative hypothesis is that release of nutrients 
from the cannibalized substrate mycelia may function as a lure to ensnare nutrient-
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seeking motile microbes, akin to a Venus flytrap or a spider in a web. Determining the 
natural functions of linearmycin will require subsequent study under conditions that 
better mimic a natural soil environment. 
 
Linearmycins as effectors of autolysis 
In addition to their competitive functions, the linearmycins may also be involved 
in S. Mg1 programmed cell death. Using S. Mg1 ΔlnyI, we observed a connection 
between extracellular vesicle production and linearmycins. In particular, we noted a 
marked defect in vesicle production by the ΔlnyI strain. Subsequently, activity assays 
and mass spectrometry confirmed the presence of linearmycins in extracellular vesicles 
fractions (Hoefler BC, Stubbendieck RM, Josyula NK, Moisan SM, Schulze EM, and 
Straight PD; in preparation). When we profiled linearmycin biosynthesis and lny 
biosynthetic gene cluster expression over the course of S. Mg1 growth, we observed 
growth phase-dependent regulation of both of these processes (Figure 18, Figure 20). In 
particular, during stationary phase we observed an increase in linearmycin-associated 
lytic activity, without a concurrent increase in cell density (Figure 17).  Instead of 
uniform spherical vesicles, we observed that the morphology of extracellular vesicles 
varied in size and shape that often were chained or clustered (Figure 24). We suspect 
that these extracellular vesicles are derived from S. Mg1 autolysis. Importantly, we note 
the absence of morphologically similar particles in the ΔlnyI strain. Given the capacity 
for linearmycins to lyse B. subtilis, we currently speculate that linearmycins may 
function in an autolytic process in S. Mg1. Our current model is that linearmycins build 
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up to a critical concentration in the S. Mg1 cytoplasmic membrane until autolysis occurs. 
Through autolysis, the cytoplasmic membrane of S. Mg1 undergoes vesiculation, which 
allows linearmycins to be released into the environment. Extracellular vesicles may be a 
necessary vehicle to deliver linearmycins under environmental conditions. On their own, 
linearmycins are relatively insoluble and tend to form aggregates under aqueous 
conditions. Thus, by intertwining linearmycins, autolysis, and vesicle biogenesis S. Mg1 
is able to release a competitive molecule into the environment that would otherwise 
likely be diffusion limited. Further work is necessary to determine how linearmycins 
trigger autolysis and the precise mechanism of extracellular vesicle biogenesis. 
 
The mechanism of linearmycin-induced lysis 
 We currently do not know the mechanism of linearmycin-induced lysis of B. 
subtilis. However, preliminary results indicate that DNA replication, transcription, 
translation, and active metabolism are not required for lysis of B. subtilis by 
linearmycins (Figure A18). An understanding of the lysis mechanism will also inform 
our efforts to determine how linearmycins mediate autolysis in S. Mg1.  
 
Linearmycin variants may have different biological activities in competition 
Through mass spectral molecular networking we have observed >50 structural 
variants of linearmycins. The tandem MS/MS spectra for some of these variants indicate 
the presence of alternative polyketide starter units, glycosylations, and other 
modifications (Hoefler BC, Stubbendieck RM, Josyula NK, Moisan SM, Schulze EM, 
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and Straight PD; in preparation). Perhaps specific linearmycin variants will have 
alternative functions in competition. For instance, the polyketide ECO-02301 is 
structurally similar to the linearmycins (176). However, after polyketide synthesis ECO-
02301 is glycosylated and an amidohydroxycyclopentenone moiety is condensed onto 
the terminal carboxylic acid group (176, 189). Linearmycin resistant mutants of B. 
subtilis are weakly cross resistant to lysis by ECO-02301 (Table 3). This suggests that 
different modifications to the linearmycin backbone can result in different biological 
activities. Currently, isolation and characterization of each linearmycin variant is not 
feasible as the abundances are low and linearmycins are unstable through extended 
purification. Further characterization of the lny biosynthetic gene cluster may result in 
identification of mutants that produce particular variants at higher abundances, which 
will allow us to identify specific activities for specific linearmycin variants. 
 
Linearmycins interface with specialized metabolites produced by B. subtilis 
Under the context of bacterial competition, we have observed functional 
associations of linearmycins with specialized metabolites produced by B. subtilis. In 
addition to providing defense against M. xanthus, bacillaene is also important for 
defense against S. Mg1. The bacillaene biosynthesis deficient mutant B. subtilis Δpks is 
hypersensitive to lysis caused by linearmycins (47). The mechanism of bacillaene-
mediated protection against linearmycins is not known. Bacillaene is a known translation 
inhibitor (29). Therefore, during competition with S. Mg1, B. subtilis may produce 
bacillaene and partially inhibit translation by S. Mg1. The ∆pks mutant may be 
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hypersensitive to lysis by S. Mg1 because the latter is uninhibited by bacillaene and 
better able to synthesize and release linearmycins. Accordingly, in the case of M. 
xanthus predation of B. subtilis, it is thought that bacillaene transiently delays M. 
xanthus development. By delaying M. xanthus development, B. subtilis has time to form 
spore-filled megastructures and escape consumption by the predator (44, 329). We have 
also observed an intersection between linearmycin and surfactin. We found that a 
surfactin biosynthesis deficient mutant B. subtilis ΔsrfAA is mostly resistant to lysis by 
S. Mg1 extracellular vesicles. Pretreatment of S. Mg1 vesicles with surfactin before 
application to B. subtilis ΔsrfAA restored lytic activity (Figure 25). We hypothesize that 
surfactin may lyse the vesicles produced by S. Mg1 or that surfactin may solubilize 
linearmycins and cause increased lytic activity. As we expand our interaction models to 
include competitors other than B. subtilis we may find new functions of linearmycins. 
 
Bacterial competition identifies multiple functions for an uncharacterized two-
component signaling system and an ATP-binding cassette transporter 
The YfiJK system senses and responds to linearmycins 
After the identification of linearmycins, we became interested in determining 
their mechanism of lysis against B. subtilis. Our initial efforts involved the identification 
of mutated loci in spontaneous resistant mutants. However, instead of identifying the 
target of linearmycin, we implicated the YfiJK two-component signaling (TCS) system 
in linearmycin resistance. Previously, there was no indication of function for this 
particular TCS system. Subsequently, we became interested in characterizing YfiJK and 
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its effects on B. subtilis as a means to understand signal transduction systems in bacterial 
competition. We found that the histidine kinase YfiJ acts as a linearmycin sensor (Figure 
14, Table 7), which triggers autophosphorylation of a conserved histidine residue. The 
phosphate is transferred to an aspartate residue on the cognate response regulator YfiK 
(Table 2). Phosphorylation of response regulators triggers a conformational change that, 
in the case of YfiK, activates a helix-turn-helix DNA-binding domain (182, 183). The 
phosphorylated YfiK then binds to the yfiLMN promoter and activates expression of the 
yfiLMN operon (Table 4, Figure A7A). YfiLMN is an ATP-binding cassette (ABC) 
transporter that is both necessary and sufficient for linearmycin resistance (Figure 6).  
 
The ABC transporter YfiLMN is involved in linearmycin resistance and biofilm 
formation 
Previous work in B. subtilis has identified three peptide antibiotic-sensing and 
detoxification (PSD) systems. In PSD systems, the TCS system and ABC transporter 
genes are encoded together and the TCS system regulates expression of the ABC 
transporter-encoding genes (193). Currently, only resistance functions have been 
ascribed to the PSD systems. However, based on the morphology of colonies of 
linearmycin resistant B. subtilis, we have identified additional functions for the YfiJK-
LMN system that extend beyond resistance. We found that expression of yfiLMN alone 
is sufficient to causes B. subtilis colonies to form biofilms (Figure 13). Intriguingly, 
unlike canonical biofilm formation in B. subtilis that requires many regulators and 
differential expression of many genes, increased expression from a single operon results 
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in a morphological similar colony structure (Table 4, Figure A7A). In addition, we found 
that biofilm formation requires yfiM and yfiN but not yfiL (Table 5). yfiM and yfiN each 
encode a membrane spanning domain of the ABC transporter complex. However, yfiL 
encodes the nucleotide-binding domain, which hydrolyzes ATP and provides energy to 
the complex (192). One hypothesis is that overloading the B. subtilis cytoplasmic 
membrane with membrane proteins may trigger a non-specific biofilm response. We 
have used transposon mutagenesis to obtain biofilm formation deficient mutants of 
linearmycin resistant strains as a first step to identify if any additional factors are 
required to act with YfiM and YfiN. We have identified several candidate genes, with an 
emphasis on chaperone related functions, and are currently attempting to understand 
how each candidate influences biofilm formation (Table 6). We also found that the 
potassium ion leakage sensor KinC is required for YfiLMN-mediated biofilm formation 
(Figure 16). We hypothesize that YfiLMN causes potassium ion leakage, which KinC 
senses as part of the mechanism for biofilm formation (27).  
 
Biofilms formed by B. subtilis and other bacteria are structures wherein the 
underlying cells are protected from environmental stresses and insults, including 
antibiotic exposure (98). We speculate that by coupling specific linearmycin resistance 
to biofilm formation through YfiLMN, B. subtilis may survive competition and prime a 
protective response against subsequent stresses. For instance, the small and transient 
linearmycin resistant colonies that we observed in regions of lysis required yfiJK, and 
thus yfiLMN expression, to form (Figure 10, Figure A6). Perhaps each small colony was 
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also in a biofilm state and protected from additional stress, akin to spore-filled 
megastructures that B. subtilis forms when it is exposed to predation by M. xanthus 
(168). Additional work is required to what, if any, environmental stresses YfiLMN-
mediated biofilms are protected from. Importantly, the yfiL deletion divorces the biofilm 
and linearmycin resistance functions for the YfiLMN system. Indeed, while yfiL is still 
required for linearmycin resistance, the nucleotide-binding domain is not required for 
biofilm formation (Table 5). The yfiL deletion mutant suggests that active transport is 
necessary to detoxify B. subtilis cells exposed to linearmycin. Further study is necessary 
to determine how YfiLMN exports linearmycin from the cell. 
 
YfiLMN enables B. subtilis to respond to a motility inducer produced by S. Mg1 
In addition to biofilm formation, we observed a colony motility phenotype when 
we cultured linearmycin resistant strains of B. subtilis with S. Mg1. We find that the 
portion of B. subtilis colonies exposed to S. Mg1 undergo a transition from an immotile 
to a spreading state (Figure 8). Using deletion mutants, we confirmed that this colony 
motility is dependent upon exopolymeric substances and surfactin, consistent with a type 
of motility known as sliding (Figure A19). Initially, we hypothesized that induction of 
sliding motility results as another function of YfiJK. However, when we cultured wild 
type B. subtilis with S. Mg1 ΔlnyI we found that motility was induced in B. subtilis 
(Figure A17). This observation indicated that motility of B. subtilis is induced by S. Mg1 
but inhibited by linearmycins. Other work from our laboratory has indicated that 
chloramphenicol and some other ribosome-targeting antibiotics induce B. subtilis 
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motility at subinhibitory concentrations (Liu Y, unpublished results). The S. Mg1 
genome encodes biosynthetic machinery for only a single recognizable translation 
inhibitor, chalcomycin A (47, 171). We find that a chalcomycin A biosynthesis mutant 
of S. Mg1 still induces B. subtilis motility during competition (Figure A20), which 
indicates chalcomycin A is either not the motility inducer or S. Mg1 may produce 
multiple motility inducers. Indeed, we have been able to extract a molecule(s) with 
motility inducing activity from S. Mg1, which are currently under investigation (Figure 
A21). 
Conclusions 
In summary, this dissertation contributes to our knowledge of a model of 
bacterial competition by ascribing functions to a previously uncharacterized family of 
specialized metabolites produced by S. Mg1 and a TCS system and ABC transporter 
complex in B. subtilis. The results of this dissertation are summarized in Figure 26. We 
find that the linearmycins likely trigger an autolytic process in S. Mg1 that results in 
release of linearmycin-laden vesiculated membrane particles as extracellular vesicles. 
Subsequent exposure to linearmycins then causes the lysis of B. subtilis. However, B. 
subtilis senses and responds to the presence of linearmycins with the YfiJK TCS system 
by activating expression of yfiLMN. The YfiLMN ABC transporter complex then 
prevents B. subtilis lysis by presumably detoxifying or pumping linearmycins out of the 
cytoplasmic membrane.  
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Figure 26. Model of linearmycin-mediated bacterial competition between B. subtilis 
and S. Mg1 
 
Linearmycins (red squiggles) are released from S. Mg1 through an autolytic process, which also causes the 
formation of extracellular vesicles, containing linearmycins either within the membrane or as cargo. 
Surfactin lyses the extracellular vesicles or solubilizes linearmycins. Exposure to linearmycins results in 
lysis of B. subtilis. However, the histidine kinase YfiJ can sense linearmycins, which triggers a signaling 
cascade that activates the response regulator YfiK and leads to expression of the yfiLMN operon. The ABC 
transporter YfiLMN is responsible for B. subtilis linearmycin resistance and biofilm formation through 
KinC.  
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Currently, bacterial competition between B. subtilis and S. Mg1 is one of the best 
studied models of interspecies interactions. Our laboratory has identified roles for the B. 
subtilis produced specialized metabolites bacillaene and surfactin in bacterial 
competition. We have also identified competitive functions for chalcomycin A and 
linearmycins produced by S. Mg1. In addition, we identified a hydrolase produced by S. 
Mg1 that is specific against surfactin and plipastatin, another lipopeptide produced by B. 
subtilis. Our current efforts are focused on identifying the motility inducer(s) produced 
by S. Mg1. Concurrently, our laboratory is also undergoing efforts to systematically 
disrupt genes encoding biosynthetic machinery for every predicted specialized 
metabolite gene cluster encoded in the S. Mg1 genome (Zhang C, unpublished data). By 
combining chemical, biochemical, and genetic approaches, we will continue to 
characterize specialized metabolites and enzymes to understand their effects on bacterial 
competition. Eventually, we can combine and apply this information, along with 
information garnered from other studies, to train new models of interspecies interactions. 
Through application of this knowledge we will understand how interactions between two 
species change dynamics in microbial communities over time. 
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APPENDIX 
 
 
Figure A1. Characterization of the molecule responsible for LDA 
 
(A) Mass spectrum of the isolated peak with lytic activity against B. subtilis. The prominent masses 
detected in the experiment match those of linearmycin B, m/z 594.9 [M+H+Na]
2+
, 605.8 [M+2Na]
2+ 
and 
1167.7 [M+H]
+
 (B) Structure of linearmycin B with 
13
C NMR chemical shift assignments obtained in 
DMSO-d6. Carbons are numbered linearly starting with the carbonyl carbon of the carboxylic acid group. 
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Figure A2. Disruption of the linearmycin biosynthetic gene cluster abolishes LDA 
 
The S. Mg1 wild type strain (A) and a strain with a chromosome arm deletion (Δ37) that includes the 
linearmycin biosynthetic gene cluster (B) were co-cultured with B. subtilis ΔpksX (PDS0067) (top left 
panels). Bacillus subtilis is not lysed by S. Mg1 Δ37. Extracts from each streptomycete were spotted on 
filter paper discs adjacent to a B. subtilis ΔpksX colony (lower left panels). The B. subtilis colony 
challenged with the S. Mg1 Δ37 extract was not lysed. The extracts were analyzed by HPLC (right 
panels). Linearmycins are detected by UV absorbance at 333 nm (blue) while the background is shown by 
the 254 nm absorbing trace (red). The predominant difference in the extracts is the presence or absence of 
linearmycins A and B. Linearmycin A (m/z 1140) and B (m/z 1166) identities were confirmed by mass 
spectrometry. Colonies were photographed after 72 h of co-incubation or after 48 h exposure to extract. 
Scale bar is 5 mm. 
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Figure A3. Genes predicted to be repressed by YfiK are not responsible for LDA 
 
Spore-killing factor (SKF) and autolysis were predicted to be regulated by YfiK. Strains of B. subtilis 
(right) with deletions in genes responsible for SKF biosynthesis (ΔskfA-H) (DL598), an autolysin inhibitor 
(ΔiseA) (PDS0785), deletions in the major autolysin regulator σD (ΔsigD) (DS323), and deletions in three 
major autolysins (ΔlytABC, ΔlytD, ΔlytF) (DS2483) were tested for resistance to LDA in co-culture with 
S. Mg1 (left). All strains lysed similarly to wild type (PDS0066). Cultures were photographed after 72 h 
co-incubation on MYM agar plates. Scale bar is 5 mm. These results were consistent across six replicates. 
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Figure A4. Complementation of yfiLMN with yfiK terminator-yfiL intergenic 
sequence fails to restore LDA resistance 
 
The yfiLMN deletion was complemented at lacA using the intergenic sequence between the terminator 
downstream of yfiK and the first coding nucleotide of yfiL as upstream sequence (143 bp).  Lysis was 
observed in a strain lacking yfiJK (PDS0687), a strain with yfiJK
+
 (PDS0688), and in strains with LDA
R
 
alleles yfiJ
A152E
K (PDS0689) and yfiJK
T83I
 (PDS0690). All cultures place S. Mg1 on the left and B. subtilis 
on the right. Cultures were photographed after 72 h co-incubation on MYM agar plates. Scale bar is 5 mm. 
These results were consistent across three replicates. 
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Figure A5. yfiL expression is increased in a LDA
R
 mutant 
 
qRT-PCR was used to quantify expression of yfiL in strains with yfiJK
+
 (PDS0627) or yfiJ
A152E
K 
(PDS0685). Expression was normalized relative to gyrB. The fold difference relative to expression in the 
yfiJK
+
 strain is reported. The error bars represent the standard deviation of the fold difference. 
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Figure A6. Small colony formation requires yfiJK 
 
We cultured eighteen wild type (PDS0066) and ΔyfiJK (PDS0554) colonies of B. subtilis with S. Mg1. 
Many small, potentially LDA
R
, colonies appeared in the region of lysis of wild type colonies. A few small 
colonies appeared in the zone of lysis of two ΔyfiJK colonies, but these did not grow similarly and lacked 
the morphological features of the yfiJK
+
 small colonies. All cultures place S. Mg1 on the left and B. 
subtilis on the right. Colonies were photographed after 96 hours co-incubation on MYM agar plates. The 
scale bar is 5 mm. 
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Figure A7. yfiLMN expression profiles 
 
(A) Differential gene expression in yfiJ
A152E
K (PDS0685) compared to yfiJK
+
 (PDS0627). Each open 
reading frame in the B. subtilis genome is represented as a diamond and are plotted from lowest to highest 
fold difference between yfiJ
A152E
K and yfiJK
+
. The dashed line represents no difference in mRNA 
abundance. (B) Expression data for yfiL from 269 different conditions. Each diamond represents one 
condition and is plotted from lowest to highest expression level. (C) Expression data for yfiL, yfiM, and 
yfiN from 269 different conditions. The center lines of the box plots show the media of expression level. 
The upper and lower box limits indicate the 25th and 75th percentiles, respectively. The whiskers extend 
1.5 times the interquartile range from the 25th and 75th percentiles. Outliers are shown as open circles. 
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Figure A8. qRT-PCR of putative genes in the YfiK regulon previously predicted by 
RNA-seq. 
 
qRT-PCR was used to quantify expression of yfiL, des, and yvfS in yfiJ
+
 strains (PDS0571) and yfiJ
A152E
 
strains (PDS0572). Expression was normalized to gyrB. The fold difference relative to expression in the 
yfiJ
+
 strain is reported. Each biological replicates is shown as an open circle. The center lines of the box 
plots show the median of the fold differences. The upper and lower box limits indicate the 25th and 75th 
percentiles, respectively. The whiskers extend 1.5 times the interquartile range from the 25th and 75th 
percentiles. Note, the reported scales are different for each gene. 
 
 
 
 
 
Figure A9. Overexpression of des does not affect linearmycin resistance or colony 
morphology 
 
(top panels) Bacillus subtilis (right) yfiJK
+
 (PDS0627) is lysed by S. Mg1 (left) while yfiJ
A152E
K 
(PDS0685) is linearmycin resistant. (bottom panels) Artificial overexpression of des from a xylose-
inducible promoter has no effect on B. subtilis lysis or colony morphology, when compared to the above 
strains. The photograph was taken after 72 h co-incubation on MYM agar with or without 0.3% w/v 
xylose. The photograph is representative of duplicate samples. Scale bar is 5 mm. 
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Figure A10. Nitrate supplementation does not affect the wrinkled phenotype of 
yfiJ
A152E
 
 
When grown from single cells, the B. subtilis yfiJ
+
 (PDS0571) colony develops as a relatively flat and 
featureless colony whereas the yfiJ
A152E
 colony (PDS0572) spreads and forms a wrinkled colony. The 
addition of 40 mM potassium nitrate (+KNO3) causes both strains to form smaller, lighter pigmented 
colonies but the yfiJ
A152E
 colony remains wrinkled. The photograph was taken after 48 h incubation on 
MYM agar. Scale bar is 5 mm.  
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Figure A11. Disruption of ilvD affects yfiJ
A152E
 colony morphology 
 
The B. subtilis yfiJ
+
 colony (PDS0571) develops as a smooth colony but the yfiJ
A152E
 colony (PDS0572) 
forms a biofilm. Disruption of ilvD by the transposable element TnYLB-1 has no effect on yfiJ
+
 colony 
morphology but results in the yfiJ
A152E
 colony edges becoming lobate and the colony center to become 
more mucoid.  The photograph was taken after 48 h incubation on MYM agar. The photograph is 
representative of duplicate samples. Scale bar is 5 mm.  
 
 
 
 
Figure A12. Isoleucine supplementation has no effect on linearmycin resistance or 
colony morphology 
 
Wild type S. Mg1 (PDS0543) colonies (left) was co-spotted with B. subtilis colonies (right). The different 
genotypes of the B. subtilis colonies are labeled on the right. (left) Co-culture on media without isoleucine 
(Ile) supplementation. (right) Co-culture on media supplemented with 150 µM Ile. There are no visible 
differences between the two conditions. The photograph was taken after 72 h co-incubation on MYM agar. 
The photograph is representative of quadruplicate samples. Scale bar is 5 mm. 
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Figure A13. Preconditioning B. subtilis in increasing concentrations of nystatin 
enhances linearmycin resistance 
 
Wild type B. subtilis (PDS0742) was preconditioned in 0, 10, 50, or 100 µg/mL nystatin then embedded in 
a soft agar overlay at equal cell density and spread over a MYM plate with the same concentration of 
nystatin. Two-fold serial dilutions of linearmycins were plated on top of the agar overlay. After 18 h 
incubation, the plates were photographed. As the preconditioned concentration of nystatin increases, B. 
subtilis becomes more resistant to subsequent nystatin exposure. The numbers on the left indicate the 
dilution factor [(1/2)
n
] for each panel. 
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Figure A14. Predicted transmembrane topology for YfiJ and BceS 
 
The transmembrane topologies for YfiJ (A) and BceS (B) were predicted using Protter (330). Residues 
changed in linearmycin resistant B. subtilis are shown in gray. 
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Figure A15. Expression of lny gene cluster during S. Mg1 growth normalized to 
hrdB 
 
qRT-PCR was used to determine the relative fold expression in wild type S. Mg1 of the first (lnyHA) and 
last (lnyHI) PKS-encoding open-reading frame in the lny biosynthetic gene cluster. Expression was 
normalized to hrdB. The error bars represent the standard deviation of the fold difference. 
 
 
 
 
 
 
Figure A16. Expression of hrdB during S. Mg1 growth 
 
qRT-PCR was used to determine the relative fold expression in wild type S. Mg1 of hrdB. The error bars 
represent the standard deviation of the fold difference. 
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Figure A17. Linearmycins inhibit B. subtilis motility 
 
Strains of B. subtilis (horizontal) were cross-plated with strains of S. Mg1 (vertical). The genotype of B. 
subtilis is indicated on the left and the genotype of S. Mg1 is indicated on the top. The yfiJK
+
 strain of B. 
subtilis (PDS0627) is lysed by wild type (WT) S. Mg1 (PDS0543) but the yfiJ
A152E
K B. subtilis strain 
(PDS0685) resists lysis and exhibits induced motility. If either B. subtilis strain is plated with the S. Mg1 
linearmycin biosynthesis mutant ΔlnyI (PDS0755) then both strains are motile. Photographs were taken 
after 72 h co-incubation on GYM7 agar. Scale bar is 5 mm. 
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Figure A18. Lysis of B. subtilis by linearmycins occurs independent of major 
cellular pathways 
 
Wild type B. subtilis (PDS0742) was grown in liquid MYM to OD600 = 1. The cells were washed and 
resuspended in MYM containing 0.25 M sucrose (osmoprotectant), 2.5 mM DCC (ATPase inhibitor), 200 
µg/mL phleomycin (DNA replication inhibitor), 1 µg/mL rifamycin (transcription inhibitor), or 250 and 
100 µg/mL chloramphenicol and spectinomycin (translation inhibitor), or plain MYM with and without 
linearmycins (400 units). The linearmycin treated samples (black lines) were lysed similarly, except with 
sucrose stabilization, whereas the control treated samples (gray lines) halted growth. The data points were 
sampled at 5 min intervals in a plate reader and the average of triplicates is reported here. 
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Figure A19. Linearmycin resistant B. subtilis motility is consistent with sliding 
 
Linearmycin resistant B. subtilis yfiJ
A152E
K (PDS0685, horizontal) was cross-plated with wild type S. Mg1 
(PDS543, vertical). The genotype of B. subtilis is indicated on the top. The yfiJ
A152E
K strains with 
deletions in epsH or srfAA are immotile whereas strains with deletions in sigD and hag are motile when 
cultured with S. Mg1. Photographs were taken after 72 h co-incubation on GYM7 agar. Scale bar is 5 mm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A20. Chalcomycin is not required to induce motility of linearmycin resistant 
B. subtilis 
 
Strains of B. subtilis (vertical) were cross-plated with chalcomycin biosynthesis deficient (ChlA
-
) S. Mg1 
(horizontal). The genotype of B. subtilis is indicated on the top. The yfiJ
+
 (PDS0067) strain of B. subtilis S. 
Mg1 but the yfiJ
A152E
 B. subtilis strain (RM7) resists lysis and exhibits induced motility. Photographs were 
taken after 72 h co-incubation on GYM7 agar. Scale bar is 5 mm. 
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Figure A21. Motility inducing fraction extracted from S. Mg1 
 
Wild type B. subtilis (PDS0742) was spotted vertically. Extracts from a S. Mg1 (PDS0543) culture were 
spotted onto the paper discs next to B. subtilis. The numbers below each panel indicate the dilution factor 
[(1/2)
n
]. At lower dilutions the extract is inhibitory for B. subtilis growth. After two dilutions B. subtilis 
motility is induced by the extract. All photographs were taken after 72 h co-spotting on GYM7 agar. Scale 
bar is 5 mm. 
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Table A1.  
13
C Chemical Shifts for Linearmycin B 
 
C-No. δC C-No. δC C-No. δC C-No. δC C-No. δC 
33 212.07  132.40  75.13  45.83  24.27 
1 174.78  132.09 39 71.12 18 45.11  24.18 
 138.52  131.75 19 71.09 36 44.98 16-Me 18.55 
 136.85  131.29 31 70.41 34 44.88 2-Me 10.91 
 135.69  131.24 17 69.58 38 40.64 32-Me 10.26 
 135.32  131.10 43 68.90 16 39.65 18-Me 9.25 
 135.25  130.02  68.76 30 38.58   
 134.97  128.98  68.48  34.45   
40 133.62 41 128.91  67.75  32.68   
 133.56  128.75 37 66.86 42 31.91   
 133.22  126.72 35 65.49  31.39   
 132.93  126.65  63.83  29.91   
 132.86  126.38  63.65  29.13   
 132.80  125.06 32 51.86  28.82   
 132.74  125.01  48.70  28.47   
 
Spectra were collected in DMSO-d6 on a Bruker Avance 500 MHz spectrometer equipped with a 
cryoprobe. Chemical shifts (δ) are reported in ppm with reference to the residual solvent peak. Designated 
carbons are listed. The carbon number (C-No.) is with reference to the numbering in Figure A1B. 
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Table A2. Mutations in spontaneous LDA
R
 mutants not related to yfiJK 
 
Gene Nucleotide change Effect Annotation 
fosB G57T none 
bacillithiol-S-transferase, fosfomycin resistance 
protein 
rnc C299T P100L RNase III 
nrdEB
*
 A622G K208E 
SPβ phage ribonucleoside-diphosphate reductase, 
alpha subunit 
yodT
*
 C582T none putative aminovalerate aminotransferase 
yozT
*
 A66G none unknown 
ypzE
*
 A124G K42E unknown 
nadD
†
 T392A V131E nicotinate-nucleotide adenylyltransferase 
recJ
†
 C499T A150V single-strand DNA-specific exonuclease 
tpx
†
 A209G E70G putative peroxiredoxin 
yhgB
†
 32_33insG frame shift unknown 
yopC
†
 yopC::TnYLB-1 disruption unknown membrane protein 
 
All numbering is with respect to the first amino acid or the first nucleotide of the start codon. 
*
Mutations 
identified in the same spontaneous mutant. 
†
Mutations identified in a transposon-mutagenized strain. 
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Table A3. Strains of Bacillus subtilis used in Chapter II 
 
Strain Genotype Source 
PDS0066 NCIB3610  undomesticated wild type strain Laboratory collection 
PDS0067 NCIB3610  ΔpksX::spc Laboratory collection  
PDS0121 NCIB3610  pMarA Laboratory collection 
PDS0312 PY79  wild type Laboratory collection 
PDS0540 PY79  pDR244 Laboratory collection 
PDS0546 PY79 ΔyfiJK::kn This study 
PDS0547 NCIB3610  ΔyfiJ::mls This study 
PDS0548 NCIB3610  ΔyopC::mls This study 
PDS0553 NCIB3610  ΔyfiK::mls This study 
PDS0554 NCIB3610  ΔyfiJK::kn This study 
PDS0555 NCIB3610  ΔyfiJ This study 
PDS0556 NCIB3610  ΔyfiK This study 
PDS0559 168  ΔyfiJ This study 
PDS0562 168  ΔyfiJ  lacA::yfiJ  (mls) This study 
PDS0563 168  ΔyfiJ  lacA::yfiJA152E  (mls) This study 
PDS0564 168  ΔyfiJ  lacA::yfiJT164M  (mls) This study 
PDS0565 168  ΔyfiJ  lacA::yfiJH167Y  (mls) This study 
PDS0566 168  ΔyfiJ  lacA::yfiJA88V  (mls) This study 
PDS0567 168  ΔyfiJ  lacA::yfiJH201N  (mls) This study 
PDS0571 NCIB3610  ΔyfiJ  lacA::yfiJ (mls) This study 
PDS0572 NCIB3610  ΔyfiJ  lacA::yfiJA152E (mls) This study 
PDS0573 NCIB3610  ΔyfiJ  lacA::yfiJT164M (mls) This study 
PDS0574 NCIB3610  ΔyfiJ  lacA::yfiJH167Y (mls) This study 
PDS0575 NCIB3610  ΔyfiJ  lacA::yfiJA88V (mls) This study 
PDS0576 NCIB3610  ΔyfiJ  lacA::yfiJH201N (mls) This study 
PDS0594 168  ΔyfiJ  lacA::yfiJA152E, H201N (mls) This study 
PDS0604 NCIB3610  ΔyfiJ  lacA::yfiJA152E, H201N (mls) This study 
PDS0608 NCIB3610  ΔyfiJ  ∆epsH::kn  lacA::yfiJA152E (mls) This study 
PDS0623 PY79  ΔyfiJK::kn  amyE::yfiJK (spc) This study 
PDS0624 PY79  ΔyfiJK::kn  amyE::yfiJKT83I (spc) This study 
PDS0625 PY79  ΔyfiJK::kn  amyE::yfiJKD54A (spc) This study 
PDS0626 PY79  ΔyfiJK::kn  amyE::yfiJKD54A, T83I (spc) This study 
PDS0627 NCIB3610  ∆yfiJK::kn  amyE::yfiJK (spc) This study 
PDS0628 NCIB3610  ∆yfiJK::kn  amyE::yfiJKT83I (spc) This study 
PDS0629 NCIB3610  ∆yfiJK::kn  amyE::yfiJKD54A (spc) This study 
PDS0630 NCIB3610  ∆yfiJK::kn  amyE::yfiJKD54A, T83I (spc) This study 
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PDS0652 PY79  ∆yfiJKLMN::kn This study 
PDS0653 NCIB3610  ∆yfiJKLMN::kn This study 
PDS0658 NCIB3610  ∆yfiJKLMN::kn  amyE::yfiJK (spc) This study 
PDS0660 NCIB3610  ∆yfiJKLMN::kn  amyE::yfiJKT83I (spc) This study 
PDS0685 NCIB3610  ∆yfiJK::kn  amyE::yfiJA152EK (spc) This study 
PDS0686 NCIB3610  ∆yfiJKLMN::kn  amyE::yfiJA152EK (spc) This study 
PDS0687 NCIB3610 ∆yfiJKLMN::kn  lacA::yfiLMN (mls) This study 
PDS0688 NCIB3610 ∆yfiJKLMN::kn  amyE::yfiJK (spc)  lacA::yfiLMN (mls) This study 
PDS0689 NCIB3610 ∆yfiJKLMN::kn  amyE::yfiJA152EK (spc)  lacA::yfiLMN (mls) This study 
PDS0690 NCIB3610 ∆yfiJKLMN::kn  amyE::yfiJKT83I (spc)  lacA::yfiLMN (mls) This study 
PDS0691 PY79  ∆yfiJKLMN::kn  lacA::yfiLMN (mls) This study 
PDS0717 PY79  ∆yfiJKLMN::kn  yhdG::Pspac(c)yfiLMN (cm) This study 
PDS0718 NCIB3610  ∆yfiJKLMN::kn  yhdG::Pspac(c)yfiLMN (cm) This study 
PDS0719 NCIB3610  ∆yfiJKLMN::kn  amyE::yfiJK (spc) yhdG::Pspac(c)yfiLMN (cm) This study 
PDS0720 NCIB3610  ∆yfiJKLMN::kn  amyE::yfiJ152EK (spc) yhdG::Pspac(c)yfiLMN (cm) This study 
PDS0721 NCIB3610  ∆yfiJKLMN::kn  amyE::yfiJKT83I (spc) yhdG::Pspac(c)yfiLMN (cm) This study 
PDS0731 NCIB3610  ΔyfiJ  ΔepsH::kn  lacA::yfiJ (mls) This study 
PDS0732 NCIB3610  ΔyfiJ  ΔsinR::spc  lacA::yfiJ (mls) This study 
PDS0733 NCIB3610  ΔyfiJ  ΔsigD::tet  lacA::yfiJ (mls) This study 
PDS0734 NCIB3610  ΔyfiJ  ΔdegU::tet  lacA::yfiJ (mls) This study 
PDS0735 NCIB3610  ΔyfiJ  ΔsinR::spc  lacA::yfiJA152E (mls) This study 
PDS0736 NCIB3610  ΔyfiJ  ΔsigD::tet  lacA::yfiJA152E (mls) This study 
PDS0737 NCIB3610  ΔyfiJ  ΔdegU::tet  lacA::yfiJA152E (mls) This study 
PDS0738 NCIB3610  ΔyfiJ  lacA::yfiJL254P (mls) This study 
PDS0739 NCIB3610  ∆yfiJK::kn  amyE::yfiJA152EKD54A (spc) This study 
PDS0740 NCIB3610  ∆yfiJK::kn  amyE::yfiJH201NKT83I (spc) This study 
PDS0785 NCIB3610  ΔiseA::mls This study 
BKE18380 168  ΔiseA::mls Bacillus Genetic Stock Center 
BKE20940 168  ΔyopC::mls Bacillus Genetic Stock Center 
BKE08290 168  ΔyfiJ::mls Bacillus Genetic Stock Center 
BKE08300 168  ΔyfiK::mls Bacillus Genetic Stock Center 
DL598 NCIB3610  ΔskfABCDEFGH::cm R. Kolter Laboratory 
DS323 NCIB3610  ΔsigD::tet D. Kearns Laboratory 
DS2483 NCIB3610  ΔlytABC::kn  ΔlytD::mls  ΔlytF::tet D. Kearns Laboratory 
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Table A4. Primers used in Chapter II 
 
Primer Sequence (5′ - 3′) 
kn-Fwd CAGCGAACCATTTGAGGTGATAGG 
kn-Rev CGATACAAATTCCTCGTAGGCGCTCGG 
13 GGCAGGAAATCAAAGCGCTC 
14 GCGCCTACGAGGAATTTGTATCGCCATCAAGGTGAACATTCTCGT 
15 CCTATCACCTCAAATGGTTCGCTGAGAACCCAAGCCGCCATTTA 
16 TTTCATTGCCGTCCCTCCTC 
25 CCATGGATCCATTGATGCAGGGATCGAGGG 
26 TCATGAATTCGATGCCAGCCCTTCTCTGAC 
42 GGCGCGTGAAATCAATGATACAGTGGGG 
43 CCCCACTGTATCATTGATTTCACGCGCC 
50 GGATATCGTGTTAATGGCCATCCGCATGCCGGTTTC 
51 GAAACCGGCATGCGGATGGCCATTAACACGATATCC 
54 GCGACCGGCGCTCAGGATCCATTGATGCAGGGATCGAGGG 
59 CCCTCGATCCCTGCATCAATGGATCCTGAGCGCCGGTCGC 
74 TATGTTCTATCTGCCGCTACGAATTCCTGCAGCCCTGGCG 
75 GTAGCGGCAGATAGAACATA 
76 GGCCGCCCGCGGTAGGATCCTTGTAAGGCGGCGCTTGAAG 
77 CCTACGAGGAATTTGTATCGGCTCATCACTCCCGATACCC 
78 TCACCTCAAATGGTTCGCTGAAAACATCTGCCGTTTAGGC 
79 CCCGGGGAGCTCATGAATTCACGACAGGATTATGTACTGACTC 
112 ATGCGAATTCTACACAGCCCAGTC 
113 ATGCACTAGTAACCGGATTCCACACATTATGCCAC 
118 ACTAGTAACCGGATTCCACA 
119 GGATCCCATACGGCAATAGT 
120 TGTGGAATCCGGTTACTAGTAGGAGTGAGACGACGTGCTG 
121 ACTATTGCCGTATGGGATCCTTAGGCTCGGAGCGCTTTCA 
q1: yfiL-F AAGCGTTTCTTGTGGCGATC 
q2: yfiL-R TGATGAGCCGCAGAAATGTC 
gyrB-F GGGCAACTCAGAAGCACGGACG 
gyrB-R GCCATTCTTGCTCTTGCCGCC 
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Table A5. Strains of Bacillus subtilis used in Chapter III 
 
Strain Genotype Source 
BKE08310 168 ΔyfiL::mls Bacillus Genetic Stock Center 
BKE08320 168 ΔyfiM::mls Bacillus Genetic Stock Center 
BKE08330 168 ΔyfiN::mls Bacillus Genetic Stock Center 
BKE14490 168 ΔkinC::mls Bacillus Genetic Stock Center 
DS7817 NCIB3610 ΔcomI W. Winkler 
PDS0555 NCIB3610 ΔyfiJ (248) 
PDS0559 168 ΔyfiJ (248) 
PDS0562 168 ΔyfiJ lacA::yfiJ+ (mls) (248) 
PDS0563 168 ΔyfiJ lacA::yfiJA152E (mls) (248) 
PDS0571 NCIB3610 ΔyfiJ lacA::yfiJ+ (mls) (248) 
PDS0572 NCIB3610 ΔyfiJ lacA::yfiJA152E (mls) (248) 
PDS0627 NCIB3610 ΔyfiJK::kn amyE::yfiJK+ (spc) (248) 
PDS0685 NCIB3610 ΔyfiJK::kn amyE::yfiJA152EK (spc) (248) 
PDS0742 NCIB3610 undomesticated wild type strain Laboratory Collection 
PDS0788 NCIB3610 ΔyfiJ ΔyfiL::mls This Study 
PDS0789 NCIB3610 ΔyfiJ ΔyfiL This Study 
PDS0790 NCIB3610 ΔyfiJ ΔyfiL lacA::yfiJ+ (mls) This Study 
PDS0791 NCIB3610 ΔyfiJ ΔyfiL lacA::yfiJA152E (mls) This Study 
PDS0795 168 ΔyfiJ ΔyfiLMN::mls This Study 
PDS0796 NCIB3610 ΔyfiJ ΔyfiLMN::mls This Study 
PDS0797 NCIB3610 ΔyfiJ ΔyfiLMN This Study 
PDS0798 NCIB3610 ΔyfiJ ΔyfiLMN lacA::yfiJ+ (mls) This Study 
PDS0799 NCIB3610 ΔyfiJ ΔyfiLMN lacA::yfiJA152E (mls) This Study 
PDS0801 NCIB3610 ΔyfiJ ΔyfiLMN lacA::yfiJ+ (mls) yhdG::Pspac(c)-yfiLMN (cm) This Study 
PDS0802 NCIB3610 ΔyfiJ ΔyfiLMN lacA::yfiJA152E (mls) yhdG::Pspac(c)-yfiLMN (cm) This Study 
PDS0810 168 ΔyfiJ ΔyfiM::mls This Study 
PDS0811 168 ΔyfiJ ΔyfiN::mls This Study 
PDS0812 NCIB3610 ΔyfiJ ΔyfiM::mls This Study 
PDS0813 NCIB3610 ΔyfiJ ΔyfiN::mls This Study 
PDS0814 NCIB3610 ΔyfiJ ΔyfiM This Study 
PDS0815 NCIB3610 ΔyfiJ ΔyfiN This Study 
PDS0816 NCIB3610 ΔyfiJ ΔyfiM lacA::yfiJ+ (mls) This Study 
PDS0817 NCIB3610 ΔyfiJ ΔyfiM lacA::yfiJA152E (mls) This Study 
PDS0818 NCIB3610 ΔyfiJ ΔyfiN lacA::yfiJ+ (mls) This Study 
PDS0819 NCIB3610 ΔyfiJ ΔyfiN lacA::yfiJA152E (mls) This Study 
PDS0838 NCIB3610 amyE::PyfiLMN-RBSspoVG-lacZ (cm)  ΔcomI This Study 
PDS0840 NCIB3610 ΔyfiJ lacA::yfiJ+ (mls) amyE::PyfiLMN-RBSspoVG-lacZ (cm) This Study 
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PDS0841 NCIB3610 ΔyfiJ lacA::yfiJA152E (mls) amyE::PyfiLMN-RBSspoVG-lacZ (cm) This Study 
PDS0842 
NCIB3610 ΔyfiJ ΔyfiLMN lacA::yfiJ+ (mls) amyE::PyfiLMN-RBSspoVG-lacZ (cm) 
(cm) 
This Study 
PDS0843 NCIB3610 ΔyfiJ ΔyfiLMN lacA::yfiJA152E (mls) amyE::PyfiLMN-RBSspoVG-lacZ (cm) This Study 
PDS0909 NCIB3610 ΔyfiJ amyE::PyfiLMN-RBSspoVG-lacZ (cm) This Study 
PDS0910 168 ΔyfiJ lacA::yfiJΔTMD (mls) This Study 
PDS0911 168 ΔyfiJ lacA::yfiJΔTMD, A152E (mls) This Study 
PDS0912 NCIB3610 ΔyfiJ lacA::yfiJΔTMD (mls) amyE::PyfiLMN-RBSspoVG-lacZ (cm) This Study 
PDS0913 NCIB3610 ΔyfiJ lacA::yfiJΔTMD, A152E (mls) amyE::PyfiLMN-RBSspoVG-lacZ (cm) This Study 
PDS0914 NCIB3610 ΔyfiJ ΔkinC lacA::yfiJ+ (mls)  This Study 
PDS0915 NCIB3610 ΔyfiJ ΔkinC lacA::yfiJA152E (mls)  This Study 
PDS0916 NCIB3610 ΔyfiJ ΔkinC This Study 
PDS0917 PY79 amyE::PbceA-RBSspoVG-lacZ (cm) This Study 
PDS0918 NCIB 3610 ΔyfiJ amyE::PbceA-RBSspoVG-lacZ (cm) This Study 
PDS0919 168 ΔyfiJ lacA::yfiJTMD-bceScyto (mls) This Study 
PDS0920 
NCIB3610 ΔyfiJ lacA::yfiJTMD-bceScyto (mls) amyE::PbceA-RBSspoVG-lacZ (cm) 
(cm) 
This Study 
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Table A6. Primers used in Chapter III 
 
Primer Sequence (5′ - 3′) 
Degen3 TAGAGTTATTAATGGAATTGCTGATNNNNNNNNNNN 
oIPCR-1 GCTTGTAAATTCTATCATAATTG 
oIPCR-2 AGGGAATCATTTGAAGGTTGG 
oIPCR-3 GCATTTAATACTAGCGACGCC 
11 AGGCAGCACTTGGTTTTGGT 
26 TCATGAATTCGATGCCAGCCCTTCTCTGAC 
46 GGCCGCCCGCGGTAGGATCCATTGATGCAGGGATCGAGGG 
60 GCATCCAACAGCTTGCGCATGCTCATCACTCCCGATACCC 
62 ATGCGCAAGCTGTTGGATGC 
75 GTAGCGGCAGATAGAACATA 
79 CCCGGGGAGCTCATGAATTCACGACAGGATTATGTACTGACTC 
81 AGCACAGCCAGATTTACCCT 
92 CGCAAGCTGTTGGATGAGCAGGATACGGCAAAAC 
93 GTTTTGCCGTATCCTGCTCATCCAACAGCTTGCG 
153 TATGTTCTATCTGCCGCTACGCAGGCGAGAAAGGAGAG 
154 CGAGGCTCCTGTCACTGC 
155 GCAGTGACAGGAGCCTCGAAAACATCTGCCGTTTAGGC 
173 ATGCAAGCTTTTTTTTGATCCATTGCCATTG 
174 ATGCGAATTCAGAACCCAAGCCGCCATTTA 
175 GGCCGCCCGCGGTAGGATCCATTGATGCAGGGATCGAGGG 
176 GATTAATTTGCCCACGACACC 
177 GTGTCGTGGGCAAATTAATCCGCTATCGGAAAGAAACAGC 
178 CCCGGGGAGCTCATGAATTCTCACACGCTTATGACATGTTC 
180 ATGCGAATTCGAACATGTCATAAGCGTGTG 
181 ATGCAAGCTTTATCGATGCCCTTCAGCACTTCC 
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Table A7. qRT-PCR primers used in Chapter III 
Primer Sequence (5′ - 3′) 
q1: yfiL-F AAGCGTTTCTTGTGGCGATC 
q2: yfiL-R TGATGAGCCGCAGAAATGTC 
q7: des-F TGGTGCAAGGCCCGATATTT 
q8: des-R GCCTGAACGTAGCTCCAGTT 
q11: yvfS-F TTCTGTTCGGCGCAATCATC 
q12: yvfS-R GCGCCAAACAAAATCCACAG 
gyrB-F GAAGGATTGGAAGCTGTTCG 
gyrB-R GCGAGGGCTTCGTCAATACT 
 
Table A8. qRT-PCR primers used in Chapter IV 
 
Primer Sequence (5′ - 3′) 
q21: lnyHA-F GTGCCTTCGTACCCGTCATG 
q22: lnyHA-R TGCGACCAGTTCACCTTCAG 
q23: lnyHI-F CCTCGTCGACATCTACTCGC 
q24: lnyHI-R AGTCGAAGAACTGCTCCTGC 
q27: hrdB-F CTGGCCAAGGAACTCGACAT 
q28: hrdB-R CTGGAGGAGGGTGAAGGAGA 
 
 
